
<html lang="en"     class="pb-page"  data-request-id="72fa5d5f-989d-445e-b3d1-ac807cb85c16"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2011.54.issue-1;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm1011319;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway" /></meta><meta name="dc.Creator" content="Stephanos  Ioannidis" /></meta><meta name="dc.Creator" content="Michelle L.  Lamb" /></meta><meta name="dc.Creator" content="Tao  Wang" /></meta><meta name="dc.Creator" content="Lynsie  Almeida" /></meta><meta name="dc.Creator" content="Michael H.  Block" /></meta><meta name="dc.Creator" content="Audrey M.  Davies" /></meta><meta name="dc.Creator" content="Bo  Peng" /></meta><meta name="dc.Creator" content="Mei  Su" /></meta><meta name="dc.Creator" content="Hai-Jun  Zhang" /></meta><meta name="dc.Creator" content="Ethan  Hoffmann" /></meta><meta name="dc.Creator" content="Caroline  Rivard" /></meta><meta name="dc.Creator" content="Isabelle  Green" /></meta><meta name="dc.Creator" content="Tina  Howard" /></meta><meta name="dc.Creator" content="Hannah  Pollard" /></meta><meta name="dc.Creator" content="Jon  Read" /></meta><meta name="dc.Creator" content="Marat  Alimzhanov" /></meta><meta name="dc.Creator" content="Geraldine  Bebernitz" /></meta><meta name="dc.Creator" content="Kirsten  Bell" /></meta><meta name="dc.Creator" content="Minwei  Ye" /></meta><meta name="dc.Creator" content="Dennis  Huszar" /></meta><meta name="dc.Creator" content="Michael  Zinda" /></meta><meta name="dc.Description" content="The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematological malignancies characterized by clo..." /></meta><meta name="Description" content="The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematological malignancies characterized by clo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 7, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1011319" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1011319" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1011319" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1011319" /></link>
        
    
    

<title>Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1011319" /></meta><meta property="og:title" content="Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0016.jpeg" /></meta><meta property="og:description" content="The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematological malignancies characterized by clonal expansion of one or more myeloid lineages. The discovery of the Jak2 V617F gain of function mutation highlighted Jak2 as a potential therapeutic target in the MPNs. Herein, we disclose the discovery of a series of pyrazol-3-yl pyrimidin-4-amines and the identification of 9e (AZD1480) as a potent Jak2 inhibitor. 9e inhibits signaling and proliferation of Jak2 V617F cell lines in vitro, demonstrates in vivo efficacy in a TEL-Jak2 model, has excellent physical properties and preclinical pharmacokinetics, and is currently being evaluated in Phase I clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1011319"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1011319">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1011319&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1011319&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1011319&amp;href=/doi/10.1021/jm1011319" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 262-276</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101104z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101156y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 5-Chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanos++Ioannidis">Stephanos Ioannidis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+L.++Lamb">Michelle L. Lamb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Wang">Tao Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lynsie++Almeida">Lynsie Almeida</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+H.++Block">Michael H. Block</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Audrey+M.++Davies">Audrey M. Davies</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Peng">Bo Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei++Su">Mei Su</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Jun++Zhang">Hai-Jun Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ethan++Hoffmann">Ethan Hoffmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Rivard">Caroline Rivard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Green">Isabelle Green</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tina++Howard">Tina Howard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hannah++Pollard">Hannah Pollard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon++Read">Jon Read</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marat++Alimzhanov">Marat Alimzhanov</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geraldine++Bebernitz">Geraldine Bebernitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kirsten++Bell">Kirsten Bell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minwei++Ye">Minwei Ye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Huszar">Dennis Huszar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Zinda">Michael Zinda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Cancer Chemistry</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Cancer Bioscience</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Department of Drug Metabolism and Pharmacokinetics</span></div><div class="aff-info" id="affa"><span class="aff-text">AstraZeneca R&D, Boston, Massachusetts, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Discovery Enabling Capabilities and SciencesâCells, Protein & Structural Sciences, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Tel.: (781) 839-4556. Fax: (781) 839-4630. E-mail: <a href="/cdn-cgi/l/email-protection#ddaea9b8adb5bcb3b2aef3b4b2bcb3b3b4b9b4ae9dbcaea9afbca7b8b3b8bebcf3beb2b0"><span class="__cf_email__" data-cfemail="95e6e1f0e5fdf4fbfae6bbfcfaf4fbfbfcf1fce6d5f4e6e1e7f4eff0fbf0f6f4bbf6faf8">[emailÂ protected]</span></a></div><div class="corresp-fn" id="fn1">â¥These authors have contributed equally to the preparation of this manuscript.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1011319&amp;href=/doi/10.1021%2Fjm1011319" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 262â276</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 7, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2010</li><li><span class="item_label"><b>Published</b> online</span>7 December 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 January 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1011319" title="DOI URL">https://doi.org/10.1021/jm1011319</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D262%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStephanos%2BIoannidis%252C%2BMichelle%2BL.%2BLamb%252C%2BTao%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D1%26contentID%3Djm1011319%26title%3DDiscovery%2Bof%2B5-Chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529pyrimidine-2%252C4-diamine%2B%2528AZD1480%2529%2Bas%2Ba%2BNovel%2BInhibitor%2Bof%2Bthe%2BJak%252FStat%2BPathway%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D276%26publicationDate%3DJanuary%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1011319"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6396</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">93</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1011319" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stephanos&quot;,&quot;last_name&quot;:&quot;Ioannidis&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;L. Lamb&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Lynsie&quot;,&quot;last_name&quot;:&quot;Almeida&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;H. Block&quot;},{&quot;first_name&quot;:&quot;Audrey&quot;,&quot;last_name&quot;:&quot;M. Davies&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Mei&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Hai-Jun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ethan&quot;,&quot;last_name&quot;:&quot;Hoffmann&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Rivard&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Green&quot;},{&quot;first_name&quot;:&quot;Tina&quot;,&quot;last_name&quot;:&quot;Howard&quot;},{&quot;first_name&quot;:&quot;Hannah&quot;,&quot;last_name&quot;:&quot;Pollard&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;Read&quot;},{&quot;first_name&quot;:&quot;Marat&quot;,&quot;last_name&quot;:&quot;Alimzhanov&quot;},{&quot;first_name&quot;:&quot;Geraldine&quot;,&quot;last_name&quot;:&quot;Bebernitz&quot;},{&quot;first_name&quot;:&quot;Kirsten&quot;,&quot;last_name&quot;:&quot;Bell&quot;},{&quot;first_name&quot;:&quot;Minwei&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Huszar&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Zinda&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;262-276&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1011319&quot;},&quot;abstract&quot;:&quot;The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematological malignancies characterized by clonal expansion of one or more myeloid lineages. The discovery of the Jak2 V617F gain of function mutation highlighted Jak2 as a potential therapeutic target in the MPNs. Herein, we disclose the discovery of a series of pyrazol-3-yl pyrimidin-4-amines and the identification of 9e (AZD1480) as a potent Jak2 inhibitor. 9e inhibits signaling and proliferation of Jak2 V617F cell lines in vitro, demonstrates in vivo efficacy in a TEL-Jak2 model, has excellent physical properties and preclinical pharmacokinetics, and is currently being evaluated in Phase I clinical trials.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1011319&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1011319" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1011319&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1011319" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1011319&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1011319" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1011319&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1011319&amp;href=/doi/10.1021/jm1011319" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1011319" /></input><a href="/doi/pdf/10.1021/jm1011319" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1011319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1011319%26sid%3Dliteratum%253Aachs%26pmid%3D21138246%26genre%3Darticle%26aulast%3DIoannidis%26date%3D2011%26atitle%3DDiscovery%2Bof%2B5-Chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529pyrimidine-2%252C4-diamine%2B%2528AZD1480%2529%2Bas%2Ba%2BNovel%2BInhibitor%2Bof%2Bthe%2BJak%252FStat%2BPathway%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D1%26spage%3D262%26epage%3D276%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jmcmar.2011.54.issue-1/production/jmcmar.2011.54.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematological malignancies characterized by clonal expansion of one or more myeloid lineages. The discovery of the Jak2 V617F gain of function mutation highlighted Jak2 as a potential therapeutic target in the MPNs. Herein, we disclose the discovery of a series of pyrazol-3-yl pyrimidin-4-amines and the identification of <b>9e</b> (AZD1480) as a potent Jak2 inhibitor. <b>9e</b> inhibits signaling and proliferation of Jak2 V617F cell lines <i>in vitro,</i> demonstrates <i>in vivo</i> efficacy in a TEL-Jak2 model, has excellent physical properties and preclinical pharmacokinetics, and is currently being evaluated in Phase I clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Jak (Janus-associated kinase) family consists of four nonreceptor tyrosine kinases, Tyk2<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: CDK2, cyclin-dependent kinase 2; DIAD, diisopropylazodicarboxylate; DIPEA, diisopropylethyl amine; DMA, dimethylacetamide; dppf, 1,1â²-bis(diphenylphosphino)ferrocene; D5W, 5% dextrose (w/v) in water; ET, essential thrombocythemia; HPMC, hydroxypropylmethylcellulose; Jak2, Janus kinase 2; Jak1, Janus kinase 1; Jak3, Janus kinase 3; MF, idiopathic myelofibrosis; mpk, mg/kg; MPNs, myeloproliferative neoplasms; PEG, polyethylene glycol; PV, polycythemia vera; Stat, signal transducers and activators of transcription; pStat, phosphorylated signal transducers and activators of transcription; tStat, total signal transducers and activators of transcription; Tyk2, tyrosine kinase 2.</p></div>, Jak1, Jak2, and Jak3, which play a critical role in cytokine and growth factor mediated signal transduction.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The cytosolic receptor-associated Jaks are activated by cytokine or growth factor engagement, resulting in downstream activation of associated signaling pathways, chief among which are the Stat family of transcription factors, comprising Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b, and Stat6. Pharmacological inhibition of Jak2 became an intense focus for small molecule drug discovery efforts after the discovery of a single activating somatic mutation in the pseudokinase (Janus Homology 2, JH2) domain of Jak2 in the myeloproliferative neoplasms (MPNs).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a> The MPNs, primarily comprising essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), are a heterogeneous but related group of hematological malignancies characterized by clonal expansion of one or more myeloid lineages. Among these, MF represents the greatest unmet medical need and has been the starting point for clinical trials of Jak2 inhibitors. Typical clinical features of MF include marked symptomatic splenomegaly, progressive anemia, and constitutional symptoms including weight loss, fever, and night sweats. Morbidity and mortality commonly occur as a result of infection, thrombohemorrhagic events, portal hypertension, organ failure, and leukemic transformation. INCB018424 (<b>1</b>),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> TG101348 (<b>2</b>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> CYT387 (<b>3</b>),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and CEP-701 (<b>4</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> are among the Jak inhibitors that are being evaluated in man (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Collectively, they have shown dramatic reversal of splenomegaly and alleviation of constitutional symptoms, but evidence for significant impact on the natural course of the disease has been lacking.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Jak inhibitors in the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Herein, we describe the discovery of a series of pyrazol-3-yl pyrimidin-4-amines as Jak2 inhibitors and structureâactivity relationships of this series at R<sub>1</sub>, R<sub>3</sub>, and X (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The detailed biological and pharmacokinetic evaluation of our lead compounds will also be described. This work culminated in the discovery and evaluation of <b>9e</b> as a potent and selective ATP-competitive Jak2 inhibitor that is currently in phase I clinical trials.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pyrazol-3-yl pyrimidin-4-amines as Jak2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic route for the preparation of 2,4-diamino substituted pyrimidines is illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Aminopyrazoles <b>6a</b>â<b>d</b> were attached regioselectively to the 4-position of the pyrimidine ring upon treatment of an alcoholic solution of 2,4-dichloropyrimidines <b>5a</b>â<b>c</b> with base at ambient temperature. The desired 2-chloro-<i>N</i>-(1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine intermediates <b>7</b> were isolated in almost quantitative yield after simple extraction of the reaction mixture. The preparation of the intermediate 2-chloro-5-methyl-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (X = Me, <b>7f</b>) required heating of the ethanolic solution at reflux, presumably due to the reduced electrophilicity of 2,4-dichloro-5-methylpyrimidine <b>5d</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of 2,4-Diamino Substituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) For <b>5a</b>, X = Cl; <b>5b</b>, X = F; <b>5c</b>, X = Br, Et<sub>3</sub>N, EtOH, 0 Â°Câ25 Â°C; for <b>5d</b>, X = Me, Et<sub>3</sub>N, EtOH, 60 Â°C. (b) For <b>9a</b>, DIPEA, <i>n</i>-BuOH, 110 Â°C; <b>9b</b>â<b>f</b>, DIPEA, <i>n</i>-BuOH, 120 Â°C microwave; <b>9i</b>â<b>l</b>: DIPEA, <i>n</i>-BuOH, 165 Â°C, microwave.</p></p></figure><div class="NLM_p">Finally, reaction of (<i>S</i>)-5-fluoropyrimidin-2-yl-ethanamine hydrochloride<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (<i>S</i>)<b>-8</b> with 4-substituted-2-chloropyrimidines <b>7a</b>â<b>f</b> and <b>7i</b>â<b>l</b> under forcing conditions in the presence of DIPEA afforded the desired 2,4-disubstituted pyrimidines <b>9a</b>â<b>f</b> and <b>9i</b>â<b>l</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Racemic 1-(5-Fluoropyrimidin-2-yl)ethanol <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, Zn(CN)<sub>2</sub>/Zn, dppf; (b) MeMgBr, THF, 0 Â°C; (c) NaBH<sub>4</sub>, MeOH, 0 Â°C.</p></p></figure><div class="NLM_p">The synthesis of the heteroaromatic alcohol <b>12</b> is illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Palladium-catalyzed cyanation of the commercially available 2-chloro-5-fluoropyrimidine proceeded smoothly to afford the corresponding 5-fluoropyrimidine-2-carbonitrile <b>10</b>. The synthetic route was completed by Grignard addition of methylmagnesium bromide to the nitrile followed by reduction of the intermediate ketone <b>11</b> to yield the desired alcohol <b>12</b> in almost quantitative yield.</div><div class="NLM_p">Heating a solution of <b>12</b> with 2,5-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>) in presence of NaO<sup><i>t</i></sup>Bu overnight yielded the desired oxygen-substituted pyrimidines <b>9g</b> and <b>9h</b> as a mixture of enantiomers, which was readily separable by chiral purification (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>; see <a class="ref internalNav" href="#notes-1" aria-label="Figure S1">Figure S1</a> for chiral purification information).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 2-Alkoxy Pyrimidin-4-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaO<sup><i>t</i></sup>Bu, <i>t</i>-BuOH, 90 Â°C; then chiral purification.</p></p></figure><div class="NLM_p">In the case of 2,4,6-trisubstituted pyrimidines, the desired analogues were generated by first exposing the 2,4,6-trichloropyrimidines to an ethanolic solution of the pyrazol-4-yl amines <b>6a</b> and <b>6c</b> in the presence of base (e.g., DIPEA) followed by nucleophilic aromatic substitution at the C-2 position of the pyrimidine core with (<i>S</i>)<i>-</i><b>8</b>. The regioselectivity of the latter aromatic substitution was influenced by the C-5 substituent of the pyrimidine B-ring (for definition, see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The absence of substituent (X = H) at C-5 usually led to the exclusive formation of the desired regio-isomer, while the presence of a chloro (X = Cl) substituent typically gave a mixture (3:1 to 2:1 ratio) in favor of the desired (<i>S</i>)-5,6-dichloro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-<i>N</i><sup>4</sup>-(1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine intermediates <b>15</b>. Exposure of the C-5 hydrogen- and chloro-substituted 6-chloro-<i>N</i><sup>4</sup>-(1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine intermediates (<b>15a</b>,<b>c</b>,<b>d</b>,<b>f</b>) to morpholine furnished the target molecules <b>16a</b>,<b>c</b>,<b>d</b>,<b>f</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). However, when the C-5 substituent was fluorine, reaction with (<i>S</i>)-<b>8</b> favored the C-6 regio-isomer. Although the two corresponding regio-isomers could be readily separated by flash column chromatography, the overall yield of the desired regio-isomer was poor. An alternative route (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) was therefore pursued where reaction of <b>14b</b> and <b>14e</b> with morpholine proceeded smoothly to afford the intermediates <b>17a</b> and <b>17b</b>, respectively. Microwave irradiation of <b>17a</b>,<b>b</b> in the presence of the chiral (<i>S</i>)-<b>8</b> amine hydrochloride gave <b>16b</b> and <b>16e</b> in good yield (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). While the reaction with morpholine again resulted in a mixture of C-4 and C-6 substituted intermediates, the use of morpholine conserved the precious chiral amine. Trichloropyrimidines <b>13a</b> and <b>13c</b> are commercially available, while <b>13b</b> was prepared according to previously reported procedures.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 2,4,6-Trisubstituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6a</b> or <b>6c</b>, Et<sub>3</sub>N, EtOH, 0 Â°Câ 25 Â°C; (b) (<i>S</i>)-<b>8</b> hydrochloride, DIPEA, EtOH, 70 Â°C; (c) DIPEA, <i>n</i>-BuOH, 120 Â°C, microwave.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetically Preferred Route for 5-Fluoro-2,4,6-Trisubstituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Morpholine, DIPEA, <i>n</i>-BuOH, 80 Â°C; (b) (<i>S</i>)-<b>8</b> hydrochloride, DIPEA, <i>n</i>-BuOH, 190 Â°C, microwave.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Pyrazoles <b>6c</b> and <b>6d<sup>a</sup></b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, DIAD, PPh<sub>3</sub>, DCM, 0 Â°C; (b) CH<sub>3</sub>CN, <i>n</i>-BuLi, â78 Â°Câ25 Â°C, then MeI, 0 Â°C; (c) H<sub>2</sub>NNH<sub>2</sub>, EtOH, 85 Â°C.</p></p></figure><div class="NLM_p last">As depicted in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, the methoxy aminopyrazole <b>6c</b> could be readily synthesized from the commercially available 3-amino-5-hydroxypyrazole via Mitsunobu reaction.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The synthesis of dimethylamino-substituted aminopyrazole <b>6d</b> was carried out starting from methyl dimethyldithiocarbamate <b>18</b>. The thiocarbamate was accessible after treatment of carbon disulfide with dimethylamine under aqueous basic conditions (aq. NaOH). Reaction of the lithium anion of acetonitrile (prepared by exposure of the latter to <i>n</i>-BuLi) with <b>18</b> followed by quenching of the intermediate thiol with MeI furnished 3-(dimethylamino)-3-(methylthio)acrylonitrile <b>19</b> as a mixture of geometric isomers (<i>E</i> and <i>Z</i>). Subsequent formation of the pyrazole ring <b>6d</b> was accomplished in moderate yield on treatment of the diastereomeric mixture of <b>19</b> with hydrazine.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SAR Development</h3><div class="NLM_p">It was our hope that modifying the size of the R<sub>1</sub> substituent would have an influence on modulating inhibitory activity against Jak2 because of the proximity to the relatively large, aliphatic side chain of the methionine gatekeeper residue. In order to test this hypothesis, several R<sub>1</sub> substituents were examined (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Comparing the Jak2 enzymatic inhibition of the closely related analogues <b>9a</b>, <b>9b</b>, <b>9e</b>, and <b>9k</b> at K<i>m</i> ATP was inconclusive and failed to discriminate among the methoxy <b>9a</b>, cyclopropyl <b>9b</b>, and methyl <b>9e</b> analogues.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The cyclopropyl and methyl analogues gave IC<sub>50</sub> values below the detection limit of the assay, with the methoxy-substituted analogue estimated to be slightly less active. The dimethylamine substituent in <b>9k</b> was less well tolerated; however, the compound was still a single-digit nanomolar inhibitor. Likewise, the enzymatic data of close analogues <b>9c</b>, <b>9d</b>, and <b>9l</b> (X = F) as well as of <b>9i</b> with <b>9j</b> (X = Br) prevented us from establishing the preferred substituent at R<sub>1</sub>. Thus, to better differentiate the activity of these analogues against Jak2, testing at a higher concentration of ATP (5 mM) was utilized.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> We presumed that using this concentration, which is at the high end of ATP concentration in the cell, as opposed to K<i>m</i>, would allow us to more accurately discriminate among potent closely related analogues. It was also expected that the Jak2 high ATP data would more effectively predict the potential cellular activity. Hence, the observed data in our primary cellular assay employing TEL-Jak2 in Ba/F3 cells<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> should correlate well with the corresponding enzyme data at high ATP. From Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, it can be seen that indeed, in this particular series, potent activity at high ATP did translate into cellular potency. In addition, by considering both the Jak2 high ATP and TEL-Jak2 data we were able to determine that the methyl group was preferred for interaction with the Jak2 gatekeeper residue.</div><div class="NLM_p">Our strategy in the development of Jak2 inhibitors has been to build in selectivity against Jak3, in order to avoid the immunosuppression associated with Jak3 deficiency. Hence, a Jak3 high ATP (5 mM) enzyme assay was introduced in order to better evaluate selectivity in the series, by comparison to Jak2 high ATP assay.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, a significant level of selectivity against Jak3 was observed in the series. This has been attributed to the 5-fluoro substituent on the pyrimidine C-ring and its unfavorable interaction with the Jak3 binding site (vide infra). Interestingly, the methoxy (<b>9a</b> and <b>9i</b>) and dimethylamine (<b>9k</b> and <b>9l</b>) substituted compounds may show improved selectivity against Jak3, although possibly at the expense of Jak2 activity. The methyl group seems to achieve the optimum balance between Jak2 activity and selectivity versus Jak3, at both the biochemical and cellular levels.</div><div class="NLM_p">Further exploration of structureâactivity relationships involved variations of the C-5 substituent X of the central pyrimidine ring (B-ring), as depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. From the biochemical data, Me, Br, F, and Cl substituents at this position are all tolerated. In this instance, the high ATP Jak2 data were not able to distinguish among molecules due to their high potency, and prioritization could only be accomplished after using data from the TEL-Jak2 cellular assay. Compounds <b>9c</b>, <b>9e</b>, <b>9f</b>, and <b>9j</b> demonstrated a combination of favorable enzymatic and cellular activities together with selectivity over Jak3, however without preference for any substituent with respect to this selectivity. The former progressed through our cascade, while the bromo analogue (X = Br) <b>9j</b> was not profiled further due its increased lipophilicity (data not shown) over the fluoro (<b>9c</b>, X = F), chloro (<b>9e</b>, X = Cl), and methyl (<b>9f</b>, X = Me) analogues.</div><div class="NLM_p">It is noteworthy that, although switching the nitrogen linker (Y) between B-ring and C-ring from NH to O resulted in a potent Jak2 inhibitor <b>9g</b> at the biochemical level, this enzymatic activity did not secure the desired level of activity in the TEL-Jak2 cellular assay.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition, based upon examples such as <b>9g</b> and <b>9h</b>, it became apparent that the stereochemistry at the benzylic center was crucial for activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Data of Pyrazol-3-yl pyrimidin-4-amine Analogues <b>9a</b>â<b>l</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0014.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpds</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char=".">Jak2 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Jak2 (High ATP) IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Jak3 (High ATP) IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">TEL-Jak2 GI<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.108</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">Cyclo-Pr</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">Cyclo-Pr</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.058<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">1.36<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">8.35</td><td class="colsep0 rowsep0" align="char" char=".">0.096</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">12.73</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">0.346</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.108</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">4.59</td><td class="colsep0 rowsep0" align="char" char=".">0.089</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9k</b></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.488</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9l</b></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.815</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Measured at K<sub><i>m</i></sub> ATP; for experimental details, see ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">All values are an average of at least two independent doseâresponse curves.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">For experimental details, see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">For experimental details, see ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Denotes not tested.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">These data were generated according to the procedure reported in ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>. When tested in the assay reported in ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>, Jak2 IC<sub>50</sub> = 0.008 Î¼M, Jak3 IC<sub>50</sub> = 3.63 Î¼M.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Introduction of Substituents at the C-6 Position of Pyrimidine B-Ring Oriented toward the Solvent Channel</h3><div class="NLM_p">Cognizant of the potential for improvement of Jak2 activity and modulation of the overall properties by substitution at the C-6 position of the pyrimidine B-ring, due to the potential access to the solvent channel,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we elected to explore analogues <b>16a</b>â<b>c</b>. Incorporation of a C-6 morpholine moiety resulted in further improvements in cellular potency as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_p">We then sought to reevaluate the effects of having an OMe group at the R<sub>1</sub> position for analogues with morpholine occupying the solvent channel. We wanted to explore the combination of the C-6 morpholine with the 5-methoxy pyrazol-3-amine, potentially providing compounds with improved cellular potency compared to the des-morpholino analogues <b>9a</b> and <b>9i</b>. This hypothesis was less than fruitful, and the cellular activity of <b>16d</b>â<b>f</b> was much lower than the activity of the corresponding methyl analogues. It seems that, in this particular case, the methoxy substituent may be bulky enough to lead to a steric clash with the thiomethyl side-chain of the methionine gatekeeper of Jak2 kinase resulting in less than optimum potency in comparison to the C-5 methyl matched pairs. Again, the Jak3 potency seemed to be controlled by the B-ring C-5 substituent, as indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and not greatly influenced by the nature of the R<sub>1</sub> substituent. The absence of C-5 substituent (X = H) tends to shift the Jak3 activity into the nanomolar range, indicating that achievement of decent selectivity between Jak2 and Jak3 requires such substitution.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical and Cellular Data of (<i>S</i>)-<i>N</i><sup>2</sup>-(1-(5-Fluoropyrimidin-2-yl)ethyl)-6-morpholino-<i>N</i><sup>4</sup>-(1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine Analogues <b>16a</b>â<b>f</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0015.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">Jak2 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Jak2 (High ATP) IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Jak3 (High ATP) IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">TEL-Jak2 GI<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16d</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">0.073</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16e</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">30.5</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16f</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.090</td><td class="colsep0 rowsep0" align="char" char=".">2.96</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All values are an average of at least two independent doseâresponse curves.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetic Properties of Lead Compounds</h3><div class="NLM_p">Having identified leads showing excellent in vitro Jak2 inhibitory activity, we carried out an evaluation of the pharmacokinetic (PK) properties of these compounds in rats. Prior to in vivo profiling, the metabolic stability of the leads in rat liver  microsomes was determined (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). From these data, it was predicted that the compounds would exhibit reasonable metabolic stability in vivo, and indeed, analogues <b>9c</b>, <b>9e</b>, <b>9f</b>, and <b>16a</b>,<b>b</b> showed low clearance when dosed intravenously (i.v.) in rats. Surprisingly, the chloro analogue <b>16c</b> was found to be highly cleared and exhibited a higher volume of distribution than the close analogues <b>16a</b> and <b>16b</b>. The basis of this difference is unclear, but the involvement of an alternative metabolic clearance pathway is a possibility. Compound <b>9e</b> also exhibited the longest half-life when administered i.v. in rat, while <b>9f</b> and <b>16b</b> displayed reasonably good half-lives (â¼2 h) and the other three analogues displayed a shorter half-life (â¤1 h). All compounds demonstrated good solubility at physiological pH (>460 Î¼M) and low lipophilicity as assessed by log<i>D</i><sub>7.4</sub> measurements (<2.60).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Rat Microsomal Stability<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> and PK Properties<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> of Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> Î¼L/min/mg</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>%</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>obs</sub> mL/min/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="char" char=".">NT</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">221</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">For experimental details, see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Han Wistar rat male; 10 mg/kg p.o. (0.1% HPMC); 3 mg/kg i.v. (40% DMA/40% PEG/20% saline).</p></div></div></div><div class="NLM_p">Due to its excellent PK profile in rats together with the good cellular activity and enzymatic selectivity versus Jak3, we decided to progress <b>9e</b> into further in vivo studies and were gratified to observe an excellent PK profile in both mouse and dog (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The long half-life observed in dog and the excellent oral bioavailability in both species suggested possible full absorption and minimal first-pass metabolism following oral administration in both preclinical species.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mouse<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> and Dog<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> Pharmacokinetic Profile of <b>9e</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>obs</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (hours)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">57.6<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">350<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">CD-1 mice female; 10 mg/kg p.o. (0.1% HPMC); 3 mg/kg i.v. (40% DMA/40% PEG/20% saline).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Beagle dog male; 10 mg/kg p.o. (0.1% HPMC, pH 2); 2.5 mg/kg i.v. (20% TEG/D5W).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">AUC<sub>0â12 h</sub>.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">AUC<sub>0â24 h</sub>.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biological and Pharmacokinetic Evaluation of (<i>R</i>)-Enantiomer <b>21</b></h3><div class="NLM_p">To ensure that the (<i>S</i>)-stereochemistry in <b>9e</b> resulted in improved biological activity, the synthesis of (<i>R</i>)-enantiomer <b>21</b> was initiated (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Commencing from the previously reported alcohol <b>12</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> formation of the desired racemic benzylic-like azide proceeded via conversion of the alcohol into the corresponding methanesulfonate and subsequent displacement with sodium azide. The azide was converted to the target amine (<i>rac</i>)-<b>8</b> via hydrogenation under standard conditions. The racemic material <b>20</b> was readily prepared upon heating 2,5-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>) with (<i>rac</i>)<b>-8</b> in a microwave. The two antipodes, <b>9e</b> and <b>21</b>, were readily separable by chiral purification (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information ">Supporting Information </a>Figure S3).</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation (<i>rac</i>)-<b>8</b> and <b>21<sup>a</sup></b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i. MsCl, Et<sub>3</sub>N, DCM, 0 Â°C; ii. NaN<sub>3</sub>, DMF; (b) H<sub>2</sub>, Pd/C, 25 Â°C; (c) DIPEA, <i>n</i>-BuOH, 120 Â°C, microwave.</p></p></figure><div class="NLM_p">Screening <b>21</b> in our biochemical and cellular assays indicated that stereochemistry has an effect on activity, as discussed above for <b>9g</b> and <b>9h</b>. Examining the PK properties of <b>21</b> in rat showed that there are differences between the enantiomers in the overall profile, particularly increased clearance and shorter half-life (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biological and Pharmacokinetic Evaluation<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> of <b>21</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Jak2 Î¼M (K<i>m</i> ATP)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">TEL-Jak2 Î¼M<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (hours)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0â24 h</sub> (Î¼MÂ·h) p.o.</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">0.031</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">3.0</td><td class="colsep0 rowsep0" align="center">33.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Han Wistar rat male; 10 mg/kg p.o. (0.1% HPMC); 3 mg/kg i.v. (40% DMA/40% PEG/20% saline).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Average of at least two independent doseâresponse curves.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Crystal Structure of <b>9e</b> with the Kinase Domain of JAK2</h3><div class="NLM_p">The interaction of <b>9e</b> within the adenine binding site was confirmed by an X-ray structure with a Jak2 construct containing the JH1 (ATP-binding) domain. It was necessary to carry out isolation, purification, and crystallization of this construct in the presence of staurosporine. Subsequent displacement of staurosporine with the more potent <b>9e</b> afforded suitable crystals for X-ray analysis. As indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the pyrazole interacts with the hinge via a donorâacceptorâdonor hydrogen-bonding motif with the protein backbone atoms of leucine (L932) and glutamate (E930). The methyl group of the pyrazole is 3.6 Ã from the terminal carbon of methionine 929, which explains the observed preference for methyl rather than larger substituents at this position.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0019.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure (pdb:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XA4">2XA4</a>) of compound <b>9e</b> bound to Jak2 kinase. Carbon atoms for <b>9e</b> are shown in green. The protein backbone cartoon is represented in white. Selected atoms for the hinge region (on the left) from gatekeeper M929 to L932 as well as G993 (at the top) are represented as sticks. Refined electron density (2f<sub>o</sub>f<sub>c</sub>) contoured at 1.0 Ï for the inhibitor is represented as wire mesh. The glycine-rich loop has been removed for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Placement of the methyl at the chiral center of <b>9e</b> near the aliphatic side chain of valine 863 and glycine 856 in the P-loop (glycine-rich loop, not shown) contributes to the preference for (<i>S</i>)-Me over the <i>R</i>-enantiomer. The fluoropyrimidine ring occupies the hydrophobic pocket above L983 as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, and the fluoro substituent is well-accommodated due to the presence of a glycine residue (G993) in Jak2 just prior to the activation loop âDFG-motifâ. Interestingly, the difference of the amino acid backbone between Jak2 and Jak3<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (alanine, A966) at this position may be a factor in the selectivity against Jak3 observed in this series (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). It is likely that a steric clash between the fluoro substituent and the methyl side chain of alanine in Jak3 would result in tilting of the ring away from its optimal interaction within the ATP-binding site, hence the observed selectivity.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0020.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Contribution of G993/A966 residue to the observed selectivity of <b>9e</b> for Jak2 versus Jak3. Protein backbone atoms of 2XA4 (white) and 1YVJ (wheat) overlaid and represented as cartoon. Hydrogen bonds between compound <b>9e</b> and the protein are shown in yellow. Selected residues from the two structures have been represented as sticks and labeled with Jak2/Jak3 residue names and numbers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Kinase Selectivity</h3><div class="NLM_p">Evaluation of <b>9e</b> against a Millipore kinase panel, of 82 different kinases, has been previously reported and demonstrated Jak2 kinase activity inhibition with an IC<sub>50</sub> of <0.003 Î¼M (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Kinase Profiling of <b>9e<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center" char=".">enzyme fold selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Jak2</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TrkA</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora-A</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-4</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ARK5</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK3</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FAK</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Axl</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK4</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ret</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt3</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LKB1</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Jak2 inhibitory activity was measured to be <0.003 Î¼M, while for TrkA, inhibitory activity was measured to be 0.003 Î¼M. The numbers given for enzyme fold selectivity correspond to the minimum possible selectivity.</p></div></div></div><div class="NLM_p">In cells, induction of mitotic block was assessed as a phenotypic end point of Aurora A inhibition.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Changes in the G2/M phase population of the cell cycle were only observed following treatment of SW620 colorectal adenocarcinoma cells with 3.3 Î¼M of <b>9e</b> for 24 h (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S2). Thus, <b>9e</b> demonstrated significant cellular selectivity for Jak2 versus the antiproliferative activity of Aurora A/B inhibition.</div><div class="NLM_p last">Likewise, the concentration-dependent autophosphorylation of TrkA in the MCF10A-Î cell line<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was evaluated upon treatment with <b>9e</b> and showed >12-fold selectivity for Jak2 against TrkA in the cellular context.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cellular Profiling</h3><div class="NLM_p">As previously described,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>9e</b> potently inhibits the growth of the Ba/F3 TEL-Jak2 cell line in an MTS tetrazolium colorimetric assay, with a GI<sub>50</sub> of 0.06 Î¼M. This antiproliferative activity has been shown to be tightly correlated with the inhibition of Stat5 phosphorylation (pStat5) in Ba/F3 TEL-Jak2 cells (IC<sub>50</sub> of 0.046 Î¼M). We have also shown that <b>9e</b> exhibits significant selectivity against Jak3 and Tyk2, and to a smaller extent against Jak1, when tested in Ba/F3 cells transfected with the kinase domains of these JAK family members (Jak1, Jak3, and Tyk2) fused to the TEL domain, as demonstrated by growth inhibition data (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To establish the potential of <b>9e</b> to have an effect in a more clinically relevant setting, its effect on human hematopoietic cell lines identified to carry the Jak2 V617F mutation was examined.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Thus, testing in the SET-2 cell-line (a human megakaryoblastic cell line derived from an ET patient heterozygous for V617F), UKE-1 (homozygous for V617F), and HEL (homozygous and amplified copies of V617F) revealed significant growth inhibition of these lines as shown by the GI<sub>50</sub> data given in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibition of Janus Kinase Family Members Driven Cellular Proliferation in Engineered Ba/F3 Cell Lines and Cell Lines Carrying the Clinically Relevant V617F Mutation by <b>9e</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> Î¼M</th><th class="colsep0 rowsep0" align="center" char=".">fold selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ba/F3 TEL-Jak2</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ba/F3 TEL-Jak3</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ba/F3 TEL-Jak1</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ba/F3 TEL-Tyk2</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SET-2 (V617F)</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UKE-1 (V617F)</td><td class="colsep0 rowsep0" align="char" char=".">0.054</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HEL</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr></tbody></table></div></div><div class="NLM_p">Further studies in the SET-2 cell line showed that both Stat5 and Stat3 phosphorylation was inhibited (IC<sub>50</sub>: 0.025 Î¼M and 0.023 Î¼M, respectively) upon treatment with <b>9e</b>, indicating that the SET-2 GI<sub>50</sub> correlates closely with pStat inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0001.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) and pStat3 (phosphorylated Stat3) <b>9e</b> and total proteins (tStat5 and tStat3) in SET-2 human megakaryoblastic cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western Blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a similar manner, the effect of <b>9e</b> on Stat5 phosphorylation in UKE-1 cells was examined and the IC<sub>50</sub> again found to be in close correlation with the observed GI<sub>50</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0002.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) by <b>9e</b> and total proteins (tStat5) in UKE-1 (homozygous for V617F) human hematopoietic cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western Blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast, in the HEL (human erythroleukemia) cell line <b>9e</b> inhibits Stat5 phosphorylation with an IC<sub>50</sub> of 0.041 Î¼M and Stat3 phosphorylation with an IC<sub>50</sub> of 0.08 Î¼M (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The discordance between pStat IC<sub>50</sub> values (0.041â0.08 Î¼M) and the GI<sub>50</sub> value (0.39 Î¼M) may result at least in part from amplification of the Jak2 locus in this cell line, as well as secondary changes associated with leukemic transformation.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0003.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) and pStat3 by <b>9e</b> and total proteins (tStat5 and tStat3) in HEL (human erythroleukemia ) cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, duration of exposure experiments in HEL cells demonstrated onset of inhibition of Stat3 and Stat5 phosphorylation within 5 min of treatment with 0.3 Î¼M of <b>9e</b> and maximal inhibition of phosphorylation within 30â60 min of drug treatment. Recovery of phosphorylation was also rapid and was complete within 10â15 min after drug removal for both Stats (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0004.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Kinetic response of pStat3 and pStat5 to the addition of 0.3 Î¼M of <b>9e</b>. Reduction of the pStat5 levels was apparent at 15 min, and complete inhibition was observed at 60 min upon addition of <b>9e</b>. pStat3 expression could be partially inhibited after 60 min incubation with <b>9e</b>, while p-Jak2 signaling did not change upon addition of <b>9e</b>. (B) Both pStat5 and pStat3 signaling recovered 5 min after washout of <b>9e</b>. p-Jak2 denotes phosphorylated Jak2 and UT denotes untreated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <b>9e</b> Demonstrates a Clear Pharmacodynamic (PD) Effect in Mouse Allograft Model</h3><div class="NLM_p">As a biomarker of Jak2 inhibition in vivo, we measured pStat5 levels in splenic tissue from mice implanted with murine Ba/F3 TEL-Jak2 cells (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S4). Single doses of <b>9e</b> at 5â30 mg/kg were given by oral gavage and individual mice sacrificed at different time points post-dose. Almost complete inhibition of Stat5 phosphorylation was observed for at least 12 h following a single 30 mg/kg dose of <b>9e</b> as determined by quantification of pStat5 levels in spleen lysates by Western blot. At the 10 mg/kg dose, pStat5 was inhibited by >70% for at least 8 h but was largely recovered by 12 h. At the 5 mg/kg dose level, about 90% inhibition of pStat5 was observed at 2 h post-dose, but only approximately 50% inhibition was maintained at 6 h (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Thus, dose-dependent duration of pStat5 inhibition was observed with <b>9e</b> in the in vivo model.</div><figure id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0005.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Dose-dependent modulation of pStat5 levels in splenic tissue after a single dose of <b>9e</b> in a Ba/F3 TEL-Jak2 mouse model. The bars represent the mean percentage (%) inhibition in phosphorylation of Stat5 (Â±SD, <i>n</i> = 3 for each dose and each time point) and are calculated using vehicle (V, veh) and control inhibitor for establishing maximum and minimum values. The Western blots and quantitation described with the Ba/F3 engineered cells were performed as previously described.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <b>9e</b> Shows Tumor Growth Inhibition in the Mouse Ba/F3 TEL-Jak2 Allograft Efficacy Model</h3><div class="NLM_p">Ba/F3 TEL-Jak2 cells were genetically modified to express the firefly luciferase gene (<i>luc</i>), so that tumor cell growth could be readily monitored and quantified in vivo by bioluminescent imaging (BLI) using a Xenogen IVIS imaging system.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Nude mice were implanted with the Ba/F3 TEL-Jak2-<i>luc</i> cells and randomized into treatment groups one day later based on BLI. <b>9e</b> was given orally at 30 or 50 mg/kg twice daily, starting on day 3 after tumor cell implantation. In the vehicle-treated mice, the intensity of bioluminescent signal increased exponentially during the first 7 days, in agreement with rapid proliferation of the tumor cells in vivo (data not shown). In contrast, we observed a significant dose-dependent inhibition of tumor cell growth in <b>9e</b>-treated animals as indicated by a relative reduction in light emission compared to the vehicle-treated mice (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>A). On day 9, there was a 44-fold reduction in bioluminescent signal intensity in the 50 mg/kg dose group and approximately 9-fold reduction in the 30 mg/kg dose group compared to the control animals (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>B).</div><figure id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0006.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effect of <b>9e</b> treatment on Ba/F3 TEL-Jak2âluc cell growth in vivo. (A) Groups of animals were treated with either vehicle (<i>n</i> = 8) or <b>9e</b> at 30 mg/kg twice daily (<i>n</i> = 5) or <b>9e</b> at 50 mg/kg twice daily (<i>n</i> = 5) starting on day 3 post-tumor cell implantation. Pseudocolor images representing luciferase-emitted light intensity superimposed over photographs of the tumor-bearing mice from each treatment group. The images were acquired on day 9 post-tumor cell implantation. The color scheme for the luminescence intensity is shown by the color bar. (B) Total bioluminescent signal intensity over each mouse body was determined on days 4, 7, and 9 and averaged per time point and treatment group. Means Â± SE were plotted using GraphPad <i>Prism 4 </i>software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have described the discovery of a series of pyrazol-3-yl pyrimidin-4-amines as potent inhibitors of the Jak/Stat pathway. Screening in biochemical and cellular assays allowed us to select <b>9e</b> (AZD1480) for extensive preclinical evaluation. This compound showed good selectivity for Jak2 and Jak1 within the Jak family and across many other tested kinases. <b>9e</b> suppressed activation of the Jak2/Stat pathway in low nanomolar concentrations in hematopoietic lineages carrying the V617F mutation. The excellent pharmacokinetic properties of this compound prompted us to explore the pharmacodynamic effect in a TEL-Jak2 model in a dose-dependent manner. No significant weight loss or other adverse effects were observed upon dosing, and a single dose of 30 mg/kg was sufficient to prevent phosphorylation of Stat5 for over 12 h. An efficacy study with TEL-Jak2 luciferase cells demonstrated dose-dependent tumor growth inhibition at well-tolerated doses. The attractive preclinical profile of <b>9e</b> resulted in progression to clinical evaluation in myelofibrosis.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Chemistry</h3><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on either Bruker 300 or 400 MHz NMR spectrometers using deuterated DMSO (DMSO-<i>d</i><sub>6</sub>) unless otherwise stated. Temperatures are given in degrees Celsius (Â°C); operations are carried out at room temperature or ambient temperature, that is, in the range 18â25 Â°C. Chemical shifts are expressed in parts per million (ppm, Î´ units). Coupling constants are given in units of hertz (Hz). Splitting patterns describe apparent multiplicities and are designated as s (singlet), d (doublet), dd (doubletâdoublet), t (triplet), q (quartet), m (multiplet), and br s (broad singlet). Mass spectroscopy analyses were performed with an Agilent 1100 equipped with Waters columns (Atlantis T3, 2.1 Ã 50 mm, 3 Î¼m or Atlantis dC18, 2.1 Ã 50 mm, 5 Î¼m) eluted with a gradient mixture of H<sub>2</sub>Oâacetonitrile with formic acid and ammonium acetate. The purity determination of all reported compounds was performed with an Agilent 1100 equipped with Waters columns (Atlantis T3, 2.1 Ã 50 mm, 3 Î¼m; or Atlantis dC18, 2.1 Ã 50 mm, 5 Î¼m) eluted for >10 min with a gradient mixture of H<sub>2</sub>Oâacetonitrile with formic or trifluoroacetic acid at wavelengths of 220, 254, and 280 nm. All compounds analyzed were â¥95% pure. Reverse-phase chromatography was performed with Gilson systems using a YMC-AQC18 reverse-phase HPLC column with dimension 20 mm/100 and 50 mm/250 in water/MeCN with 0.1% TFA as mobile phase. Elemental analyses (C, H, N) were performed by QTI, P.O. Box 470, 291 Route 22 East, Salem Industrial Park â Bldg 5, Whitehouse, NJ 08888. Most of the reactions described were monitored by thin-layer chromatography on 0.25 mm E. Merck silica gel plates (60F-254), visualized with UV light or LC/MS . Flash column chromatography was performed on ISCO MPLC Combi-flash systems (4700 Superior Street, Lincoln, NE, USA) unless otherwise mentioned using silica gel cartridges. SFC (super critical fluid chromatography) refers to Analytical SFC (ASC-1000 Analytical SFC System with Diode Array Detector) and/or Preparative SFC (APS-1000 AutoPrep Preparative SFC), obtained from SFC Mettler Toledo AutoChem, Inc. (7075 Samuel Morse Drive Columbia, MD 21046, USA) and used according to the manufacturerâs instruction.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-Methoxy-1<i>H</i>-pyrazol-3-amine (<b>6c</b>)</h4><div class="NLM_p last">To a solution of 3-amino-5-hydroxypyrazole (50.0 g) in CH<sub>2</sub>Cl<sub>2</sub> (800 mL) was added triphenyl phosphine (155.6 g) and the resulting mixture cooled to 0 Â°C. Diisopropyl azodicarboxylate (117.6 mL) was added dropwise over a period of 35 min (maintaining an internal temperature <2 Â°C) to give a slurry. The reaction mixture was then stirred at 0 Â°C for 1 h. A beige precipitate formed after 20 min. MeOH (50 mL) was then added dropwise over a period of 15 min at 0 Â°C as the slurry thinned considerably to give a lighter yellow slurry. The reaction mixture was then stirred at 0 Â°C for 1 h and then warmed slowly to ambient temperature over a period of 2 h. The reaction mixture was then stirred at ambient temperatures for 22 h when it was filtered to remove precipitates. The filtrate was dried over MgSO<sub>4</sub> and concentrated under reduced pressure to give a yellowâorange oil. Purification by flash column chromatography (5â10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a waxy solid (yield: 40%). <sup>1</sup>H NMR (300 MHz) Î´: 4.67 (s, 1H) 3.61 (s, 3H). <i>m</i>/<i>z</i>: 114. The hydrochloride salt was obtained after dissolving 5-methoxy-1<i>H</i>-pyrazol-3-amine in MeOH and dropwise treatment of the resulting mixture with a solution of HCl (4 N in dioxane). The mixture was allowed to stir at room temperature for 1 h, and evaporation of the volatiles under reduced pressure afforded the hydrochloride salt as white solid (yield: quantitative).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-Dimethyl-1<i>H</i>-pyrazole-3,5-diamine (<b>6d</b>)</h4><div class="NLM_p last">A mixture of (2<i>E</i> and <i>Z</i>)-3-(dimethylamino)-3-(methylthio)acrylonitrile (9.5 g) and hydrazine hydrate (10 mL) in ethanol (70 mL) was heated at 85 Â°C overnight. The volatiles were removed under reduced pressure, and the residue left was purified by flash column chromatography with a gradient of 0â10% methanol in CH<sub>2</sub>Cl<sub>2</sub> with 1% NH<sub>4</sub>OH) to afford the title compound (yield: 69%) as thick oil. <sup>1</sup>H NMR (400 MHz) Î´ 9.51 (br, 1H), 4.67 (s, 1H), 2.62 (s, 6H). <i>m</i>/<i>z</i>: 127.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2,5-Dichloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7a</b>)</h4><div class="NLM_p">To a solution of 5-methoxy-1<i>H</i>-pyrazol-3-amine (<b>6c</b>, 0.9 g) in absolute EtOH (20 mL) was added triethylamine (3.3 mL) and 2,4,5-trichloropyrimidine (1.4 g) at ambient temperature. The resulting solution was aged at room temperature for 12 h, whereupon it was partitioned between EtOAc and H<sub>2</sub>O. The organic layer was washed with brine and dried over MgSO<sub>4</sub>. The solvents were removed under reduced pressure to give the title compound as an oil, which crystallized upon standing (yield: 97%). <i>m</i>/<i>z</i>: 261.</div><div class="NLM_p last">Following a similar procedure to that of <b>7a</b>, the following compounds were synthesized.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2,5-Dichloro-<i>N</i>-(5-cyclopropyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7b</b>)</h4><div class="NLM_p last">From 5-cyclopropyl-1<i>H</i>-pyrazol-3-amine <b>6b</b> and 2,4,5-trichloropyrimidine (yield: 95%). <i>m</i>/<i>z</i>: 271.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Chloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7c</b>)</h4><div class="NLM_p last">From 5-methyl-1<i>H</i>-pyrazol-3-ylamine <b>6a</b> and 2,4-dichloro-5-fluoropyrimidine (yield: 97%). <i>m</i>/<i>z</i>: 228.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Chloro-<i>N</i>-(5-cyclopropyl-1<i>H</i>-pyrazol-3-yl)-5-fluoropyrimidin-4-amine (<b>7d</b>)</h4><div class="NLM_p last">From 5-cyclopropyl-1<i>H</i>-pyrazol-3-amine <b>6b</b> and 2,4-dichloro-5-fluoropyrimidine (yield: 95%). <i>m</i>/<i>z</i>: 254.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2,5-Dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>)</h4><div class="NLM_p last">From 5-methyl-1<i>H</i>-pyrazol-3-ylamine <b>6a</b> and 2,4,5-trichloropyrimidine (yield: 95%). <i>m</i>/<i>z</i>: 245.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-Bromo-2-chloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7i</b>)</h4><div class="NLM_p last">From 5-methoxy-1<i>H</i>-pyrazol-3-amine <b>6c</b> and 5-bromo-2,4-dichloropyrimidine (yield: 95%). <i>m</i>/<i>z</i>: 305.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-Bromo-2-chloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7j</b>)</h4><div class="NLM_p last">From 5-methyl-1<i>H</i>-pyrazol-3-amine <b>6a</b> and 5-bromo-2,4-dichloropyrimidine (yield: 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 2.24 (s, 3H), 6.24 (s, 1H), 8.41 (s, 1H), 9.29 (s, 1H), 12.32 (s, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i><sup>3</sup>-(2-Chloro-5-fluoropyrimidin-4-yl)-<i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-dimethyl-1<i>H</i>-pyrazole-3,5-diamine (<b>7l</b>)</h4><div class="NLM_p last">From <i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-dimethyl-1<i>H</i>-pyrazole-3,5-diamine <b>6d</b> and 2,4-dichloro-5-fluoropyrimidine. <sup>1</sup>H NMR (400 MHz, 80 Â°C) 11.60 (br s, 1H), 10.26 (br s, 1H), 8.23 (s, 1H), 5.73 (s, 1H), 2.76 (s, 6H). <i>m</i>/<i>z</i>: 257.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i><sup>3</sup>-(2,5-dichloropyrimidin-4-yl)-<i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-dimethyl-1<i>H</i>-pyrazole-3,5<u class="uu">-</u>diamine (<b>7k</b>)</h4><div class="NLM_p last">From <i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-dimethyl-1<i>H</i>-pyrazole-3,5-diamine <b>6d</b> and 2,4,5-trichloropyrimidine. <sup>1</sup>H (400 MHz, 80 Â°C) 11.67 (br, 1H), 9.51 (br s, 1H), 8.34 (s, 1H), 5.68 (s, 1H), 2.76 (s, 6H). <i>m</i>/<i>z</i>: 273.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Chloro-5-methyl-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7f</b>)</h4><div class="NLM_p last">To a solution of 2,4-dichloro-5-methylpyrimidine (1.25 g) in EtOH (30 mL) was added 5-methyl-1<i>H</i>-pyrazol-3-ylamine (<b>6a</b>, 0.75 mg) and DIPEA (2.8 mL), at room temperature. The mixture was heated at 70 Â°C overnight. The mixture was allowed to cool to room temperature whereupon a precipitate was observed. The title compound was collected by filtration under vacuum as a white solid (yield: 41%). <sup>1</sup>H NMR 12.17 (s, 1H), 9.30 (s, 1H), 7.97 (s, 1H), 6.37 (s, 1H), 2.25 (s, 3H), 2.13 (s, 3H). <i>m</i>/<i>z</i>: 224.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(5-Fluoropyrimidin-2-yl)ethanamine (<i>rac</i>)-<b>8</b></h4><div class="NLM_p">A round-bottom flask containing 1-(5-fluoropyrimidin-2-yl)ethanol (<b>12</b>, 0.79 g) was charged with triethylamine (0.93 mL) and anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at ambient temperature. The solution was cooled to 0 Â°C, and methanesulfonyl chloride (0.7 g) was added dropwise. The resulting mixture was allowed to stir at room temperature for 2 h, at which point the volatile components were removed under reduced pressure. The residue was dissolved in DMF (15 mL) and treated with sodium azide (0.7 g). The resulting mixture was stirred at room temperature for 60 h and was then partitioned between EtOAc and brine. The organic layer was collected, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to dryness. The crude material was purified by flash column chromatography with 50% EtOAc and hexanes gradient to afford 2-(1-azidoethyl)-5-fluoropyrimidine as a colorless oil (yield: 65% yield over two steps). GC-MS, 167 (M), 138 (M-N<sub>2</sub>), 125 (M-N<sub>3</sub>); <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.60 (s, 2H), 4.60 (m, 1H), 1.65 (d, 3H).</div><div class="NLM_p last">A round-bottom flask containing 2-(1-azidoethyl)-5-fluoropyrimidine (0.6 g) was charged with 10% Pd/C (0.19 g) and was evacuated and backfilled with H<sub>2</sub> via a filled balloon. MeOH (10 mL) was added, and the mixture was stirred at room temperature for 3 h. The mixture was filtered through a plug of diatomaceous earth, which was subsequently washed well with MeOH. The filtrates were concentrated under reduced pressure to give the title compound as a pale yellow oil (yield: 99%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 8.60 (s, 2H), 4.65 (br s 2H), 4.10 (m, 1H), 1.20 (d, 3H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-Chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9a</b>)</h4><div class="NLM_p last">A mixture of 2,5-dichloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7a</b>, 0.06 g) and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.04 g) in <i>n</i>-BuOH (0.8 mL) and DIPEA (0.13 mL) was heated at 110 Â°C overnight. The solvent was evaporated under reduced pressure, and the remaining material was separated between EtOAc and water, and the combined organic extract washed with brine and dried over MgSO<sub>4</sub>. Evaporation of the solvent under reduced pressure gave a brown oil (0.06 g). Purification by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O 0.1% TFA, 15 min) afforded the trifluoroacetate salt of the title compound as a white solid (yield: 40%). <sup>1</sup>H NMR: 9.64 (s, 1H), 8.78 (d, 2H), 8.18 (s, 1H), 7.86 (s, 1H), 5.52 (s, 1H), 4.99â5.15 (m, 1H), 3.65 (s, 3H), 1.43 (d, 3H). <i>m</i>/<i>z</i>: 366.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-Chloro-<i>N</i><sup>4</sup>-(5-cyclopropyl-1<i>H</i>-pyrazol-3-yl)-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]pyrimidine-2,4-diamine (<b>9b</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.09 g), 2,5-dichloro-<i>N</i>-(5-cyclopropyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7b</b>, 0.13 g), and DIPEA (0.26 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 6 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O 0.1%TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 25%). <sup>1</sup>H NMR: 10.64 (s, 1H), 8.91 (s, 3H), 8.30 (s, 1H), 5.97 (s, 1H), 5.17 (s, 1H), 1.83â1.97 (m, 1H), 1.56 (d, 3H), 0.93â1.09 (m, 2H), 0.63â0.77 (m, 2H). <i>m</i>/<i>z</i>: 413.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-Fluoro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9c</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (95 mg), 2-chloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7c</b>, 0.11 g) and DIPEA (0.13 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 6 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O, 0.1% TFA 15 min) to give the trifluoroacetate salt of the title compound (yield: 18%). <sup>1</sup>H NMR: 11.26 (s, 1H), 9.18â8.67 (m, 3H), 8.22 (s, 1H), 6.04 (s, 1H), 4.86â5.40 (m, 1H), 2.25 (s, 3H), 1.57 (d, 3H). <i>m</i>/<i>z</i>: 333.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i><sup>4</sup>-(5-Cyclopropyl-1<i>H</i>-pyrazol-3-yl)-5-fluoro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]pyrimidine-2,4-diamine (<b>9d</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.09 g), 2-chloro-<i>N</i>-(5-cyclopropyl-1<i>H</i>-pyrazol-3-yl)-5-fluoropyrimidin-4-amine (<b>7d</b>, 0.13 g), and DIPEA (0.22 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 6 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O, 0.1% TFA 15 min) to give the trifluoroacetate salt of the title compound (yield: 20%). <sup>1</sup>H NMR: 11.28 (s, 1H), 8.92 (s, 3H), 8.24 (s, 1H), 6.04 (s, 1H), 4.92â5.54 (m, 1H), 1.82â1.98 (m, 1H), 1.56 (d, 3H), 0.94â1.06 (m, 2H), 0.64â0.80 (m, 2H). <i>m</i>/<i>z</i>: 395.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-Chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9e</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.08 g), 2,5-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>, 0.12 g) and DIPEA (0.14 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 6 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O, 0.1% TFA 15 min) to give the trifluoroacetate salt of the title compound (yield: 50%). <sup>1</sup>H NMR: 10.34 (s, 1H), 8.91 (s, 3H), 8.30 (s, 1H), 5.94 (s, 1H), 4.96â5.34 (m, 1H), 2.25 (s, 3H), 1.56 (d, 3H). <i>m</i>/<i>z</i>: 350. Anal. (C<sub>14</sub>H<sub>14</sub>ClFN<sub>8</sub>Â·0.4H<sub>2</sub>O): C, calcd 48.21, found 47.96; H, calcd 4.04, found 4.05; N, calcd 32.13, found 30.67.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-5-methyl-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9f</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine (<i>S</i>)-<b>8</b> (0.11 g), 2-chloro-5-methyl-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7f</b>, 0.50 g), and DIPEA (0.225 mL) in anhydrous <i>n</i>-BuOH (2.1 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 4 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (5â95% MeCN/H<sub>2</sub>O 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 50%). <sup>1</sup>H NMR: 10.08 (s, 1H), 8.93 (s, 2H), 8.70 (s, 1H), 7.74 (s, 1H), 5.98 (s, 1H), 4.79â5.44 (m, 1H), 2.23 (s, 3H), 2.10 (s, 3H), 1.57 (d, 3H); <i>m</i>/<i>z</i>: 330.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>S</i>)-5-Chloro-2-[1-(5-fluoropyrimidin-2-yl)ethoxy]-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>9g</b>) and (<i>R</i>)-5-Chloro-2-[1-(5-fluoropyrimidin-2-yl)ethoxy]-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>9h</b>)</h4><div class="NLM_p">Sodium <i>t</i>-butoxide (2.9 g) was added to a solution of 2,5-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>, 3.7 g) and 1-(5-fluoropyrimidin-2-yl)ethanol (<b>12</b>, 4.3 g) in <i>t</i>-BuOH (10 mL). The resulting mixture was heated at 90 Â°C overnight and then was partitioned between H<sub>2</sub>O and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with saturated NH<sub>4</sub>Cl<sub>(aq)</sub> solution, H<sub>2</sub>O, and brine. Purification by flash column chromatography (40% EtOAc/hexanes) afforded the title compounds as a mixture of enantiomers. <sup>1</sup>H NMR: 8.58 (s, 2H), 8.00 (s, 1H), 6.00 (s, 1H), 5.91 (m, 1H), 2.23 (s, 3H), 1.63 (d, 3H). <i>m</i>/<i>z</i>: 350.</div><div class="NLM_p">The mixture was separated using chiral SFC. Column and solvent conditions: Column: Chiralcel AD-H, 250 Ã 20 mm, 5 Î¼. Modifier: 30% isopropanol, 0.1% dimethylethylamine. Flow rate: 60 mL/min. Oven: 40 Â°C. Outlet: 100 bar. Post-purification purity check: Chiral SFC using ultraviolet diode array. Column: Chiralcel AD-H, 250 Ã 4.6 mm. Conditions: 30% isopropanol, 0.1% dimethylethylamine. Flow rate: 3 mL/min; 15 min. Oven: 35 Â°C. Outlet: 120 bar. </div><div class="NLM_p"><b>9g</b> was eluted first (yield: 16%) from the column with a retention time of 3.34 min, as detected using an ultraviolet diode array detector. <b>9h</b> was eluted second (yield: 15%) from the column with a retention time of 5.99 min, as detected using an ultraviolet diode array detector. Enantiomeric excess for both <b>9g</b> and <b>9h</b> was estimated to be >98%, using area percentage at 254 nm.</div><div class="NLM_p last">For <b>9g</b>, elemental analysis (C<sub>14</sub>H<sub>13</sub>ClFN<sub>7</sub>O): C, calcd 48.08, found 48.04; H, calcd 3.75, found 3.74; N, calcd 28.03, found 27.82.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-bromo-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9i</b>)</h4><div class="NLM_p">A mixture of 5-bromo-2-chloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7i</b>, 0.18 g) was added to a mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.15 g), and DIPEA (0.14 mL) in anhydrous <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 165 Â°C for 5 h. The reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by flash column chromatography, eluting with 0â5% gradient of MeOH in DCM with 1% NH<sub>4</sub>OH<sub>(aq)</sub>, to afford the title compound (yield: 40%). <sup>1</sup>H NMR: 12.03 (s, 1H), 9.38 (s, 1H), 8.82 (s, 2H), 8.12â7.97 (m, 2H), 5.60 (s, 1H), 5.13 (s, 1H), 3.75 (m, 3H), 1.49 (m, 3H). <i>m</i>/<i>z</i>: 409.</div><div class="NLM_p last">Compounds <b>9j</b>â<b>l</b> were prepared following a similar procedure to that described for (<b>9i</b>).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-bromo-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>9j</b>)</h4><div class="NLM_p last">From (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> and 5-bromo-2-chloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>7j</b> to afford the desired product (yield: 45%). <sup>1</sup>H NMR: 12.02 (s, 1H), 8.82 (s, 2H), 7.94 (s, 1H), 7.48 (s, 0.55H), 5.90 (s, 0.41H), 5.09 (s, 1H), 2.19 (m, 3H), 1.49 (m, 3H). <i>m</i>/<i>z</i>: 393.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-chloro-<i>N</i><sup>4</sup>-[5-(dimethylamino)-1<i>H</i>-pyrazol-3-yl]-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]pyrimidine-2,4-diamine (<b>9k</b>)</h4><div class="NLM_p last">From <i>N</i><sup>3</sup>-(2,5-dichloropyrimidin-4-yl)-<i>N</i><sup>5</sup>,<i>N</i><sup>5</sup>-dimethyl-1<i>H</i>-pyrazole-3,5-diamine <b>7k</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> to afford the title compound as a white solid (yield: 20%). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 8.77 (s, 2H), 8.26 (br, 1H), 5.35 (br, 1H), 3.49 (q, 1H), 3.11 (s, 6H), 1.72 (d, 3H); <i>m</i>/<i>z</i>: 378.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i><sup>4</sup>-[5-(dimethylamino)-1<i>H</i>-pyrazol-3-yl]-5-fluoro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]pyrimidine-2,4-diamine (<b>9l</b>)</h4><div class="NLM_p last">From <i>N</i><sup>3</sup>-(2-chloro-5-fluoropyrimidin-4-yl)-<i>N</i><sup><i>5</i></sup><i>,N</i><sup><i>5</i></sup>-dimethyl-1<i>H</i>-pyrazole-3,5-diamine <b>9l</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> to afford the title compound as a white solid (yield: 20%). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 8.77 (s, 2H), 8.23 (s, 1H), 5.32 (br, 1H), 3.92 (q, 1H), 3.13 (s, 6H), 1.71 (d, 3H); <i>m</i>/<i>z</i>: 362.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-Fluoropyrimidine-2-carbonitrile (<b>10</b>)</h4><div class="NLM_p last">A 10 mL microwave vial was charged with 2-chloro-5-fluoropyrimidine (2.0 g), Pd<sub>2</sub>(dba)<sub>3</sub> (0.55 g), dppf (0.7 g), zinc cyanide (1.1 g), and zinc dust (0.24 g). The flask was evacuated and backfilled with N<sub>2</sub> and anhydrous DMA (20 mL). The vial was mounted onto a Personal Chemistry microwave reactor and heated at 100 Â°C for 10 h. The reaction mixture was diluted with EtOAc and then washed with brine three times. The organic layer was obtained and evaporated to dryness under reduced pressure. The dried residue was purified by flash column chromatography, eluting with gradient 0â50% EtOAc and hexanes, to afford the title compound as a creamy solid (yield: 80%). GC-MS: 123 [M]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.80 (s, 2H).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(5-Fluoropyrimidin-2-yl)ethanone (<b>11</b>)</h4><div class="NLM_p last">To a solution of 5-fluoropyrimidine-2-carbonitrile (<b>10</b>, 2.5 g) in Et<sub>2</sub>O (50 mL) at 0 Â°C was added dropwise a solution of MeMgBr (12 mL, 3.0 M in Et<sub>2</sub>O). The resulting solution was stirred at this temperature for 30 min and was then allowed to warm to ambient temperature overnight. The mixture was quenched with a solution of saturated NH<sub>4</sub>Cl<sub>(aq)</sub> and extracted with Et<sub>2</sub>O. The organic extracts were dried over MgSO<sub>4</sub>, and evaporation under reduced pressure gave a colored residue. Purification by flash column chromatography, eluting with 3% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, afforded the title compound (yield: 60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.75 (s, 2H), 2.77 (s, 3H).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(5-Fluoropyrimidin-2-yl)ethanol (<b>12</b>)</h4><div class="NLM_p">NaBH<sub>4</sub> (12 mL, 3.0 M in Et<sub>2</sub>O) was added slowly to a solution of 1-(5-fluoropyrimidin-2-yl)ethanone (<b>11</b>, 0.8 mg) in MeOH (40 mL) at 0 Â°C. The resulting solution was allowed to stir at room temperature for 30 min. The solvent was evaporated under reduced pressure, and the residue obtained was partitioned between H<sub>2</sub>O and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with saturated NH<sub>4</sub>Cl<sub>(aq)</sub> solution, H<sub>2</sub>O, and brine. The organic extracts were dried over MgSO<sub>4</sub>, and evaporation of the volatiles under reduced pressure gave the title compound (yield: 77%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.59 (s, 2H), 4.96 (m, 1H), 3.79 (br s, 1H), 1.54 (d, 3H).</div><div class="NLM_p last">Compounds <b>14a</b>â<b>f</b> were prepared following a similar procedure to that described for <b>7a</b>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2,6-Dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14a</b>)</h4><div class="NLM_p last">From 2,4,6-trichloropyrimidine and 5-methyl-1<i>H</i>-pyrazol-3-amine <b>6a</b>. <i>m</i>/<i>z</i>: 245.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2,6-Dichloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14b</b>)</h4><div class="NLM_p last">From 2,4,6-trichloro-5-fluoropyrimidine and 5-methyl-1<i>H</i>-pyrazol-3-amine <b>6a</b>. <i>m</i>/<i>z</i>: 262.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2,5,6-Trichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14c</b>)</h4><div class="NLM_p last">From 2,4,5,6-tetrachloro-pyrimidine and 5-methyl-1<i>H</i>-pyrazol-3-amine <b>6a</b>. <i>m</i>/<i>z</i>: 277.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2,6-Dichloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14d</b>)</h4><div class="NLM_p last">From 2,4,6-trichloro-pyrimidine and 5-methoxy-1<i>H</i>-pyrazol-3-amine <b>6c</b>. <sup>1</sup>H NMR: 12.19 (s, 1H), 10.68 (s, 1H), 6.76 (s, 1H), 5.40 (s, 1H), 3.82 (s, 3H). <i>m</i>/<i>z</i>: 260.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2,6-Dichloro-5-fluoro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14e</b>)</h4><div class="NLM_p last">From 2,4,6-trichloro-5-fluoropyrimidine and 5-methoxy-1<i>H</i>-pyrazol-3-amine <b>6c</b> (yield: 75%). <i>m</i>/<i>z</i>: 278.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2,5,6-Trichloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14f</b>)</h4><div class="NLM_p">From 2,4,5,6-tetrachloropyrimidine and 5-methoxy-1<i>H</i>-pyrazol-3-amine <b>6c</b> (yield: 85%). <i>m</i>/<i>z</i>: 294.</div><div class="NLM_p last">The following compounds were synthesized following a similar procedure to that described for <b>9a</b>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-Chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15a</b>)</h4><div class="NLM_p last">From 2,6-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14a</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b>. <i>m</i>/<i>z</i>: 348.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-6-chloro-5-fluoro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-N<sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15b</b>)</h4><div class="NLM_p last">From 2,6-dichloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14b</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b>. <i>m</i>/<i>z</i>: 367.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> di(<i>S</i>)-5,6-dichloro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15c</b>)</h4><div class="NLM_p last">From 2,5,6-trichloro-<i>N</i>-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine <b>14c</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride. <i>m</i>/<i>z</i>: 383.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 6-chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15d</b>)</h4><div class="NLM_p last">From 2,6-dichloro-<i>N</i>-(5-methoxyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14d</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b>. <sup>1</sup>H NMR: 8.92 (s, 2H), 5.95 (s, 1H), 5.18 (s, 1H), 3.77 (s, 3H), 1.49 (d, 3H). <i>m</i>/<i>z</i>: 366.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-6-chloro-5-fluoro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15e</b>)</h4><div class="NLM_p last">From 2,6-dichloro-5-fluoro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14e</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b>. <i>m</i>/<i>z</i>: 383.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5,6-dichloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15f</b>)</h4><div class="NLM_p last">2,5,6-Trichloro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14f</b> and (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b>. <sup>1</sup>H NMR: 9.87 (s, 1H), 8.88 (s, 2H), 8.78 (s, 1H), 8.38 (d, 1H), 5.62 (s, 1H), 5.06â5.17 (m, 1H), 3.77 (s, 3H), 1.49 (d, 3H). <i>m</i>/<i>z</i>: 399.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Chloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidin-4-amine (<b>17a</b>)</h4><div class="NLM_p last">A mixture of morpholine (0.18 mL), 2,6-dichloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>14b</b>, 0.5 g) and DIPEA (0.5 mL) in absolute ethanol (10 mL) was heated at 80 Â°C for 5 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 29%). <sup>1</sup>H NMR: 12.05 (br s, 1H), 9.57 (s, 1H), 6.21 (s, 1H), 3.67 (t, 4H), 3.57 (t, 4H), 2.22 (s, 3H). <i>m</i>/<i>z</i>: 313.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-Chloro-5-fluoro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidin-4-amine (<b>17b</b>)</h4><div class="NLM_p last">Prepared by a similar procedure as described above for <b>17a</b> using 2,6-dichloro-5-fluoro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine <b>14e</b> as starting material (yield: 25%). <sup>1</sup>H NMR: 9.80 (s, 1H), 5.66 (s, 1H), 3.77 (s, 3H), 3.64â3.71 (m, 4H), 3.53â3.64 (m, 4H). <i>m</i>/<i>z</i>: 329.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidine-2,4-diamine (<b>16a</b>)</h4><div class="NLM_p last">A mixture of 6-chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15a</b>, 0.17 g), morpholine (0.09 mL) and DIPEA (0.13 mL) in <i>n</i>-BuOH (2.5 mL) was heated at 110 Â°C for 48 h. The solvent was removed under reduced pressure and the residue purified by reverse-phase chromatography (5â35% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 40%). <sup>1</sup>H NMR: 11.19 (s, 1H), 9.28 (s, 1H), 8.74â9.03 (m, 3H), 5.81â5.83 (m, 1H), 5.73 (s, 1H), 4.98â5.24 (m, 2H), 3.58â4.12 (m, 6H), 2.39 (s, 3H), 1.54 (d, 3H). <i>m</i>/<i>z</i>: 436.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-fluoro-<i>N</i><sup><i>2</i></sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup><i>4</i></sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidine-2,4-diamine (<b>16b</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.14 g), 2-chloro-5-fluoro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidin-4-amine (<b>17a</b>, 0.3 g), and DIPEA (0.3 mL) in <i>n</i>-BuOH (5 mL) was heated in a sealed vessel in a microwave reactor at 180 Â°C for 9 h. The solvent was removed under reduced pressure and the residue purified by reverse-phase chromatography (2â40% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 11%). <sup>1</sup>H NMR: 8.84 (s, 2H), 4.90â5.02 (m, 1H), 3.38â3.72 (m, 8H), 2.16 (s, 3H), 1.44 (d, 3H). <i>m</i>/<i>z</i>: 418.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>S</i>)-5-chloro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)-6-morpholinopyrimidine-2,4-diamine (<b>16c</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-5,6-dichloro-<i>N</i><sup>2</sup>-(1-(5-fluoropyrimidin-2-yl)ethyl)-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15c</b>, 0.23 g), morpholine (0.06 mL), and DIPEA (0.2 mL) in <i>n</i>-BuOH (5 mL) was heated at 110 Â°C for 48 h. The solvent was removed under reduced pressure and the residue purified by reverse-phase chromatography (5â35% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 20%) <sup>1</sup>H NMR: (MeOD) 8.75 (br s, 2H), 6.09 (br s, 1H), 5.35â5.09 (m, 1H), 3.90â3.50 (m, 8H), 2.38 (br s, 3H), 1.66 (d, 3H). <i>m</i>/<i>z</i>: 434.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidine-2,4-diamine (<b>16d</b>)</h4><div class="NLM_p last">A mixture of 6-chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>15d</b>, 0.3 g), morpholine (0.09 mL), and DIPEA (0.2 mL) in <i>n</i>-BuOH (4 mL) was heated at 120 Â°C overnight. The solvent was removed under reduced pressure and the residue purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 50%). <sup>1</sup>H NMR: 11.97 (s, 1H), 9.49 (s, 1H), 8.80 (s, 2H), 7.58 (s, 1H), 5.20â4.98 (m, 3H), 3.72 (s, 3H), 3.53 (br s, 4H), 3.18 (br s, 4H), 1.49 (d, 3 H). <i>m</i>/<i>z</i>: 416.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 5-fluoro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidine-2,4-diamine (<b>16e</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride (<i>S</i>)-<b>8</b> (0.2 g), 2-chloro-5-fluoro-<i>N</i>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidin-4-amine (<b>17b</b>, 0.4 g), and DIPEA (0.5 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed vessel at 170 Â°C for 24 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (2â40% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 13%). <sup>1</sup>H NMR: 10.07 (s, 1H), 8.86 (s, 2H), 5.48 (s, 1H), 5.00 (m, 1H), 3.86 (s, 3H), 3.62â3.38 (m, 8H), 1.48 (d, 3H). <i>m</i>/<i>z</i>: 434.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-chloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-6-morpholin-4-ylpyrimidine-2,4-diamine (<b>16f</b>)</h4><div class="NLM_p last">A mixture of 5,6-dichloro-<i>N</i><sup>2</sup>-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methoxy-1<i>H</i>-pyrazol-3-yl)-pyrimidine-2,4-diamine (<b>15f</b>, 0.1 g), morpholine (0.03 mL), and DIPEA (0.07 mL) in <i>n</i>-BuOH (2 mL) was heated in a sealed vessel at 150 Â°C for 24 h. The solvent was removed under reduced pressure, and the residue was purified by reverse-phase chromatography (2â40% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of the title compound (yield: 20%). <sup>1</sup>H NMR: 11.99 (s, 1H), 9.30 (s, 1H), 8.82 (s, 2H), 7.89 (d, 1H), 5.49 (s, 1H), 5.14â4.93 (m, 1H), 3.75 (s, 3H), 3.44â3.62 (m, 4H), 3.09â3.27 (m, 4H), 1.47 (d, 3H). <i>m</i>/<i>z</i>: 450.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl Dimethyldithiocarbamate (<b>18</b>)</h4><div class="NLM_p last">Dimethylamine (2 M in THF, 60 mL) was cooled at 0 Â°C and carbon disulfide (6 mL) added portionwise, followed by an aqueous solution of NaOH (4.8 g)/H<sub>2</sub>O (40 mL). The reaction mixture was stirred at 0 Â°C for 30 min and subsequently at room temperature for 2 h. The reaction mixture was then recooled at 0 Â°C, and methyl iodide (7.5 mL) was added slowly. The resulting reaction mixture was stirred at 0 Â°C for 1 h, and then at room temperature overnight. The mixture was diluted with diethyl ether (100 mL) and extracted from the aqueous layer. The organic extracts were combined and dried over MgSO<sub>4</sub>. Removal of the volatiles under reduced pressure afforded the title compound (yield: quantitative) as white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 3.52 (s, 3H), 3.35 (s, 3H), 2.61 (s, 3H).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (2<i>E</i> and <i>Z</i>)-3-(Dimethylamino)-3-(methylthio)acrylonitrile (<b>19</b>)</h4><div class="NLM_p last">Acetonitrile (12 mL) in THF (100 mL) was cooled at â78 Â°C and <i>n</i>-BuLi (2.5 M in hexane, 92 mL) was added dropwise through an addition funnel. The reaction was allowed to stir for 30 min at â78 Â°C, and then methyl dimethyldithiocarbamate (<b>18</b>, 14.1 g) was added in one portion. The resulting mixture was stirred at â78 Â°C for 30 min and subsequently at room temperature for 6 h. The reaction mixture was then cooled at 0 Â°C, and methyl iodide (10 mL) was added. The reaction mixture was allowed to warm to room temperature and stirred at room temperature overnight. The mixture was diluted with ethyl acetate (200 mL), and the organic layer was washed with water (2 Ã 100 mL). The organic phase was concentrated under reduced pressure to give a residue which was purified by flash column chromatography with gradient 0â20% ethyl acetate in hexanes to afford the title compound (yield: 74%) as a mixture of <i>E</i> and <i>Z</i> isomers. <sup>1</sup>H NMR (major isomer) (CDCl<sub>3</sub>): 4.08 (s, 1H), 3.00 (s, 6H), 2.39 (s, 3H).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-chloro-<i>N</i><sup>2</sup>-[(1<i>R</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (<b>21</b>)</h4><div class="NLM_p">A mixture of 1-(5-fluoropyrimidin-2-yl)ethanamine hydrochloride <i>rac</i>-(<b>8</b>) (0.1 g), 2,5-dichloro-<i>N</i>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine (<b>7e</b>, 0.2 g), and DIPEA (0.15 mL) in <i>n</i>-BuOH (2.5 mL) was heated in a sealed microwave vessel in a microwave reactor at 180 Â°C for 6 h. The solvent was removed under reduced pressure and purified by reverse-phase chromatography (10â50% MeCN/H<sub>2</sub>O with 0.1% TFA, 15 min) to give the trifluoroacetate salt of 5-chloro-<i>N</i><sup>2</sup>-[1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i><sup>4</sup>-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine <b>20</b> (yield: 19%).</div><div class="NLM_p">The racemic mixture was resolved using chiral SFC. Column and solvent conditions: Column: Chiralpak AD-H, 250 Ã 20 mm. Modifier: 30% isopropanol, 0.1% dimethylethylamine. Flow rate: 60 mL/min. Oven: 40 Â°C. Outlet: 100 bar. Post-purification purity check: Chiral SFC using ultraviolet diode array. Column: Chiralcel AD-H, 250 Ã 4.6 mm. Conditions: 20% isopropanol, 0.1% dimethylethylamine. Flow rate: 3 mL/min; 15 min. Oven: 35 Â°C. Outlet: 120 bar.</div><div class="NLM_p"><b>9e</b> was eluted first with a retention time of 11.3 min, as detected by an ultraviolet diode array detector. <b>21</b> eluted second with a retention time of 13.9 min, as detected by an ultraviolet diode array detector. Enantiomeric excess for <b>9e</b> (retention time 2.5 min) was >98% and for <b>21</b> (retention time 14.0 min) was estimated to be â¼97%, using peak area percentage at 254 nm.</div><div class="NLM_p last">Analytical data for <b>21</b>: <sup>1</sup>H NMR (300 MHz): 12.03 (s, 1H), 8.83 (s, 2H), 7.88 (s, 1H), 7.44 (s, 1H), 5.93 (s, 1H), 4.92â5.29 (m, 1H), 2.20 (s, 3H), 1.49 (d, 3H). <i>m</i>/<i>z</i>: 350.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Rat Microsome Stability Assay</h3><div class="NLM_p last">This primary in vitro test was carried out to assess the propensity of a compound to be metabolized by rat liver microsomal enzymes. The time-dependent disappearance of compound (2 Î¼M initial concentration) incubated with microsomes was measured using LCMS/MS. Results are reported as intrinsic clearance of compound (CL<sub>int</sub>, in Î¼L/min/mg protein).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Log <i>D</i> Measurement</h3><div class="NLM_p last">The octanolâwater partition coefficient (log <i>D</i>) is measured using the shake flask method. Aliquots of test compound stock solution were added to a mixture of phosphate buffer at pH 7.4 and <i>n</i>-octanol. The test compounds were allowed to distribute between the two phases by shaking samples at 1200 rpm, at 25 Â°C, for 1 h. Concentration of test compounds in each of the two phases was analyzed using an HPLC-UV with MS confirmation.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Aqueous Equilibrium Solubility Assay</h3><div class="NLM_p last">This primary in vitro test assesses the equilibrium solubility of a compound in pH 7.4 phosphate buffer. Solid compound was prepared by evaporation of a DMSO solution. Dried compound was incubated for 24 h with agitation in buffer at 25 Â°C. Undissolved compound was removed by filtration, and the concentration of test compound in the filtrate was measured by HPLC-UV, with MS confirmation, and calculated against a one-point standard. The lower and higher limits of quantification for this assay were 1 and 1000 Î¼M, respectively.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Aurora A Assay</h3><div class="NLM_p last">This in vitro test was used for measuring the change of DNA content in flow cytometry during the compound treatment. Cells were plated on day 1 at established seeding density. <b>9e</b> and controls were added on day 2 at required time points, and cells were harvested and fixed in ice-cold 70% ethanol. The fixed cells were resuspended in permeabilization buffer (PBS with 0.05% Triton X-100) for 10 min and washed with wash buffer (PBS with 1% BSA) once. Cells were then incubated with 1:500 dilution of antiphosphorylated histone H3 for 2 h in the dark and followed by the incubation of 1:500 dilution of Alexa Fluor 488 goat antirabbit IgG for 2 h in the dark. Cells were washed once after the incubation of each antibody. Cells were then incubated with PI staining solution (PBS with 40 Î¼g/mL PI and 100 Î¼g/mL RNase I) at 37 Â°C for 30 min. Cells were analyzed on a flow cytometer.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Mouse Allograft Tumor Models, Pharmacodynamic Studies, and Bioluminescence Imaging</h3><div class="NLM_p">Female, NCr nude mice (Taconic Farms, Germantown, NY, USA) were purchased at 5â6 weeks of age and maintained under specific-pathogen-free conditions in an AAALAC-accredited facility. Animal protocols were approved by the AstraZeneca R&D Boston Institutional Animal Care and Use Committee. All animal work was conducted in accordance with applicable internal standards and external local and national guidelines, regulations, and legislation. Animals were acclimated in-house for a period of 3 days prior to cell implantation.</div><div class="NLM_p">Mouse BaF3 cells expressing TEL-Jak2 fusion protein were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (HyClone) and <span class="smallcaps smallerCapital">l</span>-glutamine (Gibco). One million cells in 0.1 mL of sterile PBS were injected into the mouse lateral tail vein. Single-dose pharmacodynamic studies were carried out 10 days post-tumor cell implantation. <b>9e</b> was dissolved in 0.5% HPMC and 0.1% Tween80 (pH â¼2) and dosed by oral gavage to the tumor bearing mice. Mice were sacrificed at 2, 4, 6, 8, and 12 h after drug administration. Spleen samples were collected to assess phospho-Stat5 levels by Western blot as described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">For tumor growth inhibition studies, one million BaF/3 TEL-Jak2-<i>luc</i> cells in 0.1 mL of sterile PBS were injected into the mouse lateral tail vein. To track tumor burden in mice, in vivo bioluminescent imaging was performed using the IVIS 200 instrument (Caliper LifeSciences) on days 1, 4, 7, and 9 post-tumor cell implantation. Before imaging, mice received an intraperitoneal dose of <span class="smallcaps smallerCapital">d</span>-luciferin (150 mg/kg in PBS; Caliper LifeSciences), and were anesthetized with 2.5â3% isofluorane. Images were acquired with <i>LivingImage</i> software (v 2.5, Caliper LifeSciences) 10 min after <span class="smallcaps smallerCapital">d</span>-luciferin injection. The imaging data from day 1 was used to randomize the animals into experimental groups. Dosing commenced on day 3 with animals receiving vehicle or <b>9e</b>. Mice were dosed by oral gavage twice daily for a total of 7 days.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Protein Expression, Purification, Crystallization, and Structure Determination</h3><div class="NLM_p">Human Jak2 was modeled in Quanta 2000<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> using a JAK3 protein structure<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (pdb entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ">1YVJ</a>). Using this model (not detailed), construct termini and areas for potential surface entropy reduction were identified. Human 6-His-Jak2 (residues 835â1132) with mutations K943A and K945A was cloned into pT7 3.3 vector using Gateway cloning (Invitrogen). Protein was expressed in BL21* cells grown in Terrific Broth media in the presence of tetracycline (12.5 Î¼g/mL). Expression was induced at OD<sub>600</sub> 0.6 with 0.1 mM isopropyl Î²-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (IPTG). Following induction with IPTG, cells were incubated at 18 Â°C for 20 h before harvesting. Cells were resuspended in Buffer A (20 mM Tris pH 7.9, 250 mM NaCl, 10 mM imidazole, 1 mM tris(2-carboxyethyl)phosphine) supplemented with EDTA-free Complete Protease inhibitors (Roche) and 2 Î¼M staurosporine (Sigma). Cells were lysed using a cell disruptor (Constant Systems Basic Z). The supernatant was loaded onto a NiNTA affinity column (Qiagen). After washing with Buffer A, the protein was eluted with Buffer A plus 300 mM imidazole. Fractions containing 6His-Jak2 were pooled and 5 mM DTT, Lambda phosphatase (Upstate), and TEV protease were added to the protein and left to incubate overnight at 4 Â°C. The cleaved protein was exchanged into a low salt buffer (20 mM Tris pH 8.5, 25 mM NaCl, 1 mM dithiothreitol (DTT)) using an XK26 fast desalting column (GE Healthcare) before loading onto a Resource Q ion-exchange column (GE Healthcare) equilibrated in low salt buffer. Bound protein was eluted by increasing the NaCl concentration to 1 M. Fractions containing Jak2 were pooled and incubated with 60 Î¼M staurosporine on ice for 15 min before buffer exchanging into 20 mM Tris pH 8.5, 100 mM NaCl, 1 mM DTT using a Superdex S-75 size exclusion chromatography column (GE Healthcare). The Jak2âstaurosporine complex was concentrated to 8.7 mg/mL for crystallization.</div><div class="NLM_p">Crystals of Jak2âstaurosporine complex were grown using the hanging drop method at 293 K. The reservoir solution contained 28% w/v Peg3350, 200 mM ammonium acetate, 100 mM sodium citrate, pH 6.0. Drops were set up with 1.5 Î¼L protein and 1 Î¼L reservoir. Trays were incubated at 20 Â°C and bipyramidal crystals appeared after 3â6 days. Jak2âstaurosporine crystals were soaked in well solution with 5 mM of compound <b>9e</b> and 5% DMSO for 30 h at 20 Â°C. Crystals were then cryoprotected using well solution containing an additional 10% glycerol. Crystals were frozen directly into a cryostream at 100 K. Diffraction data were collected at ESRF beamline ID23-EH2 equipped with an ADSC Quantum 4 CCD X-ray detector, using a Si111 monochromated wavelength of 0.873 Ã. Data were processed using MOSFLM and SCALA and reduced using CCP4 software.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The structures were solved by molecular replacement using coordinates of the Jak2 kinase domain<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as a trial model using CCP4 software. Protein and inhibitor were modeled into the electron density using COOT<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and AFITT.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The model was refined using Refmac.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Atomic coordinates and structure factors for the human Jak2 complex with compound <b>9e</b> have been deposited in the Protein Data Bank (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XA4">2XA4</a>) together with structure factors and detailed experimental conditions.</div><div class="NLM_p last">Crystallographic statistics for the Jak2/compound <b>9e</b> complex are as follows, with statistics for the highest-resolution shell in brackets: Space group C2, unit cell 43.9, 126.7, 134.3 Ã, Î² 97.0, Resolution 33.33â2.04 (2.09â2.04) Ã, 43209 (3016) unique reflections with an overall redundancy of 3.0 (2.9) give 93.4 (87.2)% completeness with <i>R</i><sub>merge</sub> of 7.0 (40.4)% and mean <i>I</i>/Ï(<i>I</i>) of 10.3 (1.6). The final model containing 4451 protein, 308 solvent, and 48 compound atoms has an <i>R</i>-factor of 19.72% (<i>R</i><sub>free</sub> 24.46%) using 5% of the data. Mean temperature factors for the protein and the ligand are 32 and 33 Ã<sup>2</sup>, respectively. Pictures of the crystal structure of <b>9e</b> with Jak2 kinase have been generated by PyMOL.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/jm1011319">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figures S1âS4. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1011319/suppl_file/jm1011319_si_001.pdf">jm1011319_si_001.pdf (426.79 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1011319" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanos Ioannidis</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1c6f68796c747d72736f3275737d72727578756f5c7d6f686e7d667972797f7d327f7371"><span class="__cf_email__" data-cfemail="314245544159505f5e421f585e505f5f585558427150424543504b545f5452501f525e5c">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle L. Lamb</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynsie Almeida</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael H. Block</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Audrey M. Davies</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Peng</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei Su</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Jun Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ethan Hoffmann</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Metabolism and Pharmacokinetics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Rivard</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Metabolism and Pharmacokinetics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Green</span> - <span class="hlFld-Affiliation affiliation">Discovery Enabling Capabilities and SciencesâCells, Protein & Structural Sciences, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tina Howard</span> - <span class="hlFld-Affiliation affiliation">Discovery Enabling Capabilities and SciencesâCells, Protein & Structural Sciences, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah Pollard</span> - <span class="hlFld-Affiliation affiliation">Discovery Enabling Capabilities and SciencesâCells, Protein & Structural Sciences, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon Read</span> - <span class="hlFld-Affiliation affiliation">Discovery Enabling Capabilities and SciencesâCells, Protein & Structural Sciences, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marat Alimzhanov</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geraldine Bebernitz</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsten Bell</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minwei Ye</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Huszar</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Zinda</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Bioscience</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Nancy DeGrace and Kanayochukwu Azogu for chiral separations, David Scott for analysis of early screening data, David Ayres for PK sample analysis, Clare Williams for helping with reagent supply for protein isolation, Richard Mott for initial protein work, and Mark McAlister for initiating structural work. Special thanks to Susan Ashwell and John Habermann for useful discussions during the preparation of this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saharinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, V. E. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FrÃ¶hling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DÃ¶hner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.ccr.2005.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15837627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+P.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Fr%C3%B6hlingauthor=K.+D%C3%B6hnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+mutation+in+the+tyrosine+kinase+JAK2+in+polycythemia+vera%2C+essential+thrombocythemia%2C+and+myeloid+metaplasia+with+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span></div><div class="casAuthors">Levine, Ross L.; Wadleigh, Martha; Cools, Jan; Ebert, Benjamin L.; Wernig, Gerlinde; Huntly, Brian J. P.; Boggon, Titus J.; Wlodarska, Iwona; Clark, Jennifer J.; Moore, Sandra; Adelsperger, Jennifer; Koo, Sumin; Lee, Jeffrey C.; Gabriel, Stacey; Mercher, Thomas; D'Andrea, Alan; Froehling, Stefan; Doehner, Konstanze; Marynen, Peter; Vandenberghe, Peter; Mesa, Ruben A.; Tefferi, Ayalew; Griffin, James D.; Eck, Michael J.; Sellers, William R.; Meyerson, Matthew; Golub, Todd R.; Lee, Stephanie J.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-397</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.  An internet-based protocol was used to collect clin. information and biol. specimens from patients with these diseases.  High-throughput DNA re-sequencing identified a recurrent somatic missense mutation JAK2V617F in granulocyte DNA samples of 121 of 164 PV patients, of which 41 had homozygous and 80 had heterozygous mutations.  Mol. and cytogenetic analyses demonstrated that homozygous mutations were due to duplication of the mutant allele.  JAK2V617F was also identified in granulocyte DNA samples from 37 of 115 ET and 16 of 46 MMM patients, but was not obsd. in 269 normal individuals.  In vitro anal. demonstrated that JAK2V617F is a constitutively active tyrosine kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJNzUFm3Q3bVg90H21EOLACvtfcHk0lh1m20zsmq6sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D&md5=2a3e893867b114e8749cd6f5e55990b7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520mutation%2520in%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520polycythemia%2520vera%252C%2520essential%2520thrombocythemia%252C%2520and%2520myeloid%2520metaplasia%2520with%2520myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le CouÃ©dic, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarÃ§on, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacaur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">â</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.+P.+Le+Cou%C3%A9dicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Gar%C3%A7onauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennacaur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCou%25C3%25A9dic%26aufirst%3DJ.%2BP.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGar%25C3%25A7on%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennacaur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polycythemia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Baxter, E. J.; Scott, L. M.; Campbell, P. J.; East, C.; Fourouclas, N.; Swanton, S.; Vassiliou, G. S.; Bench, A. J.; Boyd, E. M.; Curtin, N.; Scott, M. A.; Erber, W. N.</span>; the Cancer Genome project; <span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span>.  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">â</span> <span class="NLM_lpage">1061</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2FS0140-6736%2805%2971142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15781101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1054-1061&author=E.+J.+Baxter&author=L.+M.+Scott&author=P.+J.+Campbell&author=C.+East&author=N.+Fourouclas&author=S.+Swanton&author=G.+S.+Vassiliou&author=A.+J.+Bench&author=E.+M.+Boyd&author=N.+Curtin&author=M.+A.+Scott&author=W.+N.+Erberauthor=A.+R.+Green&title=Acquired+mutation+of+the+tyrosine+kinase+JAK2+in+human+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span></div><div class="casAuthors">Baxter, E. Joanna; Scott, Linda M.; Campbell, Peter J.; East, Clare; Fourouclas, Nasios; Swanton, Soheila; Vassiliou, George S.; Bench, Anthony J.; Boyd, Elaine M.; Curtin, Natasha; Scott, Mike A.; Erber, Wendy N.; Green, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9464</span>),
    <span class="NLM_cas:pages">1054-1061</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Human myeloproliferative disorders form a range of clonal haematol. malignant diseases, the main members of which are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  The mol. pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders.  We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder.  Methods: We obtained DNA samples from patients with polycythemia vera, essential thrombocythemia, or idiopathic myelofibrosis.  The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both.  Allele-specific PCR, mol. cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients.  Findings: A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythemia vera, 29 (57%) of 51 with essential thrombocythemia, and eight (50%) of 16 with idiopathic myelofibrosis.  The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the neg. regulatory JH2 domain, and is predicted to dysregulate kinase activity.  It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells.  The mutation was present in all erythropoietin-independent erythroid colonies.  Interpretation: A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder.  Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biol. feature of these disorders.  Relevance to practice: Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cc-kg2leZrVg90H21EOLACvtfcHk0lhDZRaqERItaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D&md5=3c9dc565a1986a47d12e4bccd8c8cc1a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2971142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252971142-9%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DAcquired%2520mutation%2520of%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520human%2520myeloproliferative%2520disorders%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1054%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Levine, R. L.</span><span> </span><span class="NLM_article-title">Mechanisms of mutations in myeloproliferative neoplasms</span> <span class="citation_source-journal">Best Pract. Res. Clin. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">â</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.beha.2009.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19959098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFagsbzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=489-494&author=R.+L.+Levine&title=Mechanisms+of+mutations+in+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of mutations in myeloproliferative neoplasms</span></div><div class="casAuthors">Levine, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-494</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, a series of studies have provided genetic insight into the pathogenesis of myeloproliferative neoplasms (MPNs).  It is now known that JAK2V617F mutations are present in 90% of patients with polycythemia vera (PV), 60% of patients with essential thrombocytosis (ET) and 50% of patients with myelofibrosis (MF).  Despite the high prevalence of JAK2V617F mutations in these three myeloid malignancies, several questions remain.  For example, how does one mutation contribute to the pathogenesis of three clin. distinct diseases, and how do some patients develop these diseases in the absence of a JAK2V617F mutation Single nucleotide polymorphisms at various loci and somatic mutations, such as those in MPLW515L/K, TET2 and in exon 12 of JAK2, may also contribute to the pathogenesis of these MPNs.  There are likely addnl. germline and somatic genetic factors important to the MPN phenotype.  Addnl. studies of large MPN and control cohorts with new techniques will help identify these factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYBRiT16nHFLVg90H21EOLACvtfcHk0lgTOgD3k8Dytg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFagsbzJ&md5=5d3977a29c4a78be41201ca3a952c75c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2009.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2009.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26atitle%3DMechanisms%2520of%2520mutations%2520in%2520myeloproliferative%2520neoplasms%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2009%26volume%3D22%26spage%3D489%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">QuintÃ¡s-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">â</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quint%C3%A1s-Cardamaauthor=K.+Vaddiauthor=P+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of â¼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0lgTOgD3k8Dytg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">â</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5882&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shacklefordauthor=H.+Sikanyikauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyik%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">â</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Plo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaincheker, W.</span><span> </span><span class="NLM_article-title">Molecular and genetic bases of myeloproliferative disorders: questions and perspectives</span> <span class="citation_source-journal">Clin. Lymphoma, Myeloma Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S329</span><span class="NLM_x">â</span> <span class="NLM_lpage">S339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=S329-S339&issue=Suppl.3&author=I.+Ploauthor=W.+Vaincheker&title=Molecular+and+genetic+bases+of+myeloproliferative+disorders%3A+questions+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlo%26aufirst%3DI.%26aulast%3DVaincheker%26aufirst%3DW.%26atitle%3DMolecular%2520and%2520genetic%2520bases%2520of%2520myeloproliferative%2520disorders%253A%2520questions%2520and%2520perspectives%26jtitle%3DClin.%2520Lymphoma%252C%2520Myeloma%2520Leukemia%26date%3D2009%26volume%3D9%26issue%3DSuppl.3%26spage%3DS329%26epage%3DS339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4672</span><span class="NLM_x">â</span> <span class="NLM_lpage">4684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-aminopyrazolylpyrimidines+as+potent+inhibitors+of+Trk+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-aminopyrazolylpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520Trk%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4672%26epage%3D4684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Baasner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauke, E.</span><span> </span><span class="NLM_article-title">A new route to the synthesis of 5-fluorouracil</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2FS0022-1139%2800%2982875-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADyaK3cXktVKjs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=417-430&author=B.+Baasnerauthor=E.+Klauke&title=A+new+route+to+the+synthesis+of+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A new route to the synthesis of 5-fluorouracil</span></div><div class="casAuthors">Baasner, B.; Klauke, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-30</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    </div><div class="casAbstract">Starting from tetrafluoropyrimidine, selective F-Cl exchange reactions and selective hydrogenolysis of the Cl substituents are combined with a hydrolysis reaction to provide a new route to 5-fluorouracil via 4,6-dichloro-2,5-difluoropyrimidine and 4-chloro-2,5-difluoropyrimidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqvX0c_VxMbbVg90H21EOLACvtfcHk0lhipwOSsmdn_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVKjs7c%253D&md5=1f4ef9f421c7f55fa27de12aca329804</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2800%2982875-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252800%252982875-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaasner%26aufirst%3DB.%26aulast%3DKlauke%26aufirst%3DE.%26atitle%3DA%2520new%2520route%2520to%2520the%2520synthesis%2520of%25205-fluorouracil%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D1989%26volume%3D45%26spage%3D417%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32334</span><span class="NLM_x">â</span> <span class="NLM_lpage">32343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1074%2Fjbc.M803813200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=18775810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32334-32343&author=J.+M.+Gozgitauthor=G.+Bebernitzauthor=P.+Patilauthor=M.+Yeauthor=J.+Wuauthor=N.+Suauthor=T.+Wangauthor=S.+Ioannidisauthor=A.+M.+Daviesauthor=D.+Huszarauthor=M.+Zinda&title=Effects+of+the+JAK2+inhibitor%2C+AZ960%2C+on+Pim%2FBAD%2FBCL-xL+survival+signaling+in+the+human+JAK2+V617F+cell+line+SET-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span></div><div class="casAuthors">Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">32334-32343</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Janus-assocd. kinase 2 (JAK2) V617F mutation is believed to play a crit. role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  We have characterized a novel small mol. JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line.  AZ960 inhibits JAK2 kinase with a Ki of 0.00045 Î¼M in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI50 = 0.025 Î¼M).  AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members.  In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI50 = 0.033 Î¼M) predominately through the induction of mitochondrial-mediated apoptosis.  We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the anti-apoptotic protein BCL-xL.  Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a redn. of BCL-xL protein levels.  Addnl., inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression.  Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser112.  Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype obsd. following JAK2 inhibition.  These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkGcqoxCVmrVg90H21EOLACvtfcHk0lhipwOSsmdn_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE&md5=c06798f302c0c0b50d4c763ae5c731c3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803813200%26sid%3Dliteratum%253Aachs%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520the%2520JAK2%2520inhibitor%252C%2520AZ960%252C%2520on%2520Pim%252FBAD%252FBCL-xL%2520survival%2520signaling%2520in%2520the%2520human%2520JAK2%2520V617F%2520cell%2520line%2520SET-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32334%26epage%3D32343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6524</span><span class="NLM_x">â</span> <span class="NLM_lpage">6528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.bmcl.2009.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19857966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6524-6528&author=S.+Ioannidisauthor=M.+L.+Lambauthor=A.+M.+Daviesauthor=L.+Almeidaauthor=M.+Suauthor=G.+Bebernitzauthor=M.+Yeauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Discovery+of+pyrazol-3-ylamino+pyrazines+as+novel+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Davies, Audrey M.; Almeida, Lynsie; Su, Mei; Bebernitz, Geraldine; Ye, Minwei; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6524-6528</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pyridineethyl- and pyrimidineethyl-substituted pyrazoleaminopyrazines such as I (R = Me; X = N) and I (R = H; X = CH) are prepd. as selective JAK2 kinase inhibitors for potential use as anticancer agents; the GI50 values for their JAK2 and JAK3 kinase inhibition are detd.  The activities of selected pyridineethyl- and pyrimidineethyl-substituted pyrazoleaminopyrazines in a functional phosphorylation model in mice and their inhibition of aurora B kinase, cyclin-dependent kinase 2, and TrkA are detd.; the pharmacokinetics and pharmacodynamics of I (R = Me; X = N) and of I (R = H; X = CH) in rats and beagles are also detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1tQ0K-v7orVg90H21EOLACvtfcHk0lhipwOSsmdn_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLvE&md5=3029e4300eb84ea19f704264c8753df6</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520pyrazol-3-ylamino%2520pyrazines%2520as%2520novel%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6524%26epage%3D6528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><div class="note"><p class="first last">See also for the use of high versus low ATP concentration</p></div><span class="NLM_contrib-group">Knight, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=A.+Z.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0li1WUSPAemokg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DA.%2BZ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Compound <b>9g</b> displayed good activity in an EPOR Stat5 cellular assay, EC<sub>50</sub> = 0.039 mM. For more details about the assay see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">â</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.bmcl.2010.01.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=20144546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1669-1673&author=S.+Ioannidisauthor=M.+L.+Lambauthor=L.+Almeidaauthor=H.+Guanauthor=B.+Pengauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Replacement+of+pyrazol-3-yl+amine+hinge+binder+with+thiazol-2-yl+amine%3A+Discovery+of+potent+and+selective+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Almeida, Lynsie; Guan, Huiping; Peng, Bo; Bebernitz, Geraldine; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1669-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thiazol-2-yl amine was identified as an isosteric replacement for pyrazol-3-yl amine during the efforts to identify potent and selective JAK2 inhibitors.  The rationale, synthesis and biol. evaluation of several analogs I (X = N, CH; R1 = MeO, 4-morpholinyl, 4-methyl-1-piperazinyl; R2 = H, F; R3 = Me, CN) is reported, along with the in vivo evaluation of the lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4-bwWDreyrVg90H21EOLACvtfcHk0li1WUSPAemokg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D&md5=a9b1f0cdc19311aca0a314325a1cbc56</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.091%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DReplacement%2520of%2520pyrazol-3-yl%2520amine%2520hinge%2520binder%2520with%2520thiazol-2-yl%2520amine%253A%2520Discovery%2520of%2520potent%2520and%2520selective%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1669%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Guan, H.; Hayter, B. R.; Huang, S.; Ioannidis, S.; Johannes, J.; Lamb, M.; Peng, B.; Yang, B.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer.</span> WO2008132502,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Guan&author=B.+R.+Hayter&author=S.+Huang&author=S.+Ioannidis&author=J.+Johannes&author=M.+Lamb&author=B.+Peng&author=B.+Yang&title=Preparation+of+pyrazolyl-amino-substituted+pyrimidines+and+their+use+for+the+treatment+of+cancer."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520pyrazolyl-amino-substituted%2520pyrimidines%2520and%2520their%2520use%2520for%2520the%2520treatment%2520of%2520cancer.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1182%2Fblood-2005-02-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15831699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSmsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=996-1002&author=T.+J.+Boggonauthor=Y.+Liauthor=P.+W.+Manleyauthor=M.+J.+Eck&title=Crystal+structure+of+the+Jak3+kinase+domain+in+complex+with+a+staurosporine+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog</span></div><div class="casAuthors">Boggon, Titus J.; Li, Yiqun; Manley, Paul W.; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">996-1002</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Jak (Janus kinase) family nonreceptor tyrosine kinases are central mediators of cytokine signaling.  The Jak kinases exhibit distinct cytokine receptor assocn. profiles and so transduce different signals.  Jak3 expression is limited to the immune system, where it plays a key role in signal transduction from cytokine receptors contg. the common gamma chain, Î³c.  Patients unable to signal via Î³c present with severe combined immunodeficiency (SCID).  The finding that Jak3 mutations result in SCID has made it a target for development of lymphocyte-specific immunosuppressants.  Here, we present the crystal structure of the Jak3 kinase domain in complex with staurosporine analog AFN941.  The kinase domain is in the active conformation, with both activation loop tyrosine residues phosphorylated.  The phosphate group on pTyr981 in the activation loop is in part coordinated by an arginine residue in the regulatory C-helix, suggesting a direct mechanism by which the active position of the C-helix is induced by phosphorylation of the activation loop.  Such a direct coupling has not been previously obsd. in tyrosine kinases and may be unique to Jak kinases.  The crystal structure provides a detailed view of the Jak3 active site and will facilitate computational and structure-directed approaches to development of Jak3-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-bnI3-sVjLVg90H21EOLACvtfcHk0li1WUSPAemokg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSmsr4%253D&md5=12f87a37a495559c6e34dde019578371</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-02-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-02-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520the%2520Jak3%2520kinase%2520domain%2520in%2520complex%2520with%2520a%2520staurosporine%2520analog%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D996%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hedvat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowolik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">â</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=487-497&author=M.+Hedvatauthor=D.+Huszarauthor=A.+Herrmannauthor=J.+M.+Gozgitauthor=A.+Schroederauthor=A.+Sheehyauthor=R.+Buettnerauthor=D.+Proiaauthor=C.+M.+Kowolikauthor=H.+Xinauthor=B.+Armstrongauthor=G.+Bebernitzauthor=S.+Wengauthor=L.+Wangauthor=M.+Yeauthor=K.+McEachernauthor=H.+Chenauthor=D.+Morosiniauthor=K.+Bellauthor=M.+Alimzhanovauthor=S.+Ioannidisauthor=P.+McCoonauthor=Z.+A.+Caoauthor=H.+Yuauthor=R.+Joveauthor=M.+Zinda&title=The+JAK2+inhibitor+AZD1480+potently+blocks+Stat3+signaling+and+oncogenesis+in+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedvat%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DA.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DProia%26aufirst%3DD.%26aulast%3DKowolik%26aufirst%3DC.%2BM.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DArmstrong%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DMcCoon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DThe%2520JAK2%2520inhibitor%2520AZD1480%2520potently%2520blocks%2520Stat3%2520signaling%2520and%2520oncogenesis%2520in%2520solid%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and in vivo activity of a new class of pyrazolylamino quinazolines as selective inhibitors of Aurora B Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2213</span><span class="NLM_x">â</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061335f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2213-2224&author=A.+A.+Mortlockauthor=K.+M.+Footeauthor=N.+M.+Heronauthor=F.+H.+Jungauthor=G.+Pasquetauthor=J-J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=C.+De+Saviauthor=N.+J.+Robertsauthor=T.+Johnsonauthor=C.+B.+Doussonauthor=G.+B.+Hillauthor=D.+Perkinsauthor=G.+Hatterauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=C.+Crafterauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwellauthor=L.+Khatriauthor=M.+C.+Bradyauthor=S.+Kearneyauthor=D.+McKillopauthor=S.+Rheadauthor=T.+Parryauthor=S.+Green&title=Discovery%2C+synthesis%2C+and+in+vivo+activity+of+a+new+class+of+pyrazolylamino+quinazolines+as+selective+inhibitors+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm061335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061335f%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLohmann%26aufirst%3DJ-J.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DHatter%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DBrady%26aufirst%3DM.%2BC.%26aulast%3DKearney%26aufirst%3DS.%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DRhead%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520activity%2520of%2520a%2520new%2520class%2520of%2520pyrazolylamino%2520quinazolines%2520as%2520selective%2520inhibitors%2520of%2520Aurora%2520B%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2213%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zage, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweidler-McKay, P. A.</span><span> </span><span class="NLM_article-title">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">â</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1158%2F1535-7163.MCT-09-0036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19509272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1818-1827&author=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=D.+Whitstonauthor=Z.-Y.+Liuauthor=E.+Hoffmannauthor=T.+Wangauthor=J.+L.+Brownauthor=K.+Websterauthor=C.+Omerauthor=P.+E.+Zageauthor=L.+Zengauthor=P.+A.+Zweidler-McKay&title=Identification+and+preclinical+characterization+of+AZ-23%2C+a+novel%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+Trk+kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span></div><div class="casAuthors">Thress, Kenneth; MacIntyre, Terry; Wang, Haiyun; Whitston, Dave; Liu, Zhong-Ying; Hoffmann, Ethan; Wang, Tao; Brown, Jeffrey L.; Webster, Kevin; Omer, Charles; Zage, Peter E.; Zeng, Lizhi; Zweidler-McKay, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (TrkA, TrkB, and TrkC) are receptor tyrosine kinases that, along with their ligands, the neurotrophins, are involved in neuronal cell growth, development, and survival.  The Trk-neurotrophin pathway may also play a role in tumorigenesis through oncogenic fusions, mutations, and autocrine signaling, prompting the development of novel Trk inhibitors as agents for cancer therapy.  This report describes the identification of AZ-23, a novel, potent, and selective Trk kinase inhibitor.  In vitro studies with AZ-23 showed improved selectivity over previous compds. and inhibition of Trk kinase activity in cells at low nanomolar concns.  AZ-23 showed in vivo TrkA kinase inhibition and efficacy in mice following oral administration in a TrkA-driven allograft model and significant tumor growth inhibition in a Trk-expressing xenograft model of neuroblastoma.  AZ-23 represents a potent and selective Trk kinase inhibitor from a novel series with the potential for use as a treatment for cancer. [Mol Cancer Ther 2009;8(7):1818-27].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2uvCSID5vbVg90H21EOLACvtfcHk0lj6dON951-YWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D&md5=8501f75147407ee64920fd4f5e733536</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0036%26sid%3Dliteratum%253Aachs%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.-Y.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DWebster%26aufirst%3DK.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DZage%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZweidler-McKay%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520and%2520preclinical%2520characterization%2520of%2520AZ-23%252C%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520Trk%2520kinase%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1818%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Quentmeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaborski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H. G.</span><span> </span><span class="NLM_article-title">JAK2V617 tyrosine kinase mutation in cell lines derived from myeloproliferative disorders</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=471-476&author=H.+Quentmeierauthor=R.+A.+MacLeodauthor=M.+Zaborskiauthor=H.+G.+Drexler&title=JAK2V617+tyrosine+kinase+mutation+in+cell+lines+derived+from+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuentmeier%26aufirst%3DH.%26aulast%3DMacLeod%26aufirst%3DR.%2BA.%26aulast%3DZaborski%26aufirst%3DM.%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DJAK2V617%2520tyrosine%2520kinase%2520mutation%2520in%2520cell%2520lines%2520derived%2520from%2520myeloproliferative%2520disorders%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rehemtulla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegman, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contag, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brian D Ross, B. D.</span><span> </span><span class="NLM_article-title">Rapid and quantitative assessment of cancer treatment response using <i>in vivo</i> bioluminescence imaging</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=491-495&author=A.+Rehemtullaauthor=L.+D.+Stegmanauthor=S.+J.+Cardozoauthor=S.+Guptaauthor=D.+E.+Hallauthor=C.+H.+Contagauthor=B.+D.+Brian+D+Ross&title=Rapid+and+quantitative+assessment+of+cancer+treatment+response+using+in+vivo+bioluminescence+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRehemtulla%26aufirst%3DA.%26aulast%3DStegman%26aufirst%3DL.%2BD.%26aulast%3DCardozo%26aufirst%3DS.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%2BE.%26aulast%3DContag%26aufirst%3DC.%2BH.%26aulast%3DBrian%2BD%2BRoss%26aufirst%3DB.%2BD.%26atitle%3DRapid%2520and%2520quantitative%2520assessment%2520of%2520cancer%2520treatment%2520response%2520using%2520in%2520vivo%2520bioluminescence%2520imaging%26jtitle%3DNeoplasia%26date%3D2000%26volume%3D2%26spage%3D491%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>QUANTA, Release 2000, <span class="NLM_publisher-loc">San Diego</span>: <span class="NLM_publisher-name">Accelrys Inc</span>.,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA%2C+Release+2000%2C+San+Diego%3A+Accelrys+Inc.%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Collaborative Computational Project Number 4</span><span> </span><span class="NLM_article-title">The <i>CCP</i>4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project+Number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lucet, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span> </span><span class="NLM_article-title">The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=176-183&author=I.+S.+Lucetauthor=E.+Fantinoauthor=M.+Stylesauthor=R.+Bamertauthor=O.+Patelauthor=S.+E.+Broughtonauthor=M.+Walterauthor=C.+J.+Burnsauthor=H.+Treutleinauthor=A.+F.+Wilksauthor=J.+Rossjohn&title=The+structural+basis+of+Janus+kinase+2+inhibition+by+a+potent+and+specific+pan-Janus+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucet%26aufirst%3DI.%2BS.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DBamert%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DBroughton%26aufirst%3DS.%2BE.%26aulast%3DWalter%26aufirst%3DM.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DRossjohn%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520basis%2520of%2520Janus%2520kinase%25202%2520inhibition%2520by%2520a%2520potent%2520and%2520specific%2520pan-Janus%2520kinase%2520inhibitor%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D176%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>COOT: <span class="NLM_contrib-group">Emsley, P.; Lohkamp, B.; Scott, W.; Cowtan, K.</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span>â <span class="NLM_lpage">501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COOT%3A+Emsley%2C+P.%3B+Lohkamp%2C+B.%3B+Scott%2C+W.%3B+Cowtan%2C+K.Acta+Crystallogr.+2010%2C+D66%2C+486%E2%88%92501."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26jtitle%3DActa%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>AFITT: <span class="NLM_publisher-name">OpenEye Scientific Software, Inc</span>., <span class="NLM_publisher-loc">Santa Fe</span>, <span class="NLM_publisher-loc">NM</span>, <span class="NLM_publisher-loc">USA</span>, <a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AFITT%3A+OpenEye+Scientific+Software%2C+Inc.%2C+Santa+Fe%2C+NM%2C+USA%2C+www.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DOpenEye%2520Scientific%2520Software%252C%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>Refmac v 5.1.17: <span class="NLM_contrib-group">Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span>â <span class="NLM_lpage">255</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Refmac+v+5.1.17%3A+Murshudov%2C+G.+N.%3B+Vagin%2C+A.+A.%3B+Dodson%2C+E.+J.Acta+Crystallogr.+1997%2C+D53%2C+240%E2%88%92255."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26jtitle%3DActa%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">DeLano, W. L.</span><span> </span><span class="NLM_article-title">The PyMOL molecular graphics system</span>; <span class="NLM_publisher-name">DeLano Scientific</span>: <span class="NLM_publisher-loc">San Carlos, CA, USA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span><a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeLano%2C+W.+L.+The+PyMOL+molecular+graphics+system%3B+DeLano+Scientific%3A+San+Carlos%2C+CA%2C+USA%2C+2002%3B+http%3A%2F%2Fwww.pymol.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26atitle%3DThe%2520PyMOL%2520molecular%2520graphics%2520system%26pub%3DDeLano%2520Scientific%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':[],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 93 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ernesto Santandrea, Christine Waldraff, Gilles Gerber, MaÃ«l Moreau, <span class="NLM_string-name hlFld-ContribAuthor">Pascal Beney</span>. </span><span class="cited-content_cbyCitation_article-title">Development of the Late-Phase Manufacturing Process of ZPL389: Control of Process Impurities by Enhanced Process Knowledge. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (5)
                                     , 1190-1205. <a href="https://doi.org/10.1021/acs.oprd.1c00077" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00077%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Bthe%252BLate-Phase%252BManufacturing%252BProcess%252Bof%252BZPL389%25253A%252BControl%252Bof%252BProcess%252BImpurities%252Bby%252BEnhanced%252BProcess%252BKnowledge%26aulast%3DSantandrea%26aufirst%3DErnesto%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D27022021%26date%3D14042021%26volume%3D25%26issue%3D5%26spage%3D1190%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Yang, Mengshi Hu, Yong Chen, Mingli Xiang, Minghai Tang, Wenyan Qi, Mingsong Shi, Jun He, Xue Yuan, Chufeng Zhang, Kongjun Liu, Jiewen Li, Zhuang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14921-14936. <a href="https://doi.org/10.1021/acs.jmedchem.0c01488" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01488%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-%252528Pyrimidin-2-yl%252529-1%25252C2%25252C3%25252C4-tetrahydroisoquinolin-6-amine%252BDerivatives%252Bas%252BSelective%252BJanus%252BKinase%252B2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BMyeloproliferative%252BNeoplasms%26aulast%3DYang%26aufirst%3DTao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26082020%26date%3D30112020%26volume%3D63%26issue%3D23%26spage%3D14921%26epage%3D14936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Yang, Mengshi Hu, Wenyan Qi, Zhuang Yang, Minghai Tang, Jun He, Yong Chen, Peng Bai, Xue Yuan, Chufeng Zhang, Kongjun Liu, Yulin Lu, Mingli Xiang, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10305-10320. <a href="https://doi.org/10.1021/acs.jmedchem.9b01348" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01348%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BOrally%252BEffective%252BDual%252BJanus%252BKinase%252B2%25252FFLT3%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BMyelogenous%252BLeukemia%252Band%252BMyeloproliferative%252BNeoplasms%26aulast%3DYang%26aufirst%3DTao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15082019%26date%3D08112019%26date%3D31102019%26volume%3D62%26issue%3D22%26spage%3D10305%26epage%3D10320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qian Zhao, James R. Manning, James Sutton, Abran Costales, Martin Sendzik, Cynthia M. Shafer, Julian R. Levell, Gang Liu, Thomas Caferro, Young Shin Cho, Mark Palermo, Gregg Chenail, Julia Dooley, Brian Villalba, Ali Farsidjani, Jinyun Chen, Stephanie Dodd, Ty Gould, Guiqing Liang, Kelly Slocum, Minying Pu, Brant Firestone, Joseph Growney, Tycho Heimbach, <span class="NLM_string-name hlFld-ContribAuthor">Raymond Pagliarini</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 746-751. <a href="https://doi.org/10.1021/acsmedchemlett.8b00182" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00182%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252B3-Pyrimidin-4-yl-oxazolidin-2-ones%252Bas%252BOrally%252BBioavailable%252Band%252BBrain%252BPenetrant%252BMutant%252BIDH1%252BInhibitors%26aulast%3DZhao%26aufirst%3DQian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16042018%26date%3D11062018%26date%3D15062018%26date%3D11062018%26volume%3D9%26issue%3D7%26spage%3D746%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Geier, Pascal Schmitz, JÄdrzej Walkowiak, Walter Leitner, <span class="NLM_string-name hlFld-ContribAuthor">Giancarlo FranciÃ²</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous Flow Asymmetric Hydrogenation with Supported Ionic Liquid Phase Catalysts Using Modified CO2 as the Mobile Phase: from Model Substrate to an Active Pharmaceutical Ingredient. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2018,</strong> <em>8 </em>
                                    (4)
                                     , 3297-3303. <a href="https://doi.org/10.1021/acscatal.8b00216" title="DOI URL">https://doi.org/10.1021/acscatal.8b00216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.8b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.8b00216%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DContinuous%252BFlow%252BAsymmetric%252BHydrogenation%252Bwith%252BSupported%252BIonic%252BLiquid%252BPhase%252BCatalysts%252BUsing%252BModified%252BCO2%252Bas%252Bthe%252BMobile%252BPhase%25253A%252Bfrom%252BModel%252BSubstrate%252Bto%252Ban%252BActive%252BPharmaceutical%252BIngredient%26aulast%3DGeier%26aufirst%3DDaniel%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17012018%26date%3D06032018%26date%3D16032018%26volume%3D8%26issue%3D4%26spage%3D3297%26epage%3D3303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sam Hofmans, Lars Devisscher, Sofie Martens, Dries Van Rompaey, Kenneth Goossens, Tatyana Divert, Wim Nerinckx, Nozomi Takahashi, Hans De Winter, Pieter Van Der Veken, Vera Goossens, Peter Vandenabeele, <span class="NLM_string-name hlFld-ContribAuthor">Koen Augustyns</span>. </span><span class="cited-content_cbyCitation_article-title">Tozasertib Analogues as Inhibitors of Necroptotic Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1895-1920. <a href="https://doi.org/10.1021/acs.jmedchem.7b01449" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTozasertib%252BAnalogues%252Bas%252BInhibitors%252Bof%252BNecroptotic%252BCell%252BDeath%26aulast%3DHofmans%26aufirst%3DSam%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29092017%26date%3D20022018%26date%3D13022018%26volume%3D61%26issue%3D5%26spage%3D1895%26epage%3D1920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian R.  Levell</span>, <span class="hlFld-ContribAuthor ">Thomas  Caferro</span>, <span class="hlFld-ContribAuthor ">Gregg  Chenail</span>, <span class="hlFld-ContribAuthor ">Ina  Dix</span>, <span class="hlFld-ContribAuthor ">Julia  Dooley</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Ty  Gould</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Growney</span>, <span class="hlFld-ContribAuthor ">Michael D.  Jones</span>, <span class="hlFld-ContribAuthor ">Raviraj  Kulathila</span>, <span class="hlFld-ContribAuthor ">Fallon  Lin</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Arne  Mueller</span>, <span class="hlFld-ContribAuthor ">Simon  van der Plas</span>, <span class="hlFld-ContribAuthor ">Kelly  Slocum</span>, <span class="hlFld-ContribAuthor ">Troy  Smith</span>, <span class="hlFld-ContribAuthor ">Remi  Terranova</span>, <span class="hlFld-ContribAuthor ">B. Barry  TourÃ©</span>, <span class="hlFld-ContribAuthor ">Viraj  Tyagi</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Fan S.  Yang</span>, <span class="hlFld-ContribAuthor ">Liping X.  Zhou</span>, <span class="hlFld-ContribAuthor ">Raymond  Pagliarini</span>, and <span class="hlFld-ContribAuthor ">Young Shin  Cho</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 151-156. <a href="https://doi.org/10.1021/acsmedchemlett.6b00334" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252B3-Pyrimidin-4-yl-oxazolidin-2-ones%252Bas%252BAllosteric%252Band%252BMutant%252BSpecific%252BInhibitors%252Bof%252BIDH1%26aulast%3DLevell%26aufirst%3DJulian%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D20082016%26date%3D16122016%26date%3D06012017%26date%3D09022017%26date%3D16122016%26volume%3D8%26issue%3D2%26spage%3D151%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zacharias  Amara</span>, <span class="hlFld-ContribAuthor ">Martyn  Poliakoff</span>, <span class="hlFld-ContribAuthor ">RubÃ©n  Duque</span>, <span class="hlFld-ContribAuthor ">Daniel  Geier</span>, <span class="hlFld-ContribAuthor ">Giancarlo  FranciÃ²</span>, <span class="hlFld-ContribAuthor ">Charles M.  Gordon</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Meadows</span>, <span class="hlFld-ContribAuthor ">Robert  Woodward</span>, and <span class="hlFld-ContribAuthor ">Walter  Leitner</span>  . </span><span class="cited-content_cbyCitation_article-title">Enabling the Scale-Up of a Key Asymmetric Hydrogenation Step in the Synthesis of an API Using Continuous Flow Solid-Supported Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (7)
                                     , 1321-1327. <a href="https://doi.org/10.1021/acs.oprd.6b00143" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00143%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnabling%252Bthe%252BScale-Up%252Bof%252Ba%252BKey%252BAsymmetric%252BHydrogenation%252BStep%252Bin%252Bthe%252BSynthesis%252Bof%252Ban%252BAPI%252BUsing%252BContinuous%252BFlow%252BSolid-Supported%252BCatalysis%26aulast%3DAmara%26aufirst%3DZacharias%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D10062016%26date%3D15072016%26volume%3D20%26issue%3D7%26spage%3D1321%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">DÃ¡vid  Bajusz</span>, <span class="hlFld-ContribAuthor ">GyÃ¶rgy G.  Ferenczy</span>, and <span class="hlFld-ContribAuthor ">GyÃ¶rgy M.  KeserÅ±</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (1)
                                     , 234-247. <a href="https://doi.org/10.1021/acs.jcim.5b00634" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BSubtype%252BSelective%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18102015%26date%3D31122015%26date%3D25012016%26date%3D18122015%26volume%3D56%26issue%3D1%26spage%3D234%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Lesley  Murray</span>, <span class="hlFld-ContribAuthor ">Hank  La</span>, <span class="hlFld-ContribAuthor ">Ning  Liu</span>, <span class="hlFld-ContribAuthor ">Peter W.  Fan</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheong</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Heise</span>, <span class="hlFld-ContribAuthor ">Sreemathy  Ramaswamy</span>, <span class="hlFld-ContribAuthor ">Robert  Mintzer</span>, <span class="hlFld-ContribAuthor ">Yanzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  Chao</span>, and <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 5121-5136. <a href="https://doi.org/10.1021/acs.jmedchem.5b00572" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00572%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%252Bof%252BGroup%252BI%252BSelective%252Bp21-Activated%252BKinase%252BInhibitors%26aulast%3DCrawford%26aufirst%3DJames%2BJ.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11042015%26date%3D12062015%26date%3D25062015%26date%3D01062015%26volume%3D58%26issue%3D12%26spage%3D5121%26epage%3D5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, and <span class="hlFld-ContribAuthor ">Weiru  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of p21-Activated Kinases (PAKs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 111-129. <a href="https://doi.org/10.1021/jm501613q" title="DOI URL">https://doi.org/10.1021/jm501613q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501613q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501613q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bp21-Activated%252BKinases%252B%252528PAKs%252529%26aulast%3DRudolph%26aufirst%3DJoachim%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D18102014%26date%3D03122014%26date%3D08012015%26date%3D21112014%26volume%3D58%26issue%3D1%26spage%3D111%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Stephanos  Ioannidis</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">Lynsie  Almeida</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Geraldine  Bebernitz</span>, <span class="hlFld-ContribAuthor ">Kirsten  Bell</span>, <span class="hlFld-ContribAuthor ">Michael  Block</span>, <span class="hlFld-ContribAuthor ">Tina  Howard</span>, <span class="hlFld-ContribAuthor ">Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Jon A.  Read</span>, <span class="hlFld-ContribAuthor ">Caroline  Rivard Costa</span>, <span class="hlFld-ContribAuthor ">Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Mei  Su</span>, <span class="hlFld-ContribAuthor ">Minwei  Ye</span>, and <span class="hlFld-ContribAuthor ">Michael  Zinda</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 144-158. <a href="https://doi.org/10.1021/jm401546n" title="DOI URL">https://doi.org/10.1021/jm401546n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401546n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401546n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-Methyl-1H-imidazole%252BDerivatives%252Bas%252BPotent%252BJak2%252BInhibitors%26aulast%3DSu%26aufirst%3DQibin%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D03102013%26date%3D20122013%26date%3D09012014%26date%3D10122013%26volume%3D57%26issue%3D1%26spage%3D144%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lianne  Frodsham</span>, <span class="hlFld-ContribAuthor ">Michael  Golden</span>, <span class="hlFld-ContribAuthor ">Susan  Hard</span>, <span class="hlFld-ContribAuthor ">Martin N.  Kenworthy</span>, <span class="hlFld-ContribAuthor ">David J.  Klauber</span>, <span class="hlFld-ContribAuthor ">Kevin  Leslie</span>, <span class="hlFld-ContribAuthor ">Claire  Macleod</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Meadows</span>, <span class="hlFld-ContribAuthor ">Keith R.  Mulholland</span>, <span class="hlFld-ContribAuthor ">Julie  Reilly</span>, <span class="hlFld-ContribAuthor ">Christopher  Squire</span>, <span class="hlFld-ContribAuthor ">Simone  Tomasi</span>, <span class="hlFld-ContribAuthor ">Denise  Watt</span>, and <span class="hlFld-ContribAuthor ">Andrew S.  Wells</span>  . </span><span class="cited-content_cbyCitation_article-title">Use of Ï-Transaminase Enzyme Chemistry in the Synthesis of a JAK2 Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (9)
                                     , 1123-1130. <a href="https://doi.org/10.1021/op400133d" title="DOI URL">https://doi.org/10.1021/op400133d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400133d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400133d%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DUse%252Bof%252B%2525CF%252589-Transaminase%252BEnzyme%252BChemistry%252Bin%252Bthe%252BSynthesis%252Bof%252Ba%252BJAK2%252BKinase%252BInhibitor%26aulast%3DFrodsham%26aufirst%3DLianne%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24052013%26date%3D28082013%26date%3D20092013%26date%3D03072013%26volume%3D17%26issue%3D9%26spage%3D1123%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Stuart I.  Ward</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Richard  Bull</span>, <span class="hlFld-ContribAuthor ">Paroma  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Peter  Crackett</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Charles  Ellwood</span>, <span class="hlFld-ContribAuthor ">Simon  Gaines</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Stefan  Gradl</span>, <span class="hlFld-ContribAuthor ">Peter  Gribling</span>, <span class="hlFld-ContribAuthor ">Chris  Hamman</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Peter  Hewitt</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Pawan  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Wyne P.  Lee</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Raman  Narukulla</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Austin  Reeve</span>, <span class="hlFld-ContribAuthor ">Scott  Savage</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Barbara  Avitabile-Woo</span>, <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, and <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4764-4785. <a href="https://doi.org/10.1021/jm4004895" title="DOI URL">https://doi.org/10.1021/jm4004895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4004895%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BC-2%252BHydroxyethyl%252BImidazopyrrolopyridines%252Bas%252BPotent%252BJAK1%252BInhibitors%252Bwith%252BFavorable%252BPhysicochemical%252BProperties%252Band%252BHigh%252BSelectivity%252Bover%252BJAK2%26aulast%3DZak%26aufirst%3DMark%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04042013%26date%3D31052013%26date%3D13062013%26date%3D09052013%26volume%3D56%26issue%3D11%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Jeff  Blaney</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Sean  Flynn</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Janusz  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, <span class="hlFld-ContribAuthor ">Claire  Morris</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Richard M.  Pastor</span>, <span class="hlFld-ContribAuthor ">Tom  Rawson</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Aihe  Zhou</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 10090-10107. <a href="https://doi.org/10.1021/jm3012239" title="DOI URL">https://doi.org/10.1021/jm3012239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3012239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3012239%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252BPyrazolopyrimidine%252BJanus%252BKinase%252B2%252BInhibitors%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22082012%26date%3D24102012%26date%3D26112012%26date%3D12102012%26volume%3D55%26issue%3D22%26spage%3D10090%26epage%3D10107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Stefan  Gradl</span>, <span class="hlFld-ContribAuthor ">Chris  Hamman</span>, <span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Peter R.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Tian  Jin</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Pawan  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Lin</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Robert J.  Maxey</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Madeleine  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Scott  Savage</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Stuart I.  Ward</span>, <span class="hlFld-ContribAuthor ">Ling  Xiao</span>, and <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (13)
                                     , 6176-6193. <a href="https://doi.org/10.1021/jm300628c" title="DOI URL">https://doi.org/10.1021/jm300628c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300628c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BC-2%252BMethyl%252BImidazopyrrolopyridines%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BJAK1%252BInhibitors%252Bwith%252BSelectivity%252Bover%252BJAK2%26aulast%3DZak%26aufirst%3DMark%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D05052012%26date%3D28062012%26date%3D12072012%26date%3D14062012%26volume%3D55%26issue%3D13%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony D.  William</span>, <span class="hlFld-ContribAuthor ">Angeline C.-H.  Lee</span>, <span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Kee Chuan  Goh</span>, <span class="hlFld-ContribAuthor ">Babita  Madan</span>, <span class="hlFld-ContribAuthor ">Stefan  Hart</span>, <span class="hlFld-ContribAuthor ">Evelyn  Tan</span>, <span class="hlFld-ContribAuthor ">Haishan  Wang</span>, <span class="hlFld-ContribAuthor ">Harish  Nagaraj</span>, <span class="hlFld-ContribAuthor ">Dizhong  Chen</span>, <span class="hlFld-ContribAuthor ">Chai Ping  Lee</span>, <span class="hlFld-ContribAuthor ">Eric T.  Sun</span>, <span class="hlFld-ContribAuthor ">Ramesh  Jayaraman</span>, <span class="hlFld-ContribAuthor ">Mohammad Khalid  Pasha</span>, <span class="hlFld-ContribAuthor ">Kantharaj  Ethirajulu</span>, <span class="hlFld-ContribAuthor ">Jeanette M.  Wood</span>, and <span class="hlFld-ContribAuthor ">Brian W.  Dymock</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Macrocycle (9E)-15-(2-(Pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a Potent Inhibitor of Janus Kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the Treatment of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2623-2640. <a href="https://doi.org/10.1021/jm201454n" title="DOI URL">https://doi.org/10.1021/jm201454n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201454n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201454n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BMacrocycle%252B%2525289E%252529-15-%2525282-%252528Pyrrolidin-1-yl%252529ethoxy%252529-7%25252C12%25252C25-trioxa-19%25252C21%25252C24-triaza-tetracyclo%25255B18.3.1.1%2525282%25252C5%252529.1%25252814%25252C18%252529%25255Dhexacosa-1%25252824%252529%25252C2%25252C4%25252C9%25252C14%25252826%252529%25252C15%25252C17%25252C20%25252C22-nonaene%252B%252528SB1578%252529%25252C%252Ba%252BPotent%252BInhibitor%252Bof%252BJanus%252BKinase%252B2%25252FFms-LikeTyrosine%252BKinase-3%252B%252528JAK2%25252FFLT3%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%26aulast%3DWilliam%26aufirst%3DAnthony%2BD.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D27102011%26date%3D06032012%26date%3D22032012%26date%3D17022012%26volume%3D55%26issue%3D6%26spage%3D2623%26epage%3D2640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Mitchell</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Cole</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Pollock</span>, <span class="hlFld-ContribAuthor ">David M.  Coppert</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Burkholder</span>, and <span class="hlFld-ContribAuthor ">Joshua R.  Clayton</span>  . </span><span class="cited-content_cbyCitation_article-title">Development and a Practical Synthesis of the JAK2 Inhibitor LY2784544. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (1)
                                     , 70-81. <a href="https://doi.org/10.1021/op200229j" title="DOI URL">https://doi.org/10.1021/op200229j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op200229j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop200229j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Band%252Ba%252BPractical%252BSynthesis%252Bof%252Bthe%252BJAK2%252BInhibitor%252BLY2784544%26aulast%3DMitchell%26aufirst%3DDavid%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D19082011%26date%3D09112011%26date%3D20012012%26date%3D22102011%26volume%3D16%26issue%3D1%26spage%3D70%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurie B.  Schenkel</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Alan  Cheng</span>, <span class="hlFld-ContribAuthor ">Holly L.  Deak</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Doherty</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Yan  Gu</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Joseph L.  Kim</span>, <span class="hlFld-ContribAuthor ">Josie  Lee</span>, <span class="hlFld-ContribAuthor ">Robert  Loberg</span>, <span class="hlFld-ContribAuthor ">Philip  Olivieri</span>, <span class="hlFld-ContribAuthor ">Jeanne  Pistillo</span>, <span class="hlFld-ContribAuthor ">Jin  Tang</span>, <span class="hlFld-ContribAuthor ">Qian  Wan</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Shen-Wu  Wang</span>, <span class="hlFld-ContribAuthor ">Mary C.  Wells</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, <span class="hlFld-ContribAuthor ">Liqin  Liu</span>, and <span class="hlFld-ContribAuthor ">Stephanie  Geuns-Meyer</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8440-8450. <a href="https://doi.org/10.1021/jm200911r" title="DOI URL">https://doi.org/10.1021/jm200911r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200911r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BHighly%252BSelective%252BThienopyridine%252BJanus%252BKinase%252B2%252BInhibitors%26aulast%3DSchenkel%26aufirst%3DLaurie%2BB.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D11072011%26date%3D16112011%26date%3D22122011%26volume%3D54%26issue%3D24%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ed  Griffen</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Graeme R.  Robb</span>, and <span class="hlFld-ContribAuthor ">Daniel J.  Warner</span>  . </span><span class="cited-content_cbyCitation_article-title">Matched Molecular Pairs as a Medicinal Chemistry Tool. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (22)
                                     , 7739-7750. <a href="https://doi.org/10.1021/jm200452d" title="DOI URL">https://doi.org/10.1021/jm200452d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200452d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMatched%252BMolecular%252BPairs%252Bas%252Ba%252BMedicinal%252BChemistry%252BTool%26aulast%3DGriffen%26aufirst%3DEd%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14042011%26date%3D22092011%26date%3D24112011%26volume%3D54%26issue%3D22%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Shapovalov</span>, <span class="hlFld-ContribAuthor ">Liliya  Kopanitsa</span>, <span class="hlFld-ContribAuthor ">Lavinia-Lorena  Pruteanu</span>, <span class="hlFld-ContribAuthor ">Graham  Ladds</span>, <span class="hlFld-ContribAuthor ">David S.  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 3780. <a href="https://doi.org/10.3390/cancers13153780" title="DOI URL">https://doi.org/10.3390/cancers13153780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13153780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13153780%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTranscriptomics-Based%252BPhenotypic%252BScreening%252BSupports%252BDrug%252BDiscovery%252Bin%252BHuman%252BGlioblastoma%252BCells%26aulast%3DShapovalov%26aufirst%3DVladimir%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D3780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinan  Qiao</span>, <span class="hlFld-ContribAuthor ">Jun  Ma</span>, <span class="hlFld-ContribAuthor ">Tristan  Knight</span>, <span class="hlFld-ContribAuthor ">Yongwei  Su</span>, <span class="hlFld-ContribAuthor ">Holly  Edwards</span>, <span class="hlFld-ContribAuthor ">Lisa  Polin</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Juiwanna  Kushner</span>, <span class="hlFld-ContribAuthor ">Sijana H.  Dzinic</span>, <span class="hlFld-ContribAuthor ">Kathryn  White</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Hai  Lin</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Wang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Taub</span>, <span class="hlFld-ContribAuthor ">Yubin  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. </span><span class="cited-content_cbyCitation_journal-name">Blood Cancer Journal</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     <a href="https://doi.org/10.1038/s41408-021-00502-7" title="DOI URL">https://doi.org/10.1038/s41408-021-00502-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41408-021-00502-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41408-021-00502-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Cancer%2520Journal%26atitle%3DThe%252Bcombination%252Bof%252BCUDC-907%252Band%252Bgilteritinib%252Bshows%252Bpromising%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bantileukemic%252Bactivity%252Bagainst%252BFLT3-ITD%252BAML%26aulast%3DQiao%26aufirst%3DXinan%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Hai  Wang</span>, <span class="hlFld-ContribAuthor ">Lian  Qin</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Qiushuang  Sun</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Yi  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhixia  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113394. <a href="https://doi.org/10.1016/j.ejmech.2021.113394" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113394%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bimidazopyrrolopyridines%252Bderivatives%252Bas%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252BJAK2%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2021%26volume%3D218%26spage%3D113394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Guang  Zheng</span>, <span class="hlFld-ContribAuthor ">Jin-An  Wang</span>, <span class="hlFld-ContribAuthor ">Long  Meng</span>, <span class="hlFld-ContribAuthor ">Xin  Pei</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  An</span>, <span class="hlFld-ContribAuthor ">Cheng-Lin  Li</span>, <span class="hlFld-ContribAuthor ">Ying-Long  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112934. <a href="https://doi.org/10.1016/j.ejmech.2020.112934" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112934%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bactivity%252Bevaluation%252Bof%252B3-%2525284-phenyl-1H-imidazol-2-yl%252529-1H-pyrazole%252Bderivatives%252Bas%252Bpotent%252BJAK%252B2%25252F3%252Band%252Baurora%252BA%25252FB%252Bkinases%252Bmulti-targeted%252Binhibitors%26aulast%3DZheng%26aufirst%3DYou-Guang%26date%3D2021%26volume%3D209%26spage%3D112934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emir  Hadzijusufovic</span>, <span class="hlFld-ContribAuthor ">Alexandra  Keller</span>, <span class="hlFld-ContribAuthor ">Daniela  Berger</span>, <span class="hlFld-ContribAuthor ">Georg  Greiner</span>, <span class="hlFld-ContribAuthor ">Bettina  Wingelhofer</span>, <span class="hlFld-ContribAuthor ">Nadine  Witzeneder</span>, <span class="hlFld-ContribAuthor ">Daniel  Ivanov</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Pecnard</span>, <span class="hlFld-ContribAuthor ">Harini  Nivarthi</span>, <span class="hlFld-ContribAuthor ">Florian K. M.  Schur</span>, <span class="hlFld-ContribAuthor ">YÃ¼ksel  Filik</span>, <span class="hlFld-ContribAuthor ">Christoph  Kornauth</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Leonhard  MÃ¼llauer</span>, <span class="hlFld-ContribAuthor ">Gary  Tin</span>, <span class="hlFld-ContribAuthor ">Jisung  Park</span>, <span class="hlFld-ContribAuthor ">Elvin D.  de Araujo</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">Gregor  Hoermann</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>, <span class="hlFld-ContribAuthor ">Robert  Kralovics</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>. </span><span class="cited-content_cbyCitation_article-title">STAT5 is Expressed in CD34+/CD38â Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 1021. <a href="https://doi.org/10.3390/cancers12041021" title="DOI URL">https://doi.org/10.3390/cancers12041021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12041021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12041021%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSTAT5%252Bis%252BExpressed%252Bin%252BCD34%25252B%25252FCD38%2525E2%252588%252592%252BStem%252BCells%252Band%252BServes%252Bas%252Ba%252BPotential%252BMolecular%252BTarget%252Bin%252BPh-Negative%252BMyeloproliferative%252BNeoplasms%26aulast%3DHadzijusufovic%26aufirst%3DEmir%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Shan</span>, <span class="hlFld-ContribAuthor ">Sheng  Yao</span>, <span class="hlFld-ContribAuthor ">Yang  Ye</span>, <span class="hlFld-ContribAuthor ">Qiang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">3-Deoxy-2Î²,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (12)
                                     , 1578-1586. <a href="https://doi.org/10.1038/s41401-019-0254-4" title="DOI URL">https://doi.org/10.1038/s41401-019-0254-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0254-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0254-4%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3D3-Deoxy-2%2525CE%2525B2%25252C16-dihydroxynagilactone%252BE%25252C%252Ba%252Bnatural%252Bcompound%252Bfrom%252BPodocarpus%252Bnagi%25252C%252Bpreferentially%252Binhibits%252BJAK2%25252FSTAT3%252Bsignaling%252Bby%252Ballosterically%252Binteracting%252Bwith%252Bthe%252Bregulatory%252Bdomain%252Bof%252BJAK2%252Band%252Binduces%252Bapoptosis%252Bof%252Bcancer%252Bcells%26aulast%3DShan%26aufirst%3DHui%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D12%26spage%3D1578%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Yin</span>, <span class="hlFld-ContribAuthor ">Cheng-Juan  Chen</span>, <span class="hlFld-ContribAuthor ">Ru-Nan  Yu</span>, <span class="hlFld-ContribAuthor ">Lei  Shu</span>, <span class="hlFld-ContribAuthor ">Tian-Tai  Zhang</span>, <span class="hlFld-ContribAuthor ">Da-Yong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1562-1576. <a href="https://doi.org/10.1016/j.bmc.2019.02.054" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bselective%252BJanus%252Bkinase%252B2%252B%252528JAK2%252529%252Binhibitors%252Bbearing%252Ba%252B1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-4-amino%252Bscaffold%26aulast%3DYin%26aufirst%3DYuan%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1562%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Catalytic Process Design: The Industrial Perspective. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 31-73. <a href="https://doi.org/10.1002/9783527807253.ch2" title="DOI URL">https://doi.org/10.1002/9783527807253.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527807253.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527807253.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DCatalytic%252BProcess%252BDesign%25253A%252BThe%252BIndustrial%252BPerspective%26date%3D2018%26date%3D2018%26spage%3D31%26epage%3D73%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DActive%252BPharmaceutical%252BIngredients%252Bin%252BSynthesis%26aulast%3DBurke%26aufirst%3DAnthony%2BJ%26date%3D2018%26volume%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shao-Ru  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Mo-Yu  Ding</span>, <span class="hlFld-ContribAuthor ">Decai  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhao</span>, <span class="hlFld-ContribAuthor ">Yitao  Wang</span>, <span class="hlFld-ContribAuthor ">Guo-Chun  Zhou</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5053-5061. <a href="https://doi.org/10.1016/j.bmc.2018.09.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAndrographolide%252Bderivative%252Bas%252BSTAT3%252Binhibitor%252Bthat%252Bprotects%252Bacute%252Bliver%252Bdamage%252Bin%252Bmice%26aulast%3DChen%26aufirst%3DShao-Ru%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5053%26epage%3D5061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">HÃ©ctor  FernÃ¡ndez-PÃ©rez</span>, <span class="hlFld-ContribAuthor ">Bugga  Balakrishna</span>, <span class="hlFld-ContribAuthor ">Anton  Vidal-Ferran</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Investigations on Enantiopure P-OP Ligands: A High-Performing P-OP Ligand for Rhodium-Catalysed Hydrogenations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (13)
                                     , 1525-1532. <a href="https://doi.org/10.1002/ejoc.201701760" title="DOI URL">https://doi.org/10.1002/ejoc.201701760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701760%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStructural%252BInvestigations%252Bon%252BEnantiopure%252BP-OP%252BLigands%25253A%252BA%252BHigh-Performing%252BP-OP%252BLigand%252Bfor%252BRhodium-Catalysed%252BHydrogenations%26aulast%3DFern%25C3%25A1ndez-P%25C3%25A9rez%26aufirst%3DH%25C3%25A9ctor%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D13%26spage%3D1525%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Long</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Zhi-Jie  Hou</span>, <span class="hlFld-ContribAuthor ">Hua-Juan  Ma</span>, <span class="hlFld-ContribAuthor ">Zi-Jie  Long</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, <span class="hlFld-ContribAuthor ">Lin-Jie  Huang</span>, <span class="hlFld-ContribAuthor ">Quentin  Liu</span>, <span class="hlFld-ContribAuthor ">Gui  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of aurora kinases inhibitors based on N -trisubstituted pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 805-812. <a href="https://doi.org/10.1016/j.ejmech.2017.12.082" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.082%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Baurora%252Bkinases%252Binhibitors%252Bbased%252Bon%252BN%252B-trisubstituted%252Bpyrimidine%252Bscaffold%26aulast%3DLong%26aufirst%3DLiang%26date%3D2018%26volume%3D145%26spage%3D805%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iva  Gudernova</span>, <span class="hlFld-ContribAuthor ">Lukas  Balek</span>, <span class="hlFld-ContribAuthor ">Miroslav  Varecha</span>, <span class="hlFld-ContribAuthor ">Jana Fialova  Kucerova</span>, <span class="hlFld-ContribAuthor ">Michaela  Kunova Bosakova</span>, <span class="hlFld-ContribAuthor ">Bohumil  Fafilek</span>, <span class="hlFld-ContribAuthor ">Veronika  Palusova</span>, <span class="hlFld-ContribAuthor ">Stjepan  Uldrijan</span>, <span class="hlFld-ContribAuthor ">Lukas  Trantirek</span>, <span class="hlFld-ContribAuthor ">Pavel  Krejci</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (65)
                                     , 109319-109331. <a href="https://doi.org/10.18632/oncotarget.22674" title="DOI URL">https://doi.org/10.18632/oncotarget.22674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22674%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibitor%252Brepurposing%252Breveals%252BALK%25252C%252BLTK%25252C%252BFGFR%25252C%252BRET%252Band%252BTRK%252Bkinases%252Bas%252Bthe%252Btargets%252Bof%252BAZD1480%26aulast%3DGudernova%26aufirst%3DIva%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D65%26spage%3D109319%26epage%3D109331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Lu</span>, <span class="hlFld-ContribAuthor ">C.C.  Hong</span>, <span class="hlFld-ContribAuthor ">P.C.  Jark</span>, <span class="hlFld-ContribAuthor ">A.L.F.V.  AssumpÃ§Ã£o</span>, <span class="hlFld-ContribAuthor ">N.  Bollig</span>, <span class="hlFld-ContribAuthor ">G.  Kong</span>, <span class="hlFld-ContribAuthor ">X.  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Veterinary Internal Medicine</span><span> <strong>2017,</strong> <em>31 </em>
                                    (6)
                                     , 1804-1815. <a href="https://doi.org/10.1111/jvim.14837" title="DOI URL">https://doi.org/10.1111/jvim.14837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jvim.14837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjvim.14837%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Veterinary%2520Internal%2520Medicine%26atitle%3DJAK1%25252F2%252BInhibitors%252BAZD1480%252Band%252BCYT387%252BInhibit%252BCanine%252BB-Cell%252BLymphoma%252BGrowth%252Bby%252BIncreasing%252BApoptosis%252Band%252BDisrupting%252BCell%252BProliferation%26aulast%3DLu%26aufirst%3DZ.%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D6%26spage%3D1804%26epage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D  Lapek</span>, <span class="hlFld-ContribAuthor ">Patricia  Greninger</span>, <span class="hlFld-ContribAuthor ">Robert  Morris</span>, <span class="hlFld-ContribAuthor ">Arnaud  Amzallag</span>, <span class="hlFld-ContribAuthor ">Iulian  Pruteanu-Malinici</span>, <span class="hlFld-ContribAuthor ">Cyril H  Benes</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Haas</span>. </span><span class="cited-content_cbyCitation_article-title">Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities. </span><span class="cited-content_cbyCitation_journal-name">Nature Biotechnology</span><span> <strong>2017,</strong> <em>35 </em>
                                    (10)
                                     , 983-989. <a href="https://doi.org/10.1038/nbt.3955" title="DOI URL">https://doi.org/10.1038/nbt.3955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nbt.3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnbt.3955%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Biotechnology%26atitle%3DDetection%252Bof%252Bdysregulated%252Bprotein-association%252Bnetworks%252Bby%252Bhigh-throughput%252Bproteomics%252Bpredicts%252Bcancer%252Bvulnerabilities%26aulast%3DLapek%26aufirst%3DJohn%2BD%26date%3D2017%26date%3D2017%26volume%3D35%26issue%3D10%26spage%3D983%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Annika  Ãstrand</span>, <span class="hlFld-ContribAuthor ">Matthew  Catley</span>, <span class="hlFld-ContribAuthor ">Neil P.  Grimster</span>, <span class="hlFld-ContribAuthor ">Magnus  Nilsson</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Richard  Woessner</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 127-143. <a href="https://doi.org/10.1080/13543776.2017.1252753" title="DOI URL">https://doi.org/10.1080/13543776.2017.1252753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1252753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1252753%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK-family%252Bkinases%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2013-2015%25252C%252Bpart%252B1%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D2%26spage%3D127%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ni</span>, <span class="hlFld-ContribAuthor ">Shaozhen  Xie</span>, <span class="hlFld-ContribAuthor ">Shakti H.  Ramkissoon</span>, <span class="hlFld-ContribAuthor ">Victor  Luu</span>, <span class="hlFld-ContribAuthor ">Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Pratiti  Bandopadhayay</span>, <span class="hlFld-ContribAuthor ">Rameen  Beroukhim</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Roberts</span>, <span class="hlFld-ContribAuthor ">Charles D.  Stiles</span>, <span class="hlFld-ContribAuthor ">Rosalind A.  Segal</span>, <span class="hlFld-ContribAuthor ">Keith L.  Ligon</span>, <span class="hlFld-ContribAuthor ">William C.  Hahn</span>, <span class="hlFld-ContribAuthor ">Jean J.  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine receptor kinase B is a drug target in astrocytomas. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology</span><span> <strong>2017,</strong> <em>19 </em>
                                    (1)
                                     , 22-30. <a href="https://doi.org/10.1093/neuonc/now139" title="DOI URL">https://doi.org/10.1093/neuonc/now139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/neuonc/now139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fneuonc%2Fnow139%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%26atitle%3DTyrosine%252Breceptor%252Bkinase%252BB%252Bis%252Ba%252Bdrug%252Btarget%252Bin%252Bastrocytomas%26aulast%3DNi%26aufirst%3DJing%26date%3D2017%26date%3D2016%26volume%3D19%26issue%3D1%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carina  Michl</span>, <span class="hlFld-ContribAuthor ">Fabio  Vivarelli</span>, <span class="hlFld-ContribAuthor ">Julia  Weigl</span>, <span class="hlFld-ContribAuthor ">Gina Rosalinda  De Nicola</span>, <span class="hlFld-ContribAuthor ">Donatella  Canistro</span>, <span class="hlFld-ContribAuthor ">Moreno  Paolini</span>, <span class="hlFld-ContribAuthor ">Renato  Iori</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , e0157430. <a href="https://doi.org/10.1371/journal.pone.0157430" title="DOI URL">https://doi.org/10.1371/journal.pone.0157430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0157430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0157430%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThe%252BChemopreventive%252BPhytochemical%252BMoringin%252BIsolated%252Bfrom%252BMoringa%252Boleifera%252BSeeds%252BInhibits%252BJAK%25252FSTAT%252BSignaling%26aulast%3DMichl%26aufirst%3DCarina%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0157430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuewu  Liang</span>, <span class="hlFld-ContribAuthor ">Yongxue  Huang</span>, <span class="hlFld-ContribAuthor ">Jie  Zang</span>, <span class="hlFld-ContribAuthor ">Qianwen  Gao</span>, <span class="hlFld-ContribAuthor ">Binghe  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (12)
                                     , 2660-2672. <a href="https://doi.org/10.1016/j.bmc.2016.04.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpreliminary%252Bbiological%252Bevaluation%252Bof%252B4-aminopyrazole%252Bderivatives%252Bas%252Bnovel%252Band%252Bpotent%252BJAKs%252Binhibitors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D2660%26epage%3D2672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parisa  Rasighaemi</span>, <span class="hlFld-ContribAuthor ">Alister C.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Upstream Janus Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 163-175. <a href="https://doi.org/10.1007/978-3-319-42949-6_6" title="DOI URL">https://doi.org/10.1007/978-3-319-42949-6_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-42949-6_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-42949-6_6%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BUpstream%252BJanus%252BKinases%26aulast%3DRasighaemi%26aufirst%3DParisa%26date%3D2016%26date%3D2016%26spage%3D163%26epage%3D175%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSTAT%252BInhibitors%252Bin%252BCancer%26aulast%3DWard%26aufirst%3DAlister%2BC.%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa M.  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Martin  Augustin</span>, <span class="hlFld-ContribAuthor ">Geraldine  Bebernitz</span>, <span class="hlFld-ContribAuthor ">Kirsten  Bell</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">Tracy  Deegan</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Kelly  Goodwin</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Aarti  Kawatkar</span>, <span class="hlFld-ContribAuthor ">Sameer  Kawatkar</span>, <span class="hlFld-ContribAuthor ">Jon  Read</span>, <span class="hlFld-ContribAuthor ">Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Holger  Steuber</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Dorin  Toader</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Richard  Woessner</span>, <span class="hlFld-ContribAuthor ">Allan  Wu</span>, <span class="hlFld-ContribAuthor ">Minwei  Ye</span>, <span class="hlFld-ContribAuthor ">Michael  Zinda</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of azabenzimidazoles as potent JAK1 selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (1)
                                     , 60-67. <a href="https://doi.org/10.1016/j.bmcl.2015.11.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bazabenzimidazoles%252Bas%252Bpotent%252BJAK1%252Bselective%252Binhibitors%26aulast%3DVasbinder%26aufirst%3DMelissa%2BM.%26date%3D2016%26volume%3D26%26issue%3D1%26spage%3D60%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao Jiao  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Cheng</span>, <span class="hlFld-ContribAuthor ">Jing  Tu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiao Yun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2016,</strong> <em>12 </em>
                                    (2)
                                     , 575-587. <a href="https://doi.org/10.1039/C5MB00747J" title="DOI URL">https://doi.org/10.1039/C5MB00747J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MB00747J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MB00747J%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DEnhancing%252Bspecificity%252Bin%252Bthe%252BJanus%252Bkinases%25253A%252Ba%252Bstudy%252Bon%252Bthe%252Bthienopyridine%252BJAK2%252Bselective%252Bmechanism%252Bcombined%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DLi%26aufirst%3DJiao%2BJiao%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D2%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao Jiao  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Tu</span>, <span class="hlFld-ContribAuthor ">Peng  Cheng</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiao Yun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into DFG-in and DFG-out JAK2 binding modes for a rational strategy of type II inhibitors combined computational study. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (51)
                                     , 45540-45552. <a href="https://doi.org/10.1039/C6RA06266K" title="DOI URL">https://doi.org/10.1039/C6RA06266K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA06266K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA06266K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInsights%252Binto%252BDFG-in%252Band%252BDFG-out%252BJAK2%252Bbinding%252Bmodes%252Bfor%252Ba%252Brational%252Bstrategy%252Bof%252Btype%252BII%252Binhibitors%252Bcombined%252Bcomputational%252Bstudy%26aulast%3DLi%26aufirst%3DJiao%2BJiao%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D51%26spage%3D45540%26epage%3D45552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanli  Meng</span>, <span class="hlFld-ContribAuthor ">Blaise  Forrester-Gauntlett</span>, <span class="hlFld-ContribAuthor ">Pavla  Turner</span>, <span class="hlFld-ContribAuthor ">Harold  Henderson</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  Oback</span>. </span><span class="cited-content_cbyCitation_article-title">Signal Inhibition Reveals JAK/STAT3 Pathway as Critical for Bovine Inner Cell Mass Development1. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2015,</strong> <em>93 </em>
                                    (6)
                                     <a href="https://doi.org/10.1095/biolreprod.115.134254" title="DOI URL">https://doi.org/10.1095/biolreprod.115.134254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1095/biolreprod.115.134254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1095%2Fbiolreprod.115.134254%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DSignal%252BInhibition%252BReveals%252BJAK%25252FSTAT3%252BPathway%252Bas%252BCritical%252Bfor%252BBovine%252BInner%252BCell%252BMass%252BDevelopment1%26aulast%3DMeng%26aufirst%3DFanli%26date%3D2015%26volume%3D93%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keiichiro  Hyakutake</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Kawasaki</span>, <span class="hlFld-ContribAuthor ">JiDong  Zhang</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kubota</span>, <span class="hlFld-ContribAuthor ">Sin-Ichi  Abe</span>, <span class="hlFld-ContribAuthor ">Kazufumi  Takamune</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetrical allocation of JAK1 mRNA during spermatogonial stem cell division in
              Xenopus laevis. </span><span class="cited-content_cbyCitation_journal-name">Development, Growth & Differentiation</span><span> <strong>2015,</strong> <em>57 </em>
                                    (5)
                                     , 389-399. <a href="https://doi.org/10.1111/dgd.12219" title="DOI URL">https://doi.org/10.1111/dgd.12219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/dgd.12219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fdgd.12219%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopment%252C%2520Growth%2520%2526%2520Differentiation%26atitle%3DAsymmetrical%252Ballocation%252Bof%252BJAK1%252BmRNA%252Bduring%252Bspermatogonial%252Bstem%252Bcell%252Bdivision%252Bin%252BXenopus%252Blaevis%26aulast%3DHyakutake%26aufirst%3DKeiichiro%26date%3D2015%26date%3D2015%26volume%3D57%26issue%3D5%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qing  Ji</span>, <span class="hlFld-ContribAuthor ">Naijing  Ye</span>, <span class="hlFld-ContribAuthor ">Hua  Sui</span>, <span class="hlFld-ContribAuthor ">Lihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Huirong  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhongze  Fan</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Cai</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, . </span><span class="cited-content_cbyCitation_article-title">Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (5)
                                     , e0123478. <a href="https://doi.org/10.1371/journal.pone.0123478" title="DOI URL">https://doi.org/10.1371/journal.pone.0123478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0123478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0123478%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DBerberine%252BInhibits%252BInvasion%252Band%252BMetastasis%252Bof%252BColorectal%252BCancer%252BCells%252Bvia%252BCOX-2%25252FPGE2%252BMediated%252BJAK2%25252FSTAT3%252BSignaling%252BPathway%26aulast%3DLiu%26aufirst%3DXuan%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D5%26spage%3De0123478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Paola  Gnocchi</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Nadia  Amboldi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Jay  Bertrand</span>, <span class="hlFld-ContribAuthor ">Simona  Bindi</span>, <span class="hlFld-ContribAuthor ">Giulia  Canevari</span>, <span class="hlFld-ContribAuthor ">Daniele  Casero</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Colombo</span>, <span class="hlFld-ContribAuthor ">Sabrina  Cribioli</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Ilaria  Motto</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (10)
                                     , 2387-2407. <a href="https://doi.org/10.1016/j.bmc.2015.03.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpyrrole%252Bcarboxamide%252Binhibitors%252Bof%252BJAK2%252Bas%252Bpotential%252Btreatment%252Bof%252Bmyeloproliferative%252Bdisorders%26aulast%3DBrasca%26aufirst%3DMaria%2BGabriella%26date%3D2015%26volume%3D23%26issue%3D10%26spage%3D2387%26epage%3D2407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Ning  Zhu</span>, <span class="hlFld-ContribAuthor ">Yuping  Du</span>, <span class="hlFld-ContribAuthor ">Qifeng  Bai</span>, <span class="hlFld-ContribAuthor ">Xing  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Nan</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Qin</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianwen  Hou</span>, <span class="hlFld-ContribAuthor ">Qin  Wang</span>, <span class="hlFld-ContribAuthor ">Jinbo  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Dehydrocrenatidine Is a Novel Janus Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2015,</strong> <em>87 </em>
                                    (4)
                                     , 572-581. <a href="https://doi.org/10.1124/mol.114.095208" title="DOI URL">https://doi.org/10.1124/mol.114.095208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.114.095208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.114.095208%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DDehydrocrenatidine%252BIs%252Ba%252BNovel%252BJanus%252BKinase%252BInhibitor%26aulast%3DZhang%26aufirst%3DJing%26date%3D2015%26date%3D2015%26volume%3D87%26issue%3D4%26spage%3D572%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhao</span>, <span class="hlFld-ContribAuthor ">Su Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Daulat Bikram  Khadka</span>, <span class="hlFld-ContribAuthor ">Yifeng  Jin</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Won-Jea  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided discovery of aminopyridines as novel JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (5)
                                     , 985-995. <a href="https://doi.org/10.1016/j.bmc.2015.01.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DComputer-aided%252Bdiscovery%252Bof%252Baminopyridines%252Bas%252Bnovel%252BJAK2%252Binhibitors%26aulast%3DZhao%26aufirst%3DChao%26date%3D2015%26volume%3D23%26issue%3D5%26spage%3D985%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valmik  Aware</span>, <span class="hlFld-ContribAuthor ">Nitin  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Sambhaji  Chavan</span>, <span class="hlFld-ContribAuthor ">Sonal  Manohar</span>, <span class="hlFld-ContribAuthor ">Julie  Bose</span>, <span class="hlFld-ContribAuthor ">Smriti  Khanna</span>, <span class="hlFld-ContribAuthor ">Chandrika  B-Rao</span>, <span class="hlFld-ContribAuthor ">Neeta  Dixit</span>, <span class="hlFld-ContribAuthor ">Kishori Sharan  Singh</span>, <span class="hlFld-ContribAuthor ">Anagha  Damre</span>, <span class="hlFld-ContribAuthor ">Rajiv  Sharma</span>, <span class="hlFld-ContribAuthor ">Sambhaji  Patil</span>, <span class="hlFld-ContribAuthor ">Abhijit  Roychowdhury</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 246-256. <a href="https://doi.org/10.1016/j.ejmech.2014.12.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclopentyl-pyrimidine%252Bbased%252Banalogues%252Bas%252Bnovel%252Band%252Bpotent%252BIGF-1R%252Binhibitor%26aulast%3DAware%26aufirst%3DValmik%26date%3D2015%26volume%3D92%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santi  Suryani</span>, <span class="hlFld-ContribAuthor ">Lauryn S.  Bracken</span>, <span class="hlFld-ContribAuthor ">Richard C.  Harvey</span>, <span class="hlFld-ContribAuthor ">Keith C.S.  Sia</span>, <span class="hlFld-ContribAuthor ">Hernan  Carol</span>, <span class="hlFld-ContribAuthor ">I-Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Kathryn  Evans</span>, <span class="hlFld-ContribAuthor ">Philipp A.  Dietrich</span>, <span class="hlFld-ContribAuthor ">Kathryn G.  Roberts</span>, <span class="hlFld-ContribAuthor ">Raushan T.  Kurmasheva</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Billups</span>, <span class="hlFld-ContribAuthor ">Charles G.  Mullighan</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Willman</span>, <span class="hlFld-ContribAuthor ">Mignon L.  Loh</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Hunger</span>, <span class="hlFld-ContribAuthor ">Peter J.  Houghton</span>, <span class="hlFld-ContribAuthor ">Malcolm A.  Smith</span>, <span class="hlFld-ContribAuthor ">Richard B.  Lock</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the
              In Vitro
              and
              In Vivo
              Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (2)
                                     , 364-374. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0647" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0647%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DEvaluation%252Bof%252Bthe%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEfficacy%252Bof%252Bthe%252BJAK%252BInhibitor%252BAZD1480%252Bagainst%252BJAK-Mutated%252BAcute%252BLymphoblastic%252BLeukemia%26aulast%3DSuryani%26aufirst%3DSanti%26date%3D2015%26date%3D2014%26volume%3D14%26issue%3D2%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pietro  Morlacchi</span>, <span class="hlFld-ContribAuthor ">Fredika M  Robertson</span>, <span class="hlFld-ContribAuthor ">Jim  Klostergaard</span>, <span class="hlFld-ContribAuthor ">John S  McMurray</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SH2 domains in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (17)
                                     , 1909-1926. <a href="https://doi.org/10.4155/fmc.14.120" title="DOI URL">https://doi.org/10.4155/fmc.14.120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.120%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSH2%252Bdomains%252Bin%252Bbreast%252Bcancer%26aulast%3DMorlacchi%26aufirst%3DPietro%26date%3D2014%26volume%3D6%26issue%3D17%26spage%3D1909%26epage%3D1926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. P.  Meares</span>, <span class="hlFld-ContribAuthor ">Y.  Liu</span>, <span class="hlFld-ContribAuthor ">R.  Rajbhandari</span>, <span class="hlFld-ContribAuthor ">H.  Qin</span>, <span class="hlFld-ContribAuthor ">S. E.  Nozell</span>, <span class="hlFld-ContribAuthor ">J. A.  Mobley</span>, <span class="hlFld-ContribAuthor ">J. A.  Corbett</span>, <span class="hlFld-ContribAuthor ">E. N.  Benveniste</span>. </span><span class="cited-content_cbyCitation_article-title">PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic Reticulum Stress-Induced Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biology</span><span> <strong>2014,</strong> <em>34 </em>
                                    (20)
                                     , 3911-3925. <a href="https://doi.org/10.1128/MCB.00980-14" title="DOI URL">https://doi.org/10.1128/MCB.00980-14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/MCB.00980-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FMCB.00980-14%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biology%26atitle%3DPERK-Dependent%252BActivation%252Bof%252BJAK1%252Band%252BSTAT3%252BContributes%252Bto%252BEndoplasmic%252BReticulum%252BStress-Induced%252BInflammation%26aulast%3DMeares%26aufirst%3DG.%2BP.%26date%3D2014%26date%3D2014%26volume%3D34%26issue%3D20%26spage%3D3911%26epage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Tiziano  Bandiera</span>, <span class="hlFld-ContribAuthor ">Jay  Bertrand</span>, <span class="hlFld-ContribAuthor ">Simona  Bindi</span>, <span class="hlFld-ContribAuthor ">Giulia  Canevari</span>, <span class="hlFld-ContribAuthor ">Davide  Carenzi</span>, <span class="hlFld-ContribAuthor ">Daniele  Casero</span>, <span class="hlFld-ContribAuthor ">Lucio  Ceriani</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cirla</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Sabrina  Cribioli</span>, <span class="hlFld-ContribAuthor ">Cinzia  Cristiani</span>, <span class="hlFld-ContribAuthor ">Franco  Della Vedova</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Danilo  Mirizzi</span>, <span class="hlFld-ContribAuthor ">Ilaria  Motto</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Paola  Vianello</span>, <span class="hlFld-ContribAuthor ">Paola  Gnocchi</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4998-5012. <a href="https://doi.org/10.1016/j.bmc.2014.06.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPyrrole-3-carboxamides%252Bas%252Bpotent%252Band%252Bselective%252BJAK2%252Binhibitors%26aulast%3DBrasca%26aufirst%3DMaria%2BGabriella%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4998%26epage%3D5012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong In  Yun</span>, <span class="hlFld-ContribAuthor ">Eun Hye  Yang</span>, <span class="hlFld-ContribAuthor ">Muhammad  Latif</span>, <span class="hlFld-ContribAuthor ">Hyeon Ji  Lee</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Chang-Soo  Yun</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Chong Ock  Lee</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Sung Yun  Cho</span>, <span class="hlFld-ContribAuthor ">Hee Jung  Jung</span>, <span class="hlFld-ContribAuthor ">Pilho  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2014,</strong> <em>37 </em>
                                    (7)
                                     , 873-881. <a href="https://doi.org/10.1007/s12272-013-0247-7" title="DOI URL">https://doi.org/10.1007/s12272-013-0247-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-013-0247-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-013-0247-7%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DNovel%252B2%25252C4-dianilino-5-fluoropyrimidine%252Bderivatives%252Bpossessing%252BALK%252Binhibitory%252Bactivities%26aulast%3DYun%26aufirst%3DJeong%2BIn%26date%3D2014%26date%3D2013%26volume%3D37%26issue%3D7%26spage%3D873%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophia  Pinz</span>, <span class="hlFld-ContribAuthor ">Samy  Unser</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , e99391. <a href="https://doi.org/10.1371/journal.pone.0099391" title="DOI URL">https://doi.org/10.1371/journal.pone.0099391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0099391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0099391%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThe%252BNatural%252BChemopreventive%252BAgent%252BSulforaphane%252BInhibits%252BSTAT5%252BActivity%26aulast%3DPinz%26aufirst%3DSophia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D6%26spage%3De99391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Saletta</span>, <span class="hlFld-ContribAuthor ">Carol  Wadham</span>, <span class="hlFld-ContribAuthor ">David S.  Ziegler</span>, <span class="hlFld-ContribAuthor ">Glenn M.  Marshall</span>, <span class="hlFld-ContribAuthor ">Michelle  Haber</span>, <span class="hlFld-ContribAuthor ">Geoffrey  McCowage</span>, <span class="hlFld-ContribAuthor ">Murray D.  Norris</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular profiling of childhood cancer: Biomarkers and novel therapies. </span><span class="cited-content_cbyCitation_journal-name">BBA Clinical</span><span> <strong>2014,</strong> <em>1 </em>, 59-77. <a href="https://doi.org/10.1016/j.bbacli.2014.06.003" title="DOI URL">https://doi.org/10.1016/j.bbacli.2014.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbacli.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbacli.2014.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBBA%2520Clinical%26atitle%3DMolecular%252Bprofiling%252Bof%252Bchildhood%252Bcancer%25253A%252BBiomarkers%252Band%252Bnovel%252Btherapies%26aulast%3DSaletta%26aufirst%3DFederica%26date%3D2014%26volume%3D1%26spage%3D59%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daijiro  Harada</span>, <span class="hlFld-ContribAuthor ">Nagio  Takigawa</span>, <span class="hlFld-ContribAuthor ">Katsuyuki  Kiura</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of STAT3 in Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2014,</strong> <em>6 </em>
                                    (2)
                                     , 708-722. <a href="https://doi.org/10.3390/cancers6020708" title="DOI URL">https://doi.org/10.3390/cancers6020708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers6020708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers6020708%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BRole%252Bof%252BSTAT3%252Bin%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DHarada%26aufirst%3DDaijiro%26date%3D2014%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D708%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Yan-Qiu  Deng</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Zi-Jie  Long</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, <span class="hlFld-ContribAuthor ">Wei  Peng</span>, <span class="hlFld-ContribAuthor ">Ji-Quan  Zhang</span>, <span class="hlFld-ContribAuthor ">Quentin  Liu</span>, <span class="hlFld-ContribAuthor ">Gui  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>78 </em>, 65-71. <a href="https://doi.org/10.1016/j.ejmech.2014.03.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevaluation%252Bof%252BN-trisubstituted%252Bpyrimidine%252Bderivatives%252Bas%252Bpotent%252Baurora%252BA%252Bkinase%252Binhibitors%26aulast%3DLuo%26aufirst%3DYu%26date%3D2014%26volume%3D78%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Haidle</span>, <span class="hlFld-ContribAuthor ">Anna A.  Zabierek</span>, <span class="hlFld-ContribAuthor ">Kaleen K.  Childers</span>, <span class="hlFld-ContribAuthor ">Craig  Rosenstein</span>, <span class="hlFld-ContribAuthor ">Anjili  Mathur</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Grace  Chan</span>, <span class="hlFld-ContribAuthor ">Lin  Xu</span>, <span class="hlFld-ContribAuthor ">Eric  Bachman</span>, <span class="hlFld-ContribAuthor ">Jan-Rung  Mo</span>, <span class="hlFld-ContribAuthor ">Melaney  Bouthillette</span>, <span class="hlFld-ContribAuthor ">Thomas  Rush</span>, <span class="hlFld-ContribAuthor ">Paul  Tempest</span>, <span class="hlFld-ContribAuthor ">C. Gary  Marshall</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (8)
                                     , 1968-1973. <a href="https://doi.org/10.1016/j.bmcl.2014.02.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.02.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.02.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThiophene%252Bcarboxamide%252Binhibitors%252Bof%252BJAK2%252Bas%252Bpotential%252Btreatments%252Bfor%252Bmyleoproliferative%252Bneoplasms%26aulast%3DHaidle%26aufirst%3DAndrew%2BM.%26date%3D2014%26volume%3D24%26issue%3D8%26spage%3D1968%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claire N  Harrison</span>, <span class="hlFld-ContribAuthor ">Michael  Bennett</span>. </span><span class="cited-content_cbyCitation_article-title">Orphan drugs for myelofibrosis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Orphan Drugs</span><span> <strong>2014,</strong> <em>2 </em>
                                    (4)
                                     , 391-405. <a href="https://doi.org/10.1517/21678707.2014.888346" title="DOI URL">https://doi.org/10.1517/21678707.2014.888346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/21678707.2014.888346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F21678707.2014.888346%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Orphan%2520Drugs%26atitle%3DOrphan%252Bdrugs%252Bfor%252Bmyelofibrosis%26aulast%3DHarrison%26aufirst%3DClaire%2BN%26date%3D2014%26date%3D2014%26volume%3D2%26issue%3D4%26spage%3D391%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edgar  CristÃ³bal-Lecina</span>, <span class="hlFld-ContribAuthor ">Pablo  Etayo</span>, <span class="hlFld-ContribAuthor ">SÃ©an  Doran</span>, <span class="hlFld-ContribAuthor ">Marc  RevÃ©s</span>, <span class="hlFld-ContribAuthor ">Pablo  MartÃ­n-Gago</span>, <span class="hlFld-ContribAuthor ">Arnald  Grabulosa</span>, <span class="hlFld-ContribAuthor ">Andrea R.  Costantino</span>, <span class="hlFld-ContribAuthor ">Anton  Vidal-Ferran</span>, <span class="hlFld-ContribAuthor ">Antoni  Riera</span>, <span class="hlFld-ContribAuthor ">Xavier  Verdaguer</span>. </span><span class="cited-content_cbyCitation_article-title">MaxPHOS Ligand: PH/NH Tautomerism and Rhodium- Catalyzed Asymmetric Hydrogenations. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2014,</strong> <em>356 </em>
                                    (4)
                                     , 795-804. <a href="https://doi.org/10.1002/adsc.201300662" title="DOI URL">https://doi.org/10.1002/adsc.201300662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300662%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMaxPHOS%252BLigand%25253A%252BPH%25252FNH%252BTautomerism%252Band%252BRhodium-%252BCatalyzed%252BAsymmetric%252BHydrogenations%26aulast%3DCrist%25C3%25B3bal-Lecina%26aufirst%3DEdgar%26date%3D2014%26date%3D2014%26volume%3D356%26issue%3D4%26spage%3D795%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophia  Pinz</span>, <span class="hlFld-ContribAuthor ">Samy  Unser</span>, <span class="hlFld-ContribAuthor ">Susanne  Brueggemann</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Besl</span>, <span class="hlFld-ContribAuthor ">Nafisah  Al-Rifai</span>, <span class="hlFld-ContribAuthor ">Hermina  Petkes</span>, <span class="hlFld-ContribAuthor ">Sabine  Amslinger</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Synthetic Î±-Bromo-2â²,3,4,4â²-Tetramethoxychalcone (Î±-Br-TMC) Inhibits the JAK/STAT Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , e90275. <a href="https://doi.org/10.1371/journal.pone.0090275" title="DOI URL">https://doi.org/10.1371/journal.pone.0090275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0090275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0090275%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThe%252BSynthetic%252B%2525CE%2525B1-Bromo-2%2525E2%252580%2525B2%25252C3%25252C4%25252C4%2525E2%252580%2525B2-Tetramethoxychalcone%252B%252528%2525CE%2525B1-Br-TMC%252529%252BInhibits%252Bthe%252BJAK%25252FSTAT%252BSignaling%252BPathway%26aulast%3DPinz%26aufirst%3DSophia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D3%26spage%3De90275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Sathyajith E.  Kumarasinghe</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Matthew  Katcher</span>, <span class="hlFld-ContribAuthor ">Alan  Northrup</span>, <span class="hlFld-ContribAuthor ">Catherine  White</span>, <span class="hlFld-ContribAuthor ">Craig  Rosenstein</span>, <span class="hlFld-ContribAuthor ">Anjili  Mathur</span>, <span class="hlFld-ContribAuthor ">Lin  Xu</span>, <span class="hlFld-ContribAuthor ">Grace  Chan</span>, <span class="hlFld-ContribAuthor ">Eric  Bachman</span>, <span class="hlFld-ContribAuthor ">Melaney  Bouthillette</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">C. Gary  Marshall</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (6)
                                     , 1466-1471. <a href="https://doi.org/10.1016/j.bmcl.2014.02.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Breverse%252Btricyclic%252Bpyridone%252BJAK2%252Binhibitors.%252BPart%252B2%25253A%252BLead%252Boptimization%26aulast%3DSiu%26aufirst%3DTony%26date%3D2014%26volume%3D24%26issue%3D6%26spage%3D1466%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitriy M.  Volochnyuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Alina O.  Gorlova</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-Containing Diazines in Medicinal Chemistry and Agrochemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 577-672. <a href="https://doi.org/10.1007/978-3-319-04435-4_7" title="DOI URL">https://doi.org/10.1007/978-3-319-04435-4_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-04435-4_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-04435-4_7%26sid%3Dliteratum%253Aachs%26atitle%3DFluorine-Containing%252BDiazines%252Bin%252BMedicinal%252BChemistry%252Band%252BAgrochemistry%26aulast%3DVolochnyuk%26aufirst%3DDmitriy%2BM.%26date%3D2014%26date%3D2014%26spage%3D577%26epage%3D672%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DFluorine%252Bin%252BHeterocyclic%252BChemistry%252BVolume%252B2%26aulast%3DNenajdenko%26aufirst%3DValentine%26date%3D2014%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  McMurray</span>, <span class="hlFld-ContribAuthor ">Jim  Klostergaard</span>. </span><span class="cited-content_cbyCitation_article-title">STAT3 Signaling in Cancer: Small Molecule Intervention as Therapy?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 216-267. <a href="https://doi.org/10.1016/B978-0-12-803963-2.50007-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-803963-2.50007-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803963-2.50007-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803963-2.50007-7%26sid%3Dliteratum%253Aachs%26atitle%3DSTAT3%252BSignaling%252Bin%252BCancer%25253A%252BSmall%252BMolecule%252BIntervention%252Bas%252BTherapy%25253F%26aulast%3DMcMurray%26aufirst%3DJohn%2BS.%26date%3D2014%26spage%3D216%26epage%3D267%26pub%3DElsevier%26atitle%3DAnti-Angiogenesis%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Braden C.  McFarland</span>, <span class="hlFld-ContribAuthor ">Suk W.  Hong</span>, <span class="hlFld-ContribAuthor ">Rajani  Rajbhandari</span>, <span class="hlFld-ContribAuthor ">George B.  Twitty</span>, <span class="hlFld-ContribAuthor ">G. Kenneth  Gray</span>, <span class="hlFld-ContribAuthor ">Hao  Yu</span>, <span class="hlFld-ContribAuthor ">Etty N.  Benveniste</span>, <span class="hlFld-ContribAuthor ">Susan E.  Nozell</span>, . </span><span class="cited-content_cbyCitation_article-title">NF-ÎºB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (11)
                                     , e78728. <a href="https://doi.org/10.1371/journal.pone.0078728" title="DOI URL">https://doi.org/10.1371/journal.pone.0078728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0078728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0078728%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DNF-%2525CE%2525BAB-Induced%252BIL-6%252BEnsures%252BSTAT3%252BActivation%252Band%252BTumor%252BAggressiveness%252Bin%252BGlioblastoma%26aulast%3DMcFarland%26aufirst%3DBraden%2BC.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D11%26spage%3De78728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Anne van  Abbema</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (21)
                                     , 5923-5930. <a href="https://doi.org/10.1016/j.bmcl.2013.08.082" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252Bnovel%252B8-oxo-pyridopyrimidine%252BJak1%25252F2%252Binhibitors%26aulast%3DLabadie%26aufirst%3DSharada%26date%3D2013%26volume%3D23%26issue%3D21%26spage%3D5923%26epage%3D5930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Gu</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Liao</span>, <span class="hlFld-ContribAuthor ">David T.  Hoang</span>, <span class="hlFld-ContribAuthor ">Ayush  Dagvadorj</span>, <span class="hlFld-ContribAuthor ">Shilpa  Gupta</span>, <span class="hlFld-ContribAuthor ">Shauna  Blackmon</span>, <span class="hlFld-ContribAuthor ">Elyse  Ellsworth</span>, <span class="hlFld-ContribAuthor ">Pooja  Talati</span>, <span class="hlFld-ContribAuthor ">Benjamin  Leiby</span>, <span class="hlFld-ContribAuthor ">Michael  Zinda</span>, <span class="hlFld-ContribAuthor ">Costas D.  Lallas</span>, <span class="hlFld-ContribAuthor ">Edouard J.  Trabulsi</span>, <span class="hlFld-ContribAuthor ">Peter  McCue</span>, <span class="hlFld-ContribAuthor ">Leonard  Gomella</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Marja T.  Nevalainen</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic Inhibition of Jak2âStat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2013,</strong> <em>19 </em>
                                    (20)
                                     , 5658-5674. <a href="https://doi.org/10.1158/1078-0432.CCR-13-0422" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-13-0422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-13-0422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-13-0422%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DPharmacologic%252BInhibition%252Bof%252BJak2%2525E2%252580%252593Stat5%252BSignaling%252BBy%252BJak2%252BInhibitor%252BAZD1480%252BPotently%252BSuppresses%252BGrowth%252Bof%252BBoth%252BPrimary%252Band%252BCastrate-Resistant%252BProstate%252BCancer%26aulast%3DGu%26aufirst%3DLei%26date%3D2013%26date%3D2013%26volume%3D19%26issue%3D20%26spage%3D5658%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiping  Guan</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Lamb</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Nancy  DeGrace</span>, <span class="hlFld-ContribAuthor ">Jon  Read</span>, <span class="hlFld-ContribAuthor ">Syeed  Hussain</span>, <span class="hlFld-ContribAuthor ">Jiaquan  Wu</span>, <span class="hlFld-ContribAuthor ">Caroline  Rivard</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Geraldine  Bebernitz</span>, <span class="hlFld-ContribAuthor ">Kirsten  Bell</span>, <span class="hlFld-ContribAuthor ">Minwei  Ye</span>, <span class="hlFld-ContribAuthor ">Michael  Zinda</span>, <span class="hlFld-ContribAuthor ">Stephanos  Ioannidis</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel Jak2âStat pathway inhibitors with extended residence time on target. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3105-3110. <a href="https://doi.org/10.1016/j.bmcl.2013.02.111" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.111%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BJak2%2525E2%252580%252593Stat%252Bpathway%252Binhibitors%252Bwith%252Bextended%252Bresidence%252Btime%252Bon%252Btarget%26aulast%3DGuan%26aufirst%3DHuiping%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3105%26epage%3D3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Cheng Shang  See</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 â 2012. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (4)
                                     , 449-501. <a href="https://doi.org/10.1517/13543776.2013.765862" title="DOI URL">https://doi.org/10.1517/13543776.2013.765862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.765862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.765862%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK2%252Band%252BJAK3%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2010%252B%2525E2%252580%252593%252B2012%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D449%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Yan</span>, <span class="hlFld-ContribAuthor ">Zhijie  Li</span>, <span class="hlFld-ContribAuthor ">Carol J  Thiele</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas
              In vitro
              and
              In vivo. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     , 433-445. <a href="https://doi.org/10.18632/oncotarget.930" title="DOI URL">https://doi.org/10.18632/oncotarget.930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.930%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252BSTAT3%252Bwith%252Borally%252Bactive%252BJAK%252Binhibitor%25252C%252BAZD1480%25252C%252Bdecreases%252Btumor%252Bgrowth%252Bin%252BNeuroblastoma%252Band%252BPediatric%252BSarcomas%252BIn%252Bvitro%252Band%252BIn%252Bvivo%26aulast%3DYan%26aufirst%3DShuang%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D3%26spage%3D433%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">YT  Yeung</span>, <span class="hlFld-ContribAuthor ">KL  McDonald</span>, <span class="hlFld-ContribAuthor ">T  Grewal</span>, <span class="hlFld-ContribAuthor ">L  Munoz</span>. </span><span class="cited-content_cbyCitation_article-title">Interleukins in glioblastoma pathophysiology: implications for therapy. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>168 </em>
                                    (3)
                                     , 591-606. <a href="https://doi.org/10.1111/bph.12008" title="DOI URL">https://doi.org/10.1111/bph.12008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12008%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DInterleukins%252Bin%252Bglioblastoma%252Bpathophysiology%25253A%252Bimplications%252Bfor%252Btherapy%26aulast%3DYeung%26aufirst%3DYT%26date%3D2013%26date%3D2013%26volume%3D168%26issue%3D3%26spage%3D591%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamad Bassam  Sonbol</span>, <span class="hlFld-ContribAuthor ">Belal  Firwana</span>, <span class="hlFld-ContribAuthor ">Ahmad  Zarzour</span>, <span class="hlFld-ContribAuthor ">Mohammad  Morad</span>, <span class="hlFld-ContribAuthor ">Vishal  Rana</span>, <span class="hlFld-ContribAuthor ">Ramon V.  Tiu</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of JAK inhibitors in myeloproliferative neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Hematology</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 15-35. <a href="https://doi.org/10.1177/2040620712461047" title="DOI URL">https://doi.org/10.1177/2040620712461047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040620712461047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040620712461047%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Hematology%26atitle%3DComprehensive%252Breview%252Bof%252BJAK%252Binhibitors%252Bin%252Bmyeloproliferative%252Bneoplasms%26aulast%3DSonbol%26aufirst%3DMohamad%2BBassam%26date%3D2013%26date%3D2012%26volume%3D4%26issue%3D1%26spage%3D15%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajesh R.  Nair</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Gebhard</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hazlehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Opportunities for Targeting the TumorâStroma Interactions for Increasing the Efficacy of Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 53-86. <a href="https://doi.org/10.1007/978-1-4614-5847-0_3" title="DOI URL">https://doi.org/10.1007/978-1-4614-5847-0_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-5847-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-5847-0_3%26sid%3Dliteratum%253Aachs%26atitle%3DEmerging%252BOpportunities%252Bfor%252BTargeting%252Bthe%252BTumor%2525E2%252580%252593Stroma%252BInteractions%252Bfor%252BIncreasing%252Bthe%252BEfficacy%252Bof%252BChemotherapy%26aulast%3DNair%26aufirst%3DRajesh%2BR.%26date%3D2013%26date%3D2012%26spage%3D53%26epage%3D86%26pub%3DSpringer%2520New%2520York%26atitle%3DCell%252BDeath%252BSignaling%252Bin%252BCancer%252BBiology%252Band%252BTreatment%26aulast%3DJohnson%26aufirst%3DDaniel%2BE.%26date%3D2013%26volume%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle S.  Lucet</span>, <span class="hlFld-ContribAuthor ">Rebecca  Bamert</span>. </span><span class="cited-content_cbyCitation_article-title">Production and Crystallization of Recombinant JAK Proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 275-300. <a href="https://doi.org/10.1007/978-1-62703-242-1_20" title="DOI URL">https://doi.org/10.1007/978-1-62703-242-1_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-62703-242-1_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-62703-242-1_20%26sid%3Dliteratum%253Aachs%26atitle%3DProduction%252Band%252BCrystallization%252Bof%252BRecombinant%252BJAK%252BProteins%26aulast%3DLucet%26aufirst%3DIsabelle%2BS.%26date%3D2013%26date%3D2012%26spage%3D275%26epage%3D300%26pub%3DHumana%2520Press%26atitle%3DJAK-STAT%252BSignalling%26aulast%3DNicholson%26aufirst%3DSandra%2BE.%26date%3D2013%26volume%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, <span class="hlFld-ContribAuthor ">Jonathan  Chernoff</span>. </span><span class="cited-content_cbyCitation_article-title">p21-Activated Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 157-180. <a href="https://doi.org/10.1016/B978-0-12-420146-0.00007-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-420146-0.00007-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420146-0.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420146-0.00007-X%26sid%3Dliteratum%253Aachs%26atitle%3Dp21-Activated%252BKinase%252BInhibitors%26aulast%3DRudolph%26aufirst%3DJoachim%26date%3D2013%26spage%3D157%26epage%3D180%26pub%3DElsevier%26atitle%3DInhibitors%252Bof%252Bthe%252BRas%252Bsuperfamily%252BG-proteins%25252C%252BPart%252BB%26date%3D2013%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pablo  Etayo</span>, <span class="hlFld-ContribAuthor ">Anton  Vidal-Ferran</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2013,</strong> <em>42 </em>
                                    (2)
                                     , 728-754. <a href="https://doi.org/10.1039/C2CS35410A" title="DOI URL">https://doi.org/10.1039/C2CS35410A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2CS35410A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2CS35410A%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DRhodium-catalysed%252Basymmetric%252Bhydrogenation%252Bas%252Ba%252Bvaluable%252Bsynthetic%252Btool%252Bfor%252Bthe%252Bpreparation%252Bof%252Bchiral%252Bdrugs%26aulast%3DEtayo%26aufirst%3DPablo%26date%3D2013%26date%3D2013%26volume%3D42%26issue%3D2%26spage%3D728%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Furqan</span>, <span class="hlFld-ContribAuthor ">Nikhil  Mukhi</span>, <span class="hlFld-ContribAuthor ">Byung  Lee</span>, <span class="hlFld-ContribAuthor ">Delong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. </span><span class="cited-content_cbyCitation_journal-name">Biomarker Research</span><span> <strong>2013,</strong> <em>1 </em>
                                    (1)
                                     , 5. <a href="https://doi.org/10.1186/2050-7771-1-5" title="DOI URL">https://doi.org/10.1186/2050-7771-1-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2050-7771-1-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2050-7771-1-5%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomarker%2520Research%26atitle%3DDysregulation%252Bof%252BJAK-STAT%252Bpathway%252Bin%252Bhematological%252Bmalignancies%252Band%252BJAK%252Binhibitors%252Bfor%252Bclinical%252Bapplication%26aulast%3DFurqan%26aufirst%3DMuhammad%26date%3D2013%26volume%3D1%26issue%3D1%26spage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy  Forsyth</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Kearney</span>, <span class="hlFld-ContribAuthor ">Byung Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">Henry W.B.  Johnson</span>, <span class="hlFld-ContribAuthor ">Naing  Aay</span>, <span class="hlFld-ContribAuthor ">Arlyn  Arcalas</span>, <span class="hlFld-ContribAuthor ">David S.  Brown</span>, <span class="hlFld-ContribAuthor ">Vicky  Chan</span>, <span class="hlFld-ContribAuthor ">Jeff  Chen</span>, <span class="hlFld-ContribAuthor ">Hongwang  Du</span>, <span class="hlFld-ContribAuthor ">Sergey  Epshteyn</span>, <span class="hlFld-ContribAuthor ">Adam A.  Galan</span>, <span class="hlFld-ContribAuthor ">Tai P.  Huynh</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Brian  Kane</span>, <span class="hlFld-ContribAuthor ">Elena S.  Koltun</span>, <span class="hlFld-ContribAuthor ">Grace  Mann</span>, <span class="hlFld-ContribAuthor ">Lisa E.  Meyr</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Lee</span>, <span class="hlFld-ContribAuthor ">Gary L.  Lewis</span>, <span class="hlFld-ContribAuthor ">Robin T.  Noguchi</span>, <span class="hlFld-ContribAuthor ">Michael  Pack</span>, <span class="hlFld-ContribAuthor ">Brian H.  Ridgway</span>, <span class="hlFld-ContribAuthor ">Xian  Shi</span>, <span class="hlFld-ContribAuthor ">Craig S.  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Peiwen  Zu</span>, <span class="hlFld-ContribAuthor ">James W.  Leahy</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">Ron  Aoyama</span>, <span class="hlFld-ContribAuthor ">Stefan  Engst</span>, <span class="hlFld-ContribAuthor ">Steven B.  Gendreau</span>, <span class="hlFld-ContribAuthor ">Robert  Kassees</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Shwu-Hwa  Lin</span>, <span class="hlFld-ContribAuthor ">Jean-Francois  Martini</span>, <span class="hlFld-ContribAuthor ">Thomas  Stout</span>, <span class="hlFld-ContribAuthor ">Philip  Tong</span>, <span class="hlFld-ContribAuthor ">John  Woolfrey</span>, <span class="hlFld-ContribAuthor ">Wentao  Zhang</span>, <span class="hlFld-ContribAuthor ">Peiwen  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7653-7658. <a href="https://doi.org/10.1016/j.bmcl.2012.10.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252B4-aryl-2-aminoalkylpyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BJanus%252Bkinase%252B2%252B%252528JAK2%252529%252Binhibitors%26aulast%3DForsyth%26aufirst%3DTimothy%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7653%26epage%3D7658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raoul  Tibes</span>, <span class="hlFld-ContribAuthor ">James M  Bogenberger</span>, <span class="hlFld-ContribAuthor ">Holly L  Geyer</span>, <span class="hlFld-ContribAuthor ">Ruben A  Mesa</span>. </span><span class="cited-content_cbyCitation_article-title">JAK2 inhibitors in the treatment of myeloproliferative neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2012,</strong> <em>21 </em>
                                    (12)
                                     , 1755-1774. <a href="https://doi.org/10.1517/13543784.2012.721352" title="DOI URL">https://doi.org/10.1517/13543784.2012.721352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2012.721352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2012.721352%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DJAK2%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bmyeloproliferative%252Bneoplasms%26aulast%3DTibes%26aufirst%3DRaoul%26date%3D2012%26date%3D2012%26volume%3D21%26issue%3D12%26spage%3D1755%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun Mi  Kim</span>, <span class="hlFld-ContribAuthor ">Oh-Joon  Kwon</span>, <span class="hlFld-ContribAuthor ">Yun Kyoung  Hong</span>, <span class="hlFld-ContribAuthor ">Joo Hang  Kim</span>, <span class="hlFld-ContribAuthor ">Flavio  Solca</span>, <span class="hlFld-ContribAuthor ">Sang-Jun  Ha</span>, <span class="hlFld-ContribAuthor ">Ross A.  Soo</span>, <span class="hlFld-ContribAuthor ">James G.  Christensen</span>, <span class="hlFld-ContribAuthor ">Ji Hyun  Lee</span>, <span class="hlFld-ContribAuthor ">Byoung Chul  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of IL-6R/JAK1/STAT3 Signaling Induces
              De Novo
              Resistance to Irreversible EGFR Inhibitors in NonâSmall Cell Lung Cancer with T790M Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (10)
                                     , 2254-2264. <a href="https://doi.org/10.1158/1535-7163.MCT-12-0311" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-12-0311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-12-0311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-12-0311%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DActivation%252Bof%252BIL-6R%25252FJAK1%25252FSTAT3%252BSignaling%252BInduces%252BDe%252BNovo%252BResistance%252Bto%252BIrreversible%252BEGFR%252BInhibitors%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%252Bwith%252BT790M%252BResistance%252BMutation%26aulast%3DKim%26aufirst%3DSun%2BMi%26date%3D2012%26date%3D2012%26volume%3D11%26issue%3D10%26spage%3D2254%26epage%3D2264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Barosi</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging targeted therapies in myelofibrosis. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Hematology</span><span> <strong>2012,</strong> <em>5 </em>
                                    (3)
                                     , 313-324. <a href="https://doi.org/10.1586/ehm.12.17" title="DOI URL">https://doi.org/10.1586/ehm.12.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/ehm.12.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2Fehm.12.17%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Hematology%26atitle%3DEmerging%252Btargeted%252Btherapies%252Bin%252Bmyelofibrosis%26aulast%3DBarosi%26aufirst%3DGiovanni%26date%3D2012%26date%3D2014%26volume%3D5%26issue%3D3%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zhong</span>, <span class="hlFld-ContribAuthor ">Min-Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Raghothama  Chaerkady</span>, <span class="hlFld-ContribAuthor ">Xinyan  Wu</span>, <span class="hlFld-ContribAuthor ">Tai-Chung  Huang</span>, <span class="hlFld-ContribAuthor ">Derese  Getnet</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Shyam M.  Palapetta</span>, <span class="hlFld-ContribAuthor ">Jyoti  Sharma</span>, <span class="hlFld-ContribAuthor ">Robert N.  O'Meally</span>, <span class="hlFld-ContribAuthor ">Robert N.  Cole</span>, <span class="hlFld-ContribAuthor ">Akinori  Yoda</span>, <span class="hlFld-ContribAuthor ">Albrecht  Moritz</span>, <span class="hlFld-ContribAuthor ">Marc M.  Loriaux</span>, <span class="hlFld-ContribAuthor ">John  Rush</span>, <span class="hlFld-ContribAuthor ">David M.  Weinstock</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Tyner</span>, <span class="hlFld-ContribAuthor ">Akhilesh  Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">TSLP Signaling Network Revealed by SILAC-Based Phosphoproteomics. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (6)
                                     , M112.017764. <a href="https://doi.org/10.1074/mcp.M112.017764" title="DOI URL">https://doi.org/10.1074/mcp.M112.017764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.M112.017764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.M112.017764%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DTSLP%252BSignaling%252BNetwork%252BRevealed%252Bby%252BSILAC-Based%252BPhosphoproteomics%26aulast%3DZhong%26aufirst%3DJun%26date%3D2012%26volume%3D11%26issue%3D6%26spage%3DM112.017764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy M.  Chapman</span>, <span class="hlFld-ContribAuthor ">Nathalie  Bouloc</span>, <span class="hlFld-ContribAuthor ">Roger S.  Buxton</span>, <span class="hlFld-ContribAuthor ">Jasveen  Chugh</span>, <span class="hlFld-ContribAuthor ">Kathryn E.A.  Lougheed</span>, <span class="hlFld-ContribAuthor ">Simon A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Barbara  Saxty</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Smerdon</span>, <span class="hlFld-ContribAuthor ">Debra L.  Taylor</span>, <span class="hlFld-ContribAuthor ">David  Whalley</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (9)
                                     , 3349-3353. <a href="https://doi.org/10.1016/j.bmcl.2012.02.107" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.02.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.02.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.02.107%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituted%252Baminopyrimidine%252Bprotein%252Bkinase%252BB%252B%252528PknB%252529%252Binhibitors%252Bshow%252Bactivity%252Bagainst%252BMycobacterium%252Btuberculosis%26aulast%3DChapman%26aufirst%3DTimothy%2BM.%26date%3D2012%26volume%3D22%26issue%3D9%26spage%3D3349%26epage%3D3353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J  Crawford</span>, <span class="hlFld-ContribAuthor ">Klaus P  Hoeflich</span>, <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>. </span><span class="cited-content_cbyCitation_article-title">p21-Activated kinase inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (3)
                                     , 293-310. <a href="https://doi.org/10.1517/13543776.2012.668758" title="DOI URL">https://doi.org/10.1517/13543776.2012.668758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.668758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.668758%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp21-Activated%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DCrawford%26aufirst%3DJames%2BJ%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D3%26spage%3D293%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Villarino</span>, <span class="hlFld-ContribAuthor ">Xiang-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Hirahara</span>, <span class="hlFld-ContribAuthor ">Yuka  Kanno</span>, <span class="hlFld-ContribAuthor ">John J.  Oâ Shea</span>, <span class="hlFld-ContribAuthor ">Arian  Laurence</span>. </span><span class="cited-content_cbyCitation_article-title">Function of JAKs and STATs in Lymphocytes: Bench to Bedside. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 205-237. <a href="https://doi.org/10.1007/978-3-7091-0891-8_13" title="DOI URL">https://doi.org/10.1007/978-3-7091-0891-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-7091-0891-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-7091-0891-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DFunction%252Bof%252BJAKs%252Band%252BSTATs%252Bin%252BLymphocytes%25253A%252BBench%252Bto%252BBedside%26aulast%3DVillarino%26aufirst%3DAlejandro%26date%3D2012%26date%3D2012%26spage%3D205%26epage%3D237%26pub%3DSpringer%2520Vienna%26atitle%3DJak-Stat%252BSignaling%252B%25253A%252BFrom%252BBasics%252Bto%252BDisease%26aulast%3DDecker%26aufirst%3DThomas%26date%3D2012%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Braden C.  McFarland</span>, <span class="hlFld-ContribAuthor ">Jing-Yuan  Ma</span>, <span class="hlFld-ContribAuthor ">Catherine P.  Langford</span>, <span class="hlFld-ContribAuthor ">G. Yancey  Gillespie</span>, <span class="hlFld-ContribAuthor ">Hao  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Zheng</span>, <span class="hlFld-ContribAuthor ">Susan E.  Nozell</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Etty N.  Benveniste</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2011,</strong> <em>10 </em>
                                    (12)
                                     , 2384-2393. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0480" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0480%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTherapeutic%252BPotential%252Bof%252BAZD1480%252Bfor%252Bthe%252BTreatment%252Bof%252BHuman%252BGlioblastoma%26aulast%3DMcFarland%26aufirst%3DBraden%2BC.%26date%3D2011%26date%3D2011%26volume%3D10%26issue%3D12%26spage%3D2384%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Guillou</span>, <span class="hlFld-ContribAuthor ">FrÃ©dÃ©ric J.  Bonhomme</span>, <span class="hlFld-ContribAuthor ">Mikhail S.  Ermolenko</span>, <span class="hlFld-ContribAuthor ">Yves L.  Janin</span>. </span><span class="cited-content_cbyCitation_article-title">Simple preparations of 4 and 5-iodinated pyrazoles as useful building blocks. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (44)
                                     , 8451-8457. <a href="https://doi.org/10.1016/j.tet.2011.09.029" title="DOI URL">https://doi.org/10.1016/j.tet.2011.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSimple%252Bpreparations%252Bof%252B4%252Band%252B5-iodinated%252Bpyrazoles%252Bas%252Buseful%252Bbuilding%252Bblocks%26aulast%3DGuillou%26aufirst%3DSandrine%26date%3D2011%26volume%3D67%26issue%3D44%26spage%3D8451%26epage%3D8457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Xin</span>, <span class="hlFld-ContribAuthor ">Andreas  Herrmann</span>, <span class="hlFld-ContribAuthor ">Karen  Reckamp</span>, <span class="hlFld-ContribAuthor ">Wang  Zhang</span>, <span class="hlFld-ContribAuthor ">Sumanta  Pal</span>, <span class="hlFld-ContribAuthor ">Michael  Hedvat</span>, <span class="hlFld-ContribAuthor ">Chunyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Liang</span>, <span class="hlFld-ContribAuthor ">Anna  Scuto</span>, <span class="hlFld-ContribAuthor ">Shaobu  Weng</span>, <span class="hlFld-ContribAuthor ">Deborah  Morosini</span>, <span class="hlFld-ContribAuthor ">Zhu A.  Cao</span>, <span class="hlFld-ContribAuthor ">Michael  Zinda</span>, <span class="hlFld-ContribAuthor ">Robert  Figlin</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Richard  Jove</span>, <span class="hlFld-ContribAuthor ">Hua  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2011,</strong> <em>71 </em>
                                    (21)
                                     , 6601-6610. <a href="https://doi.org/10.1158/0008-5472.CAN-11-1217" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-11-1217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-11-1217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-11-1217%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DAntiangiogenic%252Band%252BAntimetastatic%252BActivity%252Bof%252BJAK%252BInhibitor%252BAZD1480%26aulast%3DXin%26aufirst%3DHong%26date%3D2011%26date%3D2011%26volume%3D71%26issue%3D21%26spage%3D6601%26epage%3D6610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kh.  Dhanachandra Singh</span>, <span class="hlFld-ContribAuthor ">Muthusamy  Karthikeyan</span>, <span class="hlFld-ContribAuthor ">Palani  Kirubakaran</span>, <span class="hlFld-ContribAuthor ">Selvaraman  Nagamani</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2011,</strong> <em>30 </em>, 186-197. <a href="https://doi.org/10.1016/j.jmgm.2011.07.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2011.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2011.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bfiltering%252Band%252B3D-QSAR%252Bin%252Bthe%252Bdiscovery%252Bof%252Bnew%252BJAK2%252Binhibitors%26aulast%3DDhanachandra%2BSingh%26aufirst%3DKh.%26date%3D2011%26volume%3D30%26spage%3D186%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Stephanos  Ioannidis</span>, <span class="hlFld-ContribAuthor ">Lynsie  Almeida</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">Audrey M.  Davies</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Lamb</span>, <span class="hlFld-ContribAuthor ">David A.  Scott</span>, <span class="hlFld-ContribAuthor ">Mei  Su</span>, <span class="hlFld-ContribAuthor ">Hai-Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Geraldine  Bebernitz</span>, <span class="hlFld-ContribAuthor ">Kirsten  Bell</span>, <span class="hlFld-ContribAuthor ">Michael  Zinda</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2958-2961. <a href="https://doi.org/10.1016/j.bmcl.2011.03.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252B6-aminopyrazolyl-pyridine-3-carbonitriles%252Bas%252BJAK2%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DTao%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2958%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Masciocchi</span>, <span class="hlFld-ContribAuthor ">Arianna  Gelain</span>, <span class="hlFld-ContribAuthor ">Stefania  Villa</span>, <span class="hlFld-ContribAuthor ">Fiorella  Meneghetti</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (5)
                                     , 567-597. <a href="https://doi.org/10.4155/fmc.11.22" title="DOI URL">https://doi.org/10.4155/fmc.11.22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.22%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%25253A%252Ba%252Bpromising%252Btarget%252Bfor%252Banticancer%252Btherapy%26aulast%3DMasciocchi%26aufirst%3DDaniela%26date%3D2011%26volume%3D3%26issue%3D5%26spage%3D567%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Jak inhibitors in the clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pyrazol-3-yl pyrimidin-4-amines as Jak2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of 2,4-Diamino Substituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) For <b>5a</b>, X = Cl; <b>5b</b>, X = F; <b>5c</b>, X = Br, Et<sub>3</sub>N, EtOH, 0 Â°Câ25 Â°C; for <b>5d</b>, X = Me, Et<sub>3</sub>N, EtOH, 60 Â°C. (b) For <b>9a</b>, DIPEA, <i>n</i>-BuOH, 110 Â°C; <b>9b</b>â<b>f</b>, DIPEA, <i>n</i>-BuOH, 120 Â°C microwave; <b>9i</b>â<b>l</b>: DIPEA, <i>n</i>-BuOH, 165 Â°C, microwave.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Racemic 1-(5-Fluoropyrimidin-2-yl)ethanol <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, Zn(CN)<sub>2</sub>/Zn, dppf; (b) MeMgBr, THF, 0 Â°C; (c) NaBH<sub>4</sub>, MeOH, 0 Â°C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 2-Alkoxy Pyrimidin-4-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaO<sup><i>t</i></sup>Bu, <i>t</i>-BuOH, 90 Â°C; then chiral purification.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 2,4,6-Trisubstituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6a</b> or <b>6c</b>, Et<sub>3</sub>N, EtOH, 0 Â°Câ 25 Â°C; (b) (<i>S</i>)-<b>8</b> hydrochloride, DIPEA, EtOH, 70 Â°C; (c) DIPEA, <i>n</i>-BuOH, 120 Â°C, microwave.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetically Preferred Route for 5-Fluoro-2,4,6-Trisubstituted Pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Morpholine, DIPEA, <i>n</i>-BuOH, 80 Â°C; (b) (<i>S</i>)-<b>8</b> hydrochloride, DIPEA, <i>n</i>-BuOH, 190 Â°C, microwave.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Pyrazoles <b>6c</b> and <b>6d<sup>a</sup></b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, DIAD, PPh<sub>3</sub>, DCM, 0 Â°C; (b) CH<sub>3</sub>CN, <i>n</i>-BuLi, â78 Â°Câ25 Â°C, then MeI, 0 Â°C; (c) H<sub>2</sub>NNH<sub>2</sub>, EtOH, 85 Â°C.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation (<i>rac</i>)-<b>8</b> and <b>21<sup>a</sup></b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i. MsCl, Et<sub>3</sub>N, DCM, 0 Â°C; ii. NaN<sub>3</sub>, DMF; (b) H<sub>2</sub>, Pd/C, 25 Â°C; (c) DIPEA, <i>n</i>-BuOH, 120 Â°C, microwave.</p></p></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0019.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure (pdb:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XA4">2XA4</a>) of compound <b>9e</b> bound to Jak2 kinase. Carbon atoms for <b>9e</b> are shown in green. The protein backbone cartoon is represented in white. Selected atoms for the hinge region (on the left) from gatekeeper M929 to L932 as well as G993 (at the top) are represented as sticks. Refined electron density (2f<sub>o</sub>f<sub>c</sub>) contoured at 1.0 Ï for the inhibitor is represented as wire mesh. The glycine-rich loop has been removed for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0020.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Contribution of G993/A966 residue to the observed selectivity of <b>9e</b> for Jak2 versus Jak3. Protein backbone atoms of 2XA4 (white) and 1YVJ (wheat) overlaid and represented as cartoon. Hydrogen bonds between compound <b>9e</b> and the protein are shown in yellow. Selected residues from the two structures have been represented as sticks and labeled with Jak2/Jak3 residue names and numbers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0001.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) and pStat3 (phosphorylated Stat3) <b>9e</b> and total proteins (tStat5 and tStat3) in SET-2 human megakaryoblastic cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western Blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0002.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) by <b>9e</b> and total proteins (tStat5) in UKE-1 (homozygous for V617F) human hematopoietic cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western Blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0003.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose-dependent inhibition of pStat5 (phosphorylated Stat5) and pStat3 by <b>9e</b> and total proteins (tStat5 and tStat3) in HEL (human erythroleukemia ) cells. Cells were treated with decreasing concentration of <b>9e</b> for 1 h, harvested, and run on SDS-PAGE; phosphorylated and total Stat proteins were assayed by Western blot and quantitated using Licor Odyssey imager.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0004.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Kinetic response of pStat3 and pStat5 to the addition of 0.3 Î¼M of <b>9e</b>. Reduction of the pStat5 levels was apparent at 15 min, and complete inhibition was observed at 60 min upon addition of <b>9e</b>. pStat3 expression could be partially inhibited after 60 min incubation with <b>9e</b>, while p-Jak2 signaling did not change upon addition of <b>9e</b>. (B) Both pStat5 and pStat3 signaling recovered 5 min after washout of <b>9e</b>. p-Jak2 denotes phosphorylated Jak2 and UT denotes untreated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0005.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Dose-dependent modulation of pStat5 levels in splenic tissue after a single dose of <b>9e</b> in a Ba/F3 TEL-Jak2 mouse model. The bars represent the mean percentage (%) inhibition in phosphorylation of Stat5 (Â±SD, <i>n</i> = 3 for each dose and each time point) and are calculated using vehicle (V, veh) and control inhibitor for establishing maximum and minimum values. The Western blots and quantitation described with the Ba/F3 engineered cells were performed as previously described.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/medium/jm-2010-011319_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0006.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effect of <b>9e</b> treatment on Ba/F3 TEL-Jak2âluc cell growth in vivo. (A) Groups of animals were treated with either vehicle (<i>n</i> = 8) or <b>9e</b> at 30 mg/kg twice daily (<i>n</i> = 5) or <b>9e</b> at 50 mg/kg twice daily (<i>n</i> = 5) starting on day 3 post-tumor cell implantation. Pseudocolor images representing luciferase-emitted light intensity superimposed over photographs of the tumor-bearing mice from each treatment group. The images were acquired on day 9 post-tumor cell implantation. The color scheme for the luminescence intensity is shown by the color bar. (B) Total bioluminescent signal intensity over each mouse body was determined on days 4, 7, and 9 and averaged per time point and treatment group. Means Â± SE were plotted using GraphPad <i>Prism 4 </i>software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1011319/production/images/large/jm-2010-011319_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1011319&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saharinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, V. E. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FrÃ¶hling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DÃ¶hner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.ccr.2005.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15837627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+P.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Fr%C3%B6hlingauthor=K.+D%C3%B6hnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+mutation+in+the+tyrosine+kinase+JAK2+in+polycythemia+vera%2C+essential+thrombocythemia%2C+and+myeloid+metaplasia+with+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span></div><div class="casAuthors">Levine, Ross L.; Wadleigh, Martha; Cools, Jan; Ebert, Benjamin L.; Wernig, Gerlinde; Huntly, Brian J. P.; Boggon, Titus J.; Wlodarska, Iwona; Clark, Jennifer J.; Moore, Sandra; Adelsperger, Jennifer; Koo, Sumin; Lee, Jeffrey C.; Gabriel, Stacey; Mercher, Thomas; D'Andrea, Alan; Froehling, Stefan; Doehner, Konstanze; Marynen, Peter; Vandenberghe, Peter; Mesa, Ruben A.; Tefferi, Ayalew; Griffin, James D.; Eck, Michael J.; Sellers, William R.; Meyerson, Matthew; Golub, Todd R.; Lee, Stephanie J.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-397</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.  An internet-based protocol was used to collect clin. information and biol. specimens from patients with these diseases.  High-throughput DNA re-sequencing identified a recurrent somatic missense mutation JAK2V617F in granulocyte DNA samples of 121 of 164 PV patients, of which 41 had homozygous and 80 had heterozygous mutations.  Mol. and cytogenetic analyses demonstrated that homozygous mutations were due to duplication of the mutant allele.  JAK2V617F was also identified in granulocyte DNA samples from 37 of 115 ET and 16 of 46 MMM patients, but was not obsd. in 269 normal individuals.  In vitro anal. demonstrated that JAK2V617F is a constitutively active tyrosine kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJNzUFm3Q3bVg90H21EOLACvtfcHk0lihbnj7YgrGTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D&md5=2a3e893867b114e8749cd6f5e55990b7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520mutation%2520in%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520polycythemia%2520vera%252C%2520essential%2520thrombocythemia%252C%2520and%2520myeloid%2520metaplasia%2520with%2520myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le CouÃ©dic, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarÃ§on, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacaur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">â</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.+P.+Le+Cou%C3%A9dicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Gar%C3%A7onauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennacaur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCou%25C3%25A9dic%26aufirst%3DJ.%2BP.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGar%25C3%25A7on%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennacaur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polycythemia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Baxter, E. J.; Scott, L. M.; Campbell, P. J.; East, C.; Fourouclas, N.; Swanton, S.; Vassiliou, G. S.; Bench, A. J.; Boyd, E. M.; Curtin, N.; Scott, M. A.; Erber, W. N.</span>; the Cancer Genome project; <span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span>.  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">â</span> <span class="NLM_lpage">1061</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2FS0140-6736%2805%2971142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15781101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1054-1061&author=E.+J.+Baxter&author=L.+M.+Scott&author=P.+J.+Campbell&author=C.+East&author=N.+Fourouclas&author=S.+Swanton&author=G.+S.+Vassiliou&author=A.+J.+Bench&author=E.+M.+Boyd&author=N.+Curtin&author=M.+A.+Scott&author=W.+N.+Erberauthor=A.+R.+Green&title=Acquired+mutation+of+the+tyrosine+kinase+JAK2+in+human+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span></div><div class="casAuthors">Baxter, E. Joanna; Scott, Linda M.; Campbell, Peter J.; East, Clare; Fourouclas, Nasios; Swanton, Soheila; Vassiliou, George S.; Bench, Anthony J.; Boyd, Elaine M.; Curtin, Natasha; Scott, Mike A.; Erber, Wendy N.; Green, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9464</span>),
    <span class="NLM_cas:pages">1054-1061</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Human myeloproliferative disorders form a range of clonal haematol. malignant diseases, the main members of which are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  The mol. pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders.  We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder.  Methods: We obtained DNA samples from patients with polycythemia vera, essential thrombocythemia, or idiopathic myelofibrosis.  The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both.  Allele-specific PCR, mol. cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients.  Findings: A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythemia vera, 29 (57%) of 51 with essential thrombocythemia, and eight (50%) of 16 with idiopathic myelofibrosis.  The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the neg. regulatory JH2 domain, and is predicted to dysregulate kinase activity.  It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells.  The mutation was present in all erythropoietin-independent erythroid colonies.  Interpretation: A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder.  Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biol. feature of these disorders.  Relevance to practice: Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cc-kg2leZrVg90H21EOLACvtfcHk0liPoAY53K-3ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D&md5=3c9dc565a1986a47d12e4bccd8c8cc1a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2971142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252971142-9%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DAcquired%2520mutation%2520of%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520human%2520myeloproliferative%2520disorders%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1054%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Levine, R. L.</span><span> </span><span class="NLM_article-title">Mechanisms of mutations in myeloproliferative neoplasms</span> <span class="citation_source-journal">Best Pract. Res. Clin. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">â</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.beha.2009.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19959098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFagsbzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=489-494&author=R.+L.+Levine&title=Mechanisms+of+mutations+in+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of mutations in myeloproliferative neoplasms</span></div><div class="casAuthors">Levine, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-494</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, a series of studies have provided genetic insight into the pathogenesis of myeloproliferative neoplasms (MPNs).  It is now known that JAK2V617F mutations are present in 90% of patients with polycythemia vera (PV), 60% of patients with essential thrombocytosis (ET) and 50% of patients with myelofibrosis (MF).  Despite the high prevalence of JAK2V617F mutations in these three myeloid malignancies, several questions remain.  For example, how does one mutation contribute to the pathogenesis of three clin. distinct diseases, and how do some patients develop these diseases in the absence of a JAK2V617F mutation Single nucleotide polymorphisms at various loci and somatic mutations, such as those in MPLW515L/K, TET2 and in exon 12 of JAK2, may also contribute to the pathogenesis of these MPNs.  There are likely addnl. germline and somatic genetic factors important to the MPN phenotype.  Addnl. studies of large MPN and control cohorts with new techniques will help identify these factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYBRiT16nHFLVg90H21EOLACvtfcHk0liPoAY53K-3ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFagsbzJ&md5=5d3977a29c4a78be41201ca3a952c75c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2009.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2009.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26atitle%3DMechanisms%2520of%2520mutations%2520in%2520myeloproliferative%2520neoplasms%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2009%26volume%3D22%26spage%3D489%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">QuintÃ¡s-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">â</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quint%C3%A1s-Cardamaauthor=K.+Vaddiauthor=P+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of â¼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0li9hUbW7rHJrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">â</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5882&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shacklefordauthor=H.+Sikanyikauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyik%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">â</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Plo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaincheker, W.</span><span> </span><span class="NLM_article-title">Molecular and genetic bases of myeloproliferative disorders: questions and perspectives</span> <span class="citation_source-journal">Clin. Lymphoma, Myeloma Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S329</span><span class="NLM_x">â</span> <span class="NLM_lpage">S339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=S329-S339&issue=Suppl.3&author=I.+Ploauthor=W.+Vaincheker&title=Molecular+and+genetic+bases+of+myeloproliferative+disorders%3A+questions+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlo%26aufirst%3DI.%26aulast%3DVaincheker%26aufirst%3DW.%26atitle%3DMolecular%2520and%2520genetic%2520bases%2520of%2520myeloproliferative%2520disorders%253A%2520questions%2520and%2520perspectives%26jtitle%3DClin.%2520Lymphoma%252C%2520Myeloma%2520Leukemia%26date%3D2009%26volume%3D9%26issue%3DSuppl.3%26spage%3DS329%26epage%3DS339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4672</span><span class="NLM_x">â</span> <span class="NLM_lpage">4684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-aminopyrazolylpyrimidines+as+potent+inhibitors+of+Trk+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-aminopyrazolylpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520Trk%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4672%26epage%3D4684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Baasner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauke, E.</span><span> </span><span class="NLM_article-title">A new route to the synthesis of 5-fluorouracil</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2FS0022-1139%2800%2982875-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADyaK3cXktVKjs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=417-430&author=B.+Baasnerauthor=E.+Klauke&title=A+new+route+to+the+synthesis+of+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A new route to the synthesis of 5-fluorouracil</span></div><div class="casAuthors">Baasner, B.; Klauke, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-30</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    </div><div class="casAbstract">Starting from tetrafluoropyrimidine, selective F-Cl exchange reactions and selective hydrogenolysis of the Cl substituents are combined with a hydrolysis reaction to provide a new route to 5-fluorouracil via 4,6-dichloro-2,5-difluoropyrimidine and 4-chloro-2,5-difluoropyrimidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqvX0c_VxMbbVg90H21EOLACvtfcHk0ljJTjm2T7IiLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVKjs7c%253D&md5=1f4ef9f421c7f55fa27de12aca329804</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2800%2982875-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252800%252982875-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaasner%26aufirst%3DB.%26aulast%3DKlauke%26aufirst%3DE.%26atitle%3DA%2520new%2520route%2520to%2520the%2520synthesis%2520of%25205-fluorouracil%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D1989%26volume%3D45%26spage%3D417%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32334</span><span class="NLM_x">â</span> <span class="NLM_lpage">32343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1074%2Fjbc.M803813200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=18775810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32334-32343&author=J.+M.+Gozgitauthor=G.+Bebernitzauthor=P.+Patilauthor=M.+Yeauthor=J.+Wuauthor=N.+Suauthor=T.+Wangauthor=S.+Ioannidisauthor=A.+M.+Daviesauthor=D.+Huszarauthor=M.+Zinda&title=Effects+of+the+JAK2+inhibitor%2C+AZ960%2C+on+Pim%2FBAD%2FBCL-xL+survival+signaling+in+the+human+JAK2+V617F+cell+line+SET-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span></div><div class="casAuthors">Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">32334-32343</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Janus-assocd. kinase 2 (JAK2) V617F mutation is believed to play a crit. role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  We have characterized a novel small mol. JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line.  AZ960 inhibits JAK2 kinase with a Ki of 0.00045 Î¼M in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI50 = 0.025 Î¼M).  AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members.  In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI50 = 0.033 Î¼M) predominately through the induction of mitochondrial-mediated apoptosis.  We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the anti-apoptotic protein BCL-xL.  Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a redn. of BCL-xL protein levels.  Addnl., inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression.  Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser112.  Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype obsd. following JAK2 inhibition.  These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkGcqoxCVmrVg90H21EOLACvtfcHk0liQSupHcXnfmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE&md5=c06798f302c0c0b50d4c763ae5c731c3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803813200%26sid%3Dliteratum%253Aachs%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520the%2520JAK2%2520inhibitor%252C%2520AZ960%252C%2520on%2520Pim%252FBAD%252FBCL-xL%2520survival%2520signaling%2520in%2520the%2520human%2520JAK2%2520V617F%2520cell%2520line%2520SET-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32334%26epage%3D32343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6524</span><span class="NLM_x">â</span> <span class="NLM_lpage">6528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.bmcl.2009.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19857966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6524-6528&author=S.+Ioannidisauthor=M.+L.+Lambauthor=A.+M.+Daviesauthor=L.+Almeidaauthor=M.+Suauthor=G.+Bebernitzauthor=M.+Yeauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Discovery+of+pyrazol-3-ylamino+pyrazines+as+novel+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Davies, Audrey M.; Almeida, Lynsie; Su, Mei; Bebernitz, Geraldine; Ye, Minwei; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6524-6528</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pyridineethyl- and pyrimidineethyl-substituted pyrazoleaminopyrazines such as I (R = Me; X = N) and I (R = H; X = CH) are prepd. as selective JAK2 kinase inhibitors for potential use as anticancer agents; the GI50 values for their JAK2 and JAK3 kinase inhibition are detd.  The activities of selected pyridineethyl- and pyrimidineethyl-substituted pyrazoleaminopyrazines in a functional phosphorylation model in mice and their inhibition of aurora B kinase, cyclin-dependent kinase 2, and TrkA are detd.; the pharmacokinetics and pharmacodynamics of I (R = Me; X = N) and of I (R = H; X = CH) in rats and beagles are also detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1tQ0K-v7orVg90H21EOLACvtfcHk0liQSupHcXnfmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLvE&md5=3029e4300eb84ea19f704264c8753df6</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520pyrazol-3-ylamino%2520pyrazines%2520as%2520novel%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6524%26epage%3D6528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><div class="note"><p class="first last">See also for the use of high versus low ATP concentration</p></div><span class="NLM_contrib-group">Knight, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=A.+Z.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0liQSupHcXnfmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DA.%2BZ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Compound <b>9g</b> displayed good activity in an EPOR Stat5 cellular assay, EC<sub>50</sub> = 0.039 mM. For more details about the assay see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">â</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1016%2Fj.bmcl.2010.01.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=20144546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1669-1673&author=S.+Ioannidisauthor=M.+L.+Lambauthor=L.+Almeidaauthor=H.+Guanauthor=B.+Pengauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Replacement+of+pyrazol-3-yl+amine+hinge+binder+with+thiazol-2-yl+amine%3A+Discovery+of+potent+and+selective+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Almeida, Lynsie; Guan, Huiping; Peng, Bo; Bebernitz, Geraldine; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1669-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thiazol-2-yl amine was identified as an isosteric replacement for pyrazol-3-yl amine during the efforts to identify potent and selective JAK2 inhibitors.  The rationale, synthesis and biol. evaluation of several analogs I (X = N, CH; R1 = MeO, 4-morpholinyl, 4-methyl-1-piperazinyl; R2 = H, F; R3 = Me, CN) is reported, along with the in vivo evaluation of the lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4-bwWDreyrVg90H21EOLACvtfcHk0lgLK7JdBU-ZRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D&md5=a9b1f0cdc19311aca0a314325a1cbc56</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.091%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DReplacement%2520of%2520pyrazol-3-yl%2520amine%2520hinge%2520binder%2520with%2520thiazol-2-yl%2520amine%253A%2520Discovery%2520of%2520potent%2520and%2520selective%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1669%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Guan, H.; Hayter, B. R.; Huang, S.; Ioannidis, S.; Johannes, J.; Lamb, M.; Peng, B.; Yang, B.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer.</span> WO2008132502,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Guan&author=B.+R.+Hayter&author=S.+Huang&author=S.+Ioannidis&author=J.+Johannes&author=M.+Lamb&author=B.+Peng&author=B.+Yang&title=Preparation+of+pyrazolyl-amino-substituted+pyrimidines+and+their+use+for+the+treatment+of+cancer."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520pyrazolyl-amino-substituted%2520pyrimidines%2520and%2520their%2520use%2520for%2520the%2520treatment%2520of%2520cancer.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1182%2Fblood-2005-02-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=15831699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSmsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=996-1002&author=T.+J.+Boggonauthor=Y.+Liauthor=P.+W.+Manleyauthor=M.+J.+Eck&title=Crystal+structure+of+the+Jak3+kinase+domain+in+complex+with+a+staurosporine+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog</span></div><div class="casAuthors">Boggon, Titus J.; Li, Yiqun; Manley, Paul W.; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">996-1002</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Jak (Janus kinase) family nonreceptor tyrosine kinases are central mediators of cytokine signaling.  The Jak kinases exhibit distinct cytokine receptor assocn. profiles and so transduce different signals.  Jak3 expression is limited to the immune system, where it plays a key role in signal transduction from cytokine receptors contg. the common gamma chain, Î³c.  Patients unable to signal via Î³c present with severe combined immunodeficiency (SCID).  The finding that Jak3 mutations result in SCID has made it a target for development of lymphocyte-specific immunosuppressants.  Here, we present the crystal structure of the Jak3 kinase domain in complex with staurosporine analog AFN941.  The kinase domain is in the active conformation, with both activation loop tyrosine residues phosphorylated.  The phosphate group on pTyr981 in the activation loop is in part coordinated by an arginine residue in the regulatory C-helix, suggesting a direct mechanism by which the active position of the C-helix is induced by phosphorylation of the activation loop.  Such a direct coupling has not been previously obsd. in tyrosine kinases and may be unique to Jak kinases.  The crystal structure provides a detailed view of the Jak3 active site and will facilitate computational and structure-directed approaches to development of Jak3-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-bnI3-sVjLVg90H21EOLACvtfcHk0lgLK7JdBU-ZRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSmsr4%253D&md5=12f87a37a495559c6e34dde019578371</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-02-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-02-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520the%2520Jak3%2520kinase%2520domain%2520in%2520complex%2520with%2520a%2520staurosporine%2520analog%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D996%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hedvat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowolik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">â</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=487-497&author=M.+Hedvatauthor=D.+Huszarauthor=A.+Herrmannauthor=J.+M.+Gozgitauthor=A.+Schroederauthor=A.+Sheehyauthor=R.+Buettnerauthor=D.+Proiaauthor=C.+M.+Kowolikauthor=H.+Xinauthor=B.+Armstrongauthor=G.+Bebernitzauthor=S.+Wengauthor=L.+Wangauthor=M.+Yeauthor=K.+McEachernauthor=H.+Chenauthor=D.+Morosiniauthor=K.+Bellauthor=M.+Alimzhanovauthor=S.+Ioannidisauthor=P.+McCoonauthor=Z.+A.+Caoauthor=H.+Yuauthor=R.+Joveauthor=M.+Zinda&title=The+JAK2+inhibitor+AZD1480+potently+blocks+Stat3+signaling+and+oncogenesis+in+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedvat%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DA.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DProia%26aufirst%3DD.%26aulast%3DKowolik%26aufirst%3DC.%2BM.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DArmstrong%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DMcCoon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DThe%2520JAK2%2520inhibitor%2520AZD1480%2520potently%2520blocks%2520Stat3%2520signaling%2520and%2520oncogenesis%2520in%2520solid%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and in vivo activity of a new class of pyrazolylamino quinazolines as selective inhibitors of Aurora B Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2213</span><span class="NLM_x">â</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061335f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2213-2224&author=A.+A.+Mortlockauthor=K.+M.+Footeauthor=N.+M.+Heronauthor=F.+H.+Jungauthor=G.+Pasquetauthor=J-J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=C.+De+Saviauthor=N.+J.+Robertsauthor=T.+Johnsonauthor=C.+B.+Doussonauthor=G.+B.+Hillauthor=D.+Perkinsauthor=G.+Hatterauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=C.+Crafterauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwellauthor=L.+Khatriauthor=M.+C.+Bradyauthor=S.+Kearneyauthor=D.+McKillopauthor=S.+Rheadauthor=T.+Parryauthor=S.+Green&title=Discovery%2C+synthesis%2C+and+in+vivo+activity+of+a+new+class+of+pyrazolylamino+quinazolines+as+selective+inhibitors+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm061335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061335f%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLohmann%26aufirst%3DJ-J.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DHatter%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DBrady%26aufirst%3DM.%2BC.%26aulast%3DKearney%26aufirst%3DS.%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DRhead%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520activity%2520of%2520a%2520new%2520class%2520of%2520pyrazolylamino%2520quinazolines%2520as%2520selective%2520inhibitors%2520of%2520Aurora%2520B%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2213%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zage, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweidler-McKay, P. A.</span><span> </span><span class="NLM_article-title">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">â</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1011319&amp;key=10.1158%2F1535-7163.MCT-09-0036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1011319&amp;key=19509272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1011319&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1818-1827&author=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=D.+Whitstonauthor=Z.-Y.+Liuauthor=E.+Hoffmannauthor=T.+Wangauthor=J.+L.+Brownauthor=K.+Websterauthor=C.+Omerauthor=P.+E.+Zageauthor=L.+Zengauthor=P.+A.+Zweidler-McKay&title=Identification+and+preclinical+characterization+of+AZ-23%2C+a+novel%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+Trk+kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span></div><div class="casAuthors">Thress, Kenneth; MacIntyre, Terry; Wang, Haiyun; Whitston, Dave; Liu, Zhong-Ying; Hoffmann, Ethan; Wang, Tao; Brown, Jeffrey L.; Webster, Kevin; Omer, Charles; Zage, Peter E.; Zeng, Lizhi; Zweidler-McKay, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (TrkA, TrkB, and TrkC) are receptor tyrosine kinases that, along with their ligands, the neurotrophins, are involved in neuronal cell growth, development, and survival.  The Trk-neurotrophin pathway may also play a role in tumorigenesis through oncogenic fusions, mutations, and autocrine signaling, prompting the development of novel Trk inhibitors as agents for cancer therapy.  This report describes the identification of AZ-23, a novel, potent, and selective Trk kinase inhibitor.  In vitro studies with AZ-23 showed improved selectivity over previous compds. and inhibition of Trk kinase activity in cells at low nanomolar concns.  AZ-23 showed in vivo TrkA kinase inhibition and efficacy in mice following oral administration in a TrkA-driven allograft model and significant tumor growth inhibition in a Trk-expressing xenograft model of neuroblastoma.  AZ-23 represents a potent and selective Trk kinase inhibitor from a novel series with the potential for use as a treatment for cancer. [Mol Cancer Ther 2009;8(7):1818-27].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2uvCSID5vbVg90H21EOLACvtfcHk0lhP_iM0uJ4JOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D&md5=8501f75147407ee64920fd4f5e733536</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0036%26sid%3Dliteratum%253Aachs%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.-Y.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DWebster%26aufirst%3DK.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DZage%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZweidler-McKay%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520and%2520preclinical%2520characterization%2520of%2520AZ-23%252C%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520Trk%2520kinase%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1818%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Quentmeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaborski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H. G.</span><span> </span><span class="NLM_article-title">JAK2V617 tyrosine kinase mutation in cell lines derived from myeloproliferative disorders</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=471-476&author=H.+Quentmeierauthor=R.+A.+MacLeodauthor=M.+Zaborskiauthor=H.+G.+Drexler&title=JAK2V617+tyrosine+kinase+mutation+in+cell+lines+derived+from+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuentmeier%26aufirst%3DH.%26aulast%3DMacLeod%26aufirst%3DR.%2BA.%26aulast%3DZaborski%26aufirst%3DM.%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DJAK2V617%2520tyrosine%2520kinase%2520mutation%2520in%2520cell%2520lines%2520derived%2520from%2520myeloproliferative%2520disorders%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rehemtulla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegman, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contag, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brian D Ross, B. D.</span><span> </span><span class="NLM_article-title">Rapid and quantitative assessment of cancer treatment response using <i>in vivo</i> bioluminescence imaging</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=491-495&author=A.+Rehemtullaauthor=L.+D.+Stegmanauthor=S.+J.+Cardozoauthor=S.+Guptaauthor=D.+E.+Hallauthor=C.+H.+Contagauthor=B.+D.+Brian+D+Ross&title=Rapid+and+quantitative+assessment+of+cancer+treatment+response+using+in+vivo+bioluminescence+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRehemtulla%26aufirst%3DA.%26aulast%3DStegman%26aufirst%3DL.%2BD.%26aulast%3DCardozo%26aufirst%3DS.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%2BE.%26aulast%3DContag%26aufirst%3DC.%2BH.%26aulast%3DBrian%2BD%2BRoss%26aufirst%3DB.%2BD.%26atitle%3DRapid%2520and%2520quantitative%2520assessment%2520of%2520cancer%2520treatment%2520response%2520using%2520in%2520vivo%2520bioluminescence%2520imaging%26jtitle%3DNeoplasia%26date%3D2000%26volume%3D2%26spage%3D491%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>QUANTA, Release 2000, <span class="NLM_publisher-loc">San Diego</span>: <span class="NLM_publisher-name">Accelrys Inc</span>.,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA%2C+Release+2000%2C+San+Diego%3A+Accelrys+Inc.%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Collaborative Computational Project Number 4</span><span> </span><span class="NLM_article-title">The <i>CCP</i>4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project+Number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lucet, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span> </span><span class="NLM_article-title">The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=176-183&author=I.+S.+Lucetauthor=E.+Fantinoauthor=M.+Stylesauthor=R.+Bamertauthor=O.+Patelauthor=S.+E.+Broughtonauthor=M.+Walterauthor=C.+J.+Burnsauthor=H.+Treutleinauthor=A.+F.+Wilksauthor=J.+Rossjohn&title=The+structural+basis+of+Janus+kinase+2+inhibition+by+a+potent+and+specific+pan-Janus+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucet%26aufirst%3DI.%2BS.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DBamert%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DBroughton%26aufirst%3DS.%2BE.%26aulast%3DWalter%26aufirst%3DM.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DRossjohn%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520basis%2520of%2520Janus%2520kinase%25202%2520inhibition%2520by%2520a%2520potent%2520and%2520specific%2520pan-Janus%2520kinase%2520inhibitor%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D176%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>COOT: <span class="NLM_contrib-group">Emsley, P.; Lohkamp, B.; Scott, W.; Cowtan, K.</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span>â <span class="NLM_lpage">501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COOT%3A+Emsley%2C+P.%3B+Lohkamp%2C+B.%3B+Scott%2C+W.%3B+Cowtan%2C+K.Acta+Crystallogr.+2010%2C+D66%2C+486%E2%88%92501."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26jtitle%3DActa%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>AFITT: <span class="NLM_publisher-name">OpenEye Scientific Software, Inc</span>., <span class="NLM_publisher-loc">Santa Fe</span>, <span class="NLM_publisher-loc">NM</span>, <span class="NLM_publisher-loc">USA</span>, <a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AFITT%3A+OpenEye+Scientific+Software%2C+Inc.%2C+Santa+Fe%2C+NM%2C+USA%2C+www.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DOpenEye%2520Scientific%2520Software%252C%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>Refmac v 5.1.17: <span class="NLM_contrib-group">Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span>â <span class="NLM_lpage">255</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Refmac+v+5.1.17%3A+Murshudov%2C+G.+N.%3B+Vagin%2C+A.+A.%3B+Dodson%2C+E.+J.Acta+Crystallogr.+1997%2C+D53%2C+240%E2%88%92255."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26jtitle%3DActa%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">DeLano, W. L.</span><span> </span><span class="NLM_article-title">The PyMOL molecular graphics system</span>; <span class="NLM_publisher-name">DeLano Scientific</span>: <span class="NLM_publisher-loc">San Carlos, CA, USA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span><a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeLano%2C+W.+L.+The+PyMOL+molecular+graphics+system%3B+DeLano+Scientific%3A+San+Carlos%2C+CA%2C+USA%2C+2002%3B+http%3A%2F%2Fwww.pymol.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26atitle%3DThe%2520PyMOL%2520molecular%2520graphics%2520system%26pub%3DDeLano%2520Scientific%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XA4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XA4','PDB','2XA4'); return false;">PDB: 2XA4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ','PDB','1YVJ'); return false;">PDB: 1YVJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a href="/doi/suppl/10.1021/jm1011319">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54318"></div></div></div></div></div><hr /></hr><p class="last">Figures S1âS4. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1011319/suppl_file/jm1011319_si_001.pdf">jm1011319_si_001.pdf (426.79 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1011319&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-1%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm1011319%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1011319" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679949338864d1cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
